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ABSTRACT 
INVESTIGATION ON THE FACTORS IMPACTING THE BIOACCESSIBILITY 
OF OIL-SOLUBLE VITAMINS: FOOD MATRIX EFFECTS 
 
May 2021 
YUNBING TAN, B.A., SOUTH CHINA UNIVERSITY OF TECHNOLOGY 
M.A., SOUTH CHINA UNIVERSITY OF TECHNOLOGY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Distinguished Professor David J. McClements 
 
Food, nutrition, and pharmaceutical scientists are trying to elucidate the major 
factors impacting the bioavailability of macronutrients (e.g., lipids), micronutrients (e.g., 
vitamins), and nutraceuticals (e.g., carotenoids) so as to improve their efficacy. Currently, 
however, there is a limited understanding of how food matrix effects impact nutrient 
digestion and bioavailability. In this thesis, the impact of food matrix effects was 
elucidated by systematically examining the influence of several important factors 
(including oil type, oil concentration, droplet size, emulsifier type, and nutrient type) on 
lipid digestion and the bioaccessibility of hydrophobic bioactive agents.  Oil-in-water 
emulsions were used as model foods because their compositions and structures can easily 
be varied. An in vitro gastrointestinal model was used to measure the physicochemical 
and structural properties of the emulsions within the gastrointestinal tract, as well as lipid 
digestion and bioaccessibility. 
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Studies of the impact of oil droplet concentration (2.5 to 20%) showed that complete 
lipid digestion was achieved under fed-state gastrointestinal conditions, but could only be 
observed after a back-titration was performed. This effect was observed all experiments 
where long chain triacylglycerol oils were used. The maximum β-carotene 
bioaccessibility (93.2%) was measured at an intermediate oil level (10%). This effect was 
attributed to the fact that low oil droplet concentrations reduce the solubilization capacity 
of the mixed micelles, whereas high oil droplet concentrations lead to precipitation and 
sedimentation of some of the β-carotene. 
Studies of the impact of oil droplet diameter (0.16, 1.1 and 8.2 μm) on lipid 
digestion and bioaccessibility showed that the extent of lipid digestion fell from around 
117% to 78% as the droplet size was increased (p < 0.001), which was attributed to the 
decrease in specific surface area of the oil droplets. In addition, there was a reduction in 
β-carotene bioaccessibility from 83 to 15% (p < 0.001) with increasing droplet diameter, 
which was mainly linked to a reduction in the amount of hydrophobic carotenoids 
released from the non-digested oil droplets. 
The impact of emulsifier type was also investigated by creating emulsions stabilized 
by synthetic surfactants (Tween 20), natural surfactants (quillaja saponin), proteins 
(caseinate), polysaccharides (gum arabic), or phospholipids (soy lysolecithin). The lipid 
digestion degree was considerably lower for the emulsions stabilized by soy lysolecithin 
(93%) or caseinate (93%), which was attributed to the relatively large droplet size of the 
initial emulsions for lysolecithin (low emulsification ability) and to droplet aggregation in 
the stomach for caseinate (poor gastric stability). The overall bioaccessibility of the b-
carotene increased in the following order: lysolecithin (25%) < gum arabic (51%) < 
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caseinate (55%) < quillaja saponin (56%) < Tween 20 (62%). These effects were mainly 
attributed to reduced digestion (i.e. lysolecithin, and caseinate), the antioxidant activity of 
the emulsifiers (i.e., lysolecithin, and caseinate), or sedimentation promoted by the 
emulsifiers (i.e., lysolecithin). This series of experiments underlined the critical 
importance of considering the droplet size in foods before, during, and after 
gastrointestinal digestion when developing emulsified foods loaded with carotenoids. 
The impact of oil digestibility was also investigated by comparing the 
bioaccessibility of oil-soluble vitamins encapsulated in nanoemulsions made from 
digestible or indigestible oils.  The bioaccessibility of vitamin D was considerably lower 
when dissolved in an indigestible oil than in a digestible oil. For the nanoemulsions 
prepared with digestible oils, the vitamin bioaccessibility increased to a maximum value 
after around 30 minutes, but then decreased during the following 24 h. This effect was 
attributed to an initial solubilization of the vitamin within the mixed micelles, followed 
by their precipitation during prolonged incubation. 
The effects of calcium levels (0.525-10 mM) on lipid digestion and bioaccessibility 
was then investigated because foods often contain different amounts of this 
micronutrient. Even though the lipid phase was completely digested in all samples, the 
bioaccessibility of β-carotene decreased with increasing calcium levels: from 65.5% at 
0.525 mM Ca2+ to 23.7% at 10 mM Ca2+. This effect was attributed to the ability of the 
calcium ions to precipitate the β-carotene-loaded mixed micelles by forming insoluble 
calcium soaps. 
The addition of chitosan (0.1-0.5%) did not influence the lipid digestion, despite 
causing severe droplet flocculation in the small intestine phase. However, its presence did 
 
   vi 
decrease the bioaccessibility of vitamin D by about 37%, irrespective of the chitosan 
concentration used (0.1-0.5%). It was proposed that the cationic chitosan may have 
bound and precipitated some of the anionic vitamin-loaded mixed micelles. 
The impact of oil droplet size was further investigated for different oil-soluble 
vitamins (A, D, E). In general, similar trends were observed for all vitamins but there 
were some differences. The vitamins with higher hydrophobicity (vitamin A palmitate 
and vitamin E acetate) were mainly located in the inner core of the oil droplets, which 
retarded their release. The vitamins with larger molecular dimensions, such as vitamin E 
acetate, could not be fully accommodated in small hydrophobic domains within the 
mixed micelles, which reduced their bioaccessibility. Moreover, there was extensive 
hydrolysis of vitamin A palmitate under GIT conditions, whereas vitamin E acetate only 
exhibited slight hydrolysis. 
In summary, food matrix effects were shown to have a major impact on the 
bioaccessibility of fat-soluble bioactive agents. These effects should therefore be 
considered when designing functional food products and when making nutritional 
recommendations. More research is clearly needed, using both in vitro and in vivo 
methods, to establish the influence of specific food components on the bioaccessibility of 
lipids, vitamins, and nutraceuticals in real food products. 
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Food, nutrition, and pharmaceutical scientists are researching the factors that impact 
the bioavailability of bioactive agents, such as nutraceuticals, vitamins, minerals, and 
pharmaceuticals. Fat-soluble bioactive agents are often dissolved in a lipid phase, which 
may then be converted into lipid droplets, prior to or after ingestion. Before ingestion, 
homogenization is usually carried out using mechanical homogenizers, whereas after 
ingestion it is carried out by physical and chemical processes occurring inside the body. 
The bioactive-loaded lipid droplets formed are digested by enzymes (gastric and 
pancreatic lipases) inside the small intestine, which releases the bioactives, thereby 
allowing them to be incorporated into the mixed micelles formed by free fatty acids 
(FFA), monoglycerides, phospholipids, and bile salts. The bioactive-loaded mixed 
micelles then migrate to the periphery of the epithelium cells where they can be absorbed. 
The fraction of ingested bioactive agents that ends up within the mixed micelles is 
referred to as the bioaccessibility.  
For strongly hydrophobic bioactives, like fat-soluble vitamins and carotenoids, the 
bioaccessibility is often the rate-limiting step that determines their overall bioavailability 
1. Consequently, many researchers have been trying to establish the major factors that 
impact the bioaccessibility of these substances 2. Both in vitro and in vivo methods have 
been developed to measure the bioaccessibility of hydrophobic bioactive agents. In vitro 
digestion models are often preferred because they are relatively simple and inexpensive 
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to perform and allow researchers to rapidly screen many different factors affecting 
bioaccessibility. Moreover, they can provide useful insights into the physicochemical 
mechanisms involved and do not have the ethical concerns associated with animal or 
human feeding studies. 
Many recent studies have shown that food matrix effects may increase, decrease, or 
have no impact on the bioaccessibility of hydrophobic bioactives. An improved 
understanding of the impact of food matrix effects may therefore lead to the formulation 
of functional foods with higher and more consistent biological activities, as well as to the 
development of more accurate nutritional guidelines for dietary supplementation. In this 
article, we highlight the importance of food matrix effects by describing some of our 
recent research on the impact of specific food components on the bioaccessibility of fat-
soluble vitamins and nutraceuticals using an in vitro gastrointestinal model. Most of these 
studies were carried out using the recently updated standardized gastrointestinal model 
known as the INFOGEST method 3. This method was established and validated by a 
consortium of international scientists with the aim of producing a simulated 
gastrointestinal model that is relatively straightforward to carry out, leads to reproducible 
results, and can be compared between different research laboratories.  
1.2 Specific objectives 
1) In the model emulsion system, the impact of oil droplet characteristics, such as oil 
concentration, oil droplet size, emulsifier type, and oil digestibility, on lipid digestion and 
nutraceutical bioaccessibility were measured. Specifically, oil concentration ranged from 
2.5 to 20%; oil droplet size was in the range from 0.1 to 10 μm; five kinds of food-grade 
emulsifier was selected representing different classes: synthetic surfactants (Tween 20), 
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natural surfactants (quillaja saponin), proteins (caseinate), polysaccharides (gum arabic), 
and phospholipids (soy lysolecithin); oil digestibility was represented by corn oil 
(digestible oil), mineral oil (indigestible oil), and their mixture (1:1 digestible oil and 
indigestible oil). 
2) The influence of the aqueous phase components on lipid digestion and bioactive 
bioaccessibility was also measured by adding minerals or dietary fibers. Specifically, the 
impact of calcium level (0.525 to 10 mM) and chitosan (0.1-0.5%) were assessed. 
  
 




In the concern of health and wellness, micronutrient consumption such as vitamins 
and minerals are extensively valued all over the world. Especially, the research on 
vitamins have been one of the hottest topics in the field of nutrition and health. Vitamins 
are a group of organic components that are essential to several biochemical functions for 
human health, the deficiency of which are highly correlated with a wide range of diseases 
or even life threat, to name a few, night blindness, beriberi, pellagra, scurvy, rickets and 
osteomalacia. Recent research further showed that vitamins could also be used as 
nutritional strategies against some chronic disease (e.g. coronary heart disease, cancer 
and macular degeneration) as well as aging related issues 4-7. Till now, vitamin deficiency 
or insufficiency is prevalent in a wide range of populations. The onset of the nutrition 
deficiency derives from myriad of causes. Intrinsically, it might be due to higher 
requirement of the vitamins or inefficient absorption. For example, woman who are 
pregnant and lactating need a higher uptake of vitamins. People, such as infant, young 
children and patients with gastrointestinal disorder (e.g. biliary cirrhosis, cystic fibrosis), 
might absorb these vitamins inefficiently 8, 9. Extrinsically, diet habits, cloth preference, 
local environments and climates also greatly influence the synthesis and absorption of 
vitamins, and consequently reduce their concentration in the body. Initiatives to avoid 
vitamin deficiency or insufficiency have been propagated extensively. Since these 
vitamins could not be synthesized at all or insufficiently in vivo, diet supplementation is 
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necessary. With the discovery of synthetic vitamins from late 1930s 10, vitamin 
supplementation has been widely adapted globally as useful tools to treat vitamin 
deficiency. Recently, strategies to improve the adsorption efficacy of the vitamins 
through oral administration has attracted more interest in the fields of food, nutrition and 
pharmaceutics. 
In particular, oil soluble vitamins (OSVs), such as vitamin A, D, E and K, are highly 
investigated. The hydrophobicity of the OSVs negatively contributes to their application 
into food products as well as their absorption in the gastrointestinal tract. Therefore, the 
OSVs are dissolved in the hydrophobic areas of the food matrix (such as oils, fats, 
insoluble starches and proteins) or into some colloids formed by amphiphilic components 
(phospholipids, proteins). During the digestion process, the OSVs are released from its 
food matrix carriers into the mixed micelles produced from the phospholipid, cholesterol, 
bile salts and the lipid digestion products (such as free fatty acids, monoacylglycerols) in 
the intestinal phase. The mixed micelles transfer the loaded OSVs through the mucus 
layer lining around the epithelium cells where the absorption takes place. Therefore, a 
higher fraction of OSVs into the micelles, which is also referred as bioaccessibility, 
generally contributes to higher absorption in the intestine 11. In most cases, 
bioaccessibility could be limiting factors for the overall bioavailability, which further 
influence the bioactivities of OSVs in vivo. 
The composition and structure of the food matrix that these OSVs are vehiculated or 
consumed varied greatly among different products. In reality, the OSVs encapsulated 
products include dairy, plant-based milk, juice, functional beverage, dressings etc. These 
products cover a wide range of oil concentration (from 0 to 20%) and oil composition. 
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Different emulsifiers might be used in these products to stabilize the oil droplets. To 
ensure product stability and the sensory properties, the aqueous phase composition might 
include proteins, polysaccharides, minerals and others. These food matrix effects could 
greatly change their absorption properties (bioaccessibility and bioavailability) in either 
positive or negative means 12, 13. For example, the application of a nanoemulsion delivery 
system increases the bioavailability of drugs or nutraceuticals and provides rapid onset 
for treatments 14, 15. However, the addition of calcium chloride might greatly reduce the 
bioaccessibility of the β-carotene in an oil in water emulsion system 16. In fact, the 
bioaccessibility of the encapsulated nutraceuticals varied from 10 to 80% through 
modification of the food matrix systems 17, 18. In another word, improvement of the 
bioavailability of the OSVs through careful design of the food system could be a potential 
approach to improve their absorption efficiency against of worldwide OSVs deficiency. 
Besides, it could maximize the nutritional value of the food products. 
2.2 Oil soluble vitamins introduction 
2.2.1 Vitamin A and pro-vitamin A 
Vitamin A was firstly discovered at the beginning of 19th century as essential 
elements for health and survival 19. Back then when there was lacking knowledge in 
functional components, the history of vitamin A was well established from the use of 
liver extract enriched with vitamin A in the cure of night blindness 20. Later in 1930s, 
scientists successfully isolated and identified the chemical structure of β-carotene and 
retinol 21. Till now, there are continuous research on the subject of vitamin A in the fields 
of nutrition, pharmaceutics, biology, and food science. According to these research, 
vitamin A is important for growth, immune function, gene expression and vision 22. 
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Vitamin A deficiency could lead to some eye diseases, such as night blindness and 
xerophtalmia, and skin damage such as hyperkeratosis and phrynoderma 23, 24. Besides, it 
has shown therapeutic effects on other eye discomfort, such as corneal xerosis, 
keratomalacia, anemia, leukopenia 24. Since vitamin A cannot synthesis in vivo, the 
deficiency mostly comes from the lack of supplementation from foods due to 
undernutrition or unbalanced diets 25. For example, populations such as women during 
pregnancy and breastfeeding, children, patients with digestive dysfunction such as cystic 
fibrosis are at high risk with vitamin A deficiency 26. Regionally, it happens mostly in 
developing countries such as Africa and some Asian areas 27. In nature, there are lots of 
foods rich in vitamin A both from animal and vegetable origins, such as animal liver, 
carrot, sweet potato etc. These foods could be good source for vitamin A 
supplementation. On the other hand, the vitamin A fortified products are also observed in 
oils, margarine, cereal flours, sugar and others 28. Chemically, vitamin A family could be 
further classified as preformed vitamin A from the retinoids such as retinol, retinol esters, 
retinal, and retinoic acid, and as provitamin A from carotenoids such as β-carotene. 
Usually, animal foods contain vitamin A as retinol ester, whereas vegetables contain 
mostly carotenoids such β-carotene. Different absorption paths on the intestinal cells are 
observed in these two classes of vitamin A 29. Since retinol is the active form as vitamin 
A, the β-carotene will convert to retinol in the intestinal cells to exert vitamin A activity 
22. Interestingly, β-carotene is equal to only half retinol in weight when dissolved in oil, 
which might lead to less efficiency as vitamin A supplementation 25, 30. Nevertheless, 
large consumption of carotenoids from vegetable origins makes it a main source of 
vitamin A. 
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Table 2.1 The physiochemical properties of oil soluble vitamins 








Retinol 286.5  63.5 5.68 0.671 
β-Carotene 536.9  176-184 17.62 0.6 
Ergocalciferol 
 
396.6  115-117 8.89 50  
Cholecalciferol 384.6  84.5 7.5 1.3×10-5 
(estimate) 
α-Tocopherol 430.7  2.5-3.5 12.2 (estimate) 1.9×10-6 
(estimate) 
The data were obtained from National Center for Biotechnology Information, U.S. 
National Library of Medicine. 
 
The structure of retinol is formed by a beta-ionone ring attached with an isoprenoid 
chain, which is also called as retinyl group, whereas β-carotene can be seen as two retinyl 
groups connected through the isoprenoid tails. This retinyl structure contains an electron-
dense region which could scavenges some reactive species (such as free radicals) to 
release oxidative stress, which is vital for vitamin A activity 31. In addition, the multiple 
conjugated double bonds from the joint retinyl groups of β-carotene greatly promote its 
radical scavenging properties 32. This antioxidant activity of vitamin A comes with its 
liability to environmental conditions such as such as light, heat, transition metals and 
oxidants that could trigger oxidation degradation and or isomerization 33, 34. The use of 
vitamin A ester such retinol palmitate could be a solution for the chemical sensitivity, 
which is reported as more stable than free retinol 33 and greatly promotes its application 
in food supplementation. Nevertheless, precautions are recommended to protect vitamin 
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A during production and storage so as to preserve the bioactive compounds 34, 35. The 
retinyl structure also results in poor water solubility but high solubility in lipophilic 
solvents such as oil and alkane (Table 2.1). Therefore, strategies are often needed to 
fortify vitamin A into the food matrix, especially where there are no lipophilic 
components 31, 36. Besides, vitamin A shows a yellow or orange color which might 
influence the visual appearance of the food product. Further information of the chemical 
properties of vitamin A is listed in Table 2.1. 
2.2.2 Vitamin D 
The discovery of vitamin D could be long traced back to the investigation on rickets 
at the beginning of 19th when Sir Edward Mellanby found out that the combination of 
sunlight and cod liver oil diet cured dogs of rickets shortly 37. Through investigation on 
the cod liver, McCollum successfully differentiated vitamin D after heating and 
oxygenation against fractures from the vitamin A against night blindness 38. Later in 
1930s, 7-dehydrocholesterol, the precursor of vitamin D was eventually isolated from 
animal skin by Windaus et al. 39, and the role of UV in the conversion of this chemical to 
vitamin D was also established. Since then, previous puzzles regarding the geographic 
difference in the rickets incidence was well solved in relation to role of sunlight 
exposures for vitamin D synthesis. There is more research regarding vitamin D in both 
nutritional and pharmaceutical areas. 
In addition to the therapeutic effects on rickets and fractures, the vital role of 
vitamin D on skeletal functions was more obvious when further connection between 
vitamin D and osteomalacia in adult was discovered. Further investigation showed that 
vitamin D is responsible form calcium and phosphorus absorption, and bone 
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mineralization 40, 41. Besides its effect on bone health, vitamin D is also correlated with 
non-skeletal functions. There are several publications regarding the protective effect of 
vitamin D on some chronic disease such as cancers, diabetes and cardiovascular disease 
42-44. A claim has been made that the non-skeletal effects is correlated with calcium 
absorption 44. Further research might be needed to understand the mechanism. The fact 
that less incidence of vitamin D deficiency occur in sunny areas is due to that vitamin D 
(specially, vitamin D3) could be synthesized naturally in skin cells by UV radiation. 
Consequently, it is more severe in regions that are lacking of sunlight 45. However, this 
does not guarantee the disappearance of vitamin D deficiency in sunny areas. In fact, 
vitamin D deficiency is prevalent in a wide range of countries, which might constitute 
pandemics 46, 47. Risk populations include pregnant women, children, people of color, and 
especially people who did not get enough sun exposure 47. Nevertheless, besides low 
sunlight radiation, the cause of vitamin D deficiency due to insufficient sunlight exposure 
might be varied, such as risk for skin cancer and cloth habit 47. In particular, the prevalent 
use of sun scream in modern life could also be leading cause, which needs further 
attention. Alternatively, vitamin D deficiency could also come from inappropriate dietary 
consumption 41. Several reports showed that vitamin D rich diets could be an important 
approach against the deficiency 41.  
Chemically, vitamin D are a general term for several types of secosteroids, including 
vitamin D2 and D3, as well as D1, D4, and D5. Naturally, vitamin D commonly comes in 
vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Despite the subtle 
structurally difference in the side chain, vitamin D2 and D3 behave in high accordance 
both chemically and physiologically 47, 48. As source of nutritional supplementation, both 
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vitamin D2 and D3 are rapidly absorbed in small intestinal phase through passive 
absorption with involvement of protein transporters (i.e. NPC1L1, SR-BI and CD36) 49, 
50. After absorption, the vitamin D undergoes a couple transformations in the body in 
order to achieve its physiological functions, such as hydroxylation in the liver tissues to 
25-hydroxyvitmain D (25(OH)D), then further hydroxylation in kidneys to 1,25-
dihydroxyvitamin D (1,25(OH)2D) which is also named as vitamin D hormone 48. Report 
shows that both vitamin D2 and D3 are equally effective as vitamin D source that are 
converted into 1,25(OH)2D for the bioactivity 51. In human body, there a dynamic 
mechanism against the scenarios in excessive absorption of vitamin D. Under regulation 
of parathyroid hormone and other causes, the human body controls the blood level of 
total 1,25(OH)2D under a good kinetic equilibrium 47, 48. The source of vitamin D in 
nature could be found in various species. Especially, vitamin D2 is found in plants, such 
as mushrooms, while vitamin D3 is mostly observed in animal foods including fish, meat 
and dairy products 41. These products are equally good source for vitamin D 
supplementation. Recently, the vitamin D fortification strategies have been widely 
applied in many food products, such as milk, juice, margarines, cheese, bread and eggs, 
and are generally preferred by consumers 41, 52, 53. In production of the vitamin D fortified 
foods, its physiochemical properties should be considered. Aside from high oil solubility 
and low water solubility, vitamin D is sensitive to light, oxidation and high temperature 
on account of its double bond structure 54. Besides, vitamin D is colorless and 
transparent, which is beneficial for product design. 
2.2.3 Vitamin E 
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Vitamin E is a generic term of four types of tocopherols (α, β, γ, δ forms) and four 
types of tocotrienols (α, β, γ, δ forms). The general structure of vitamin E comprises of a 
chromane ring and a hydrophobic side chain. The structural difference in the side chain 
classifies vitamin E into tocopherols and tocotrienols, with saturated isoprenoid side 
chains as tocopherol and unsaturated ones as tocotrienols. The attachments in the 
chromane ring by hydroxyl or methyl groups further distinguish different types of 
tocopherols or tocotrienols. The attached hydroxyl groups could donate a hydrogen atom, 
which constitute the radical scavenging ability of vitamin E. Amongst, α-tocopherol 
shows the highest bioactivity as vitamin E. Recently, more research shows promising role 
of tocotrienols as antioxidants with anti-inflammatory, antidiabetic, anti-angiogenic 
effects 55, 56. 
Vitamin E is essential for human immune systems, reproduction functions, nerve 
systems, cellular signaling and gene expression 57-59. Besides, vitamin E is well known 
for its antioxidant activity, which is widely used in food, nutrition, pharmaceutics and 
cosmetic industries 60. Its antioxidant activity derives from high radical scavenging 
abilities, which could be used to effectively retard oxidation reaction in food products 
(i.e. oils and meats) and also relieve the oxidation stress in vivo 32, 59, 61, 62. Till now, 
vitamin E has shown therapeutic effects against many chronic diseases, such as cancer, 
cardiovascular disease, macular degeneration 4, 7, 63. In fact, human body needs a 
comparatively high amount of vitamin E (i.e. 15 mg/d of RDA for adult). However, 
vitamin E deficiency is not common due to its widely distribution in many food sources, 
and it happens mostly in premature infants and people with fat malabsorption 5, 24. 
Vitamin E is found rich in several food sources, such as vegetable oils, seeds and nuts, 
 
   13 
and is also found in fruits and seafoods 64. However, due to preference of low-fat diet and 
vegetable oils (contain mostly γ-tocopherol), insufficient absorption of vitamin E under 
the recommended level are observed in many countries 64, 65. Therefore, vitamin E 
fortification products are also widely available, including cereals, dairy products, 
beverages and infant formulas 66-69. Some vitamin E enriched capsules are also available 
for nutritional supplementation. Similarly, precaution is needed to preserve the 
antioxidant activity of vitamin E in the product. Vitamin E is unstable in various 
oxidation environments, and lead to significant loss of the bioactive components. 
Reportedly, it is highly susceptible to photodegradation, heat and oxygen 70, 71. 
Accordingly, the esterification form of vitamin E, especially tocopherol acetate, is often 
used due to its higher oxidation stability as well as equivalent intestinal absorption 72, 73. 
Other physical properties should also be considered during the product development. 
With a low melting point, it displays liquid condition similar to viscos oil with slight 
yellow color originated from the oxidation products at room temperature. 
As OSV, vitamin E is dissolved in the lipid phase of the foods, and therefore its 
gastrointestinal fate is correlated with that of lipid surroundings. When it is released from 
the digested oils, vitamin E is absorbed in the small intestine phase through passive 
diffusion, and then it binds to low-density β-lipoproteins for circulation 74. The 
absorption process requires the involvements of some membrane proteins, which are also 
used for absorption of other vitamins (vitamin D or carotenoid) 64. Therefore, competitive 
absorption might occur when nutraceuticals are consumed together. Asides from this, the 
absorption is also influenced by the food matrix effects and solubility in mixed micelles, 
so the efficiency of absorption varies in the range of 10% to 79% 73. There are several 
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reports showing improved bioavailability of vitamin E through medication of the food 
matrix systems 75, 76. 
2.3 Gastrointestinal digestion and bioavailability 
The fortification strategies of the OSVs have been widely applied in many products 
(foods, capsules, and pills) as prevention measures against various types of acute or 
chronic diseases 77. However, the nutritional efficiency of these products could vary 
greatly when different delivery systems and precautions are used. In terms, they might be 
greatly different in encapsulation efficiency, storage stability, and bioavailability for the 
OSVs. Especially, bioavailability, which reflects the efficiency of these systems to be 
utilized by the body, is one of important evaluation references. To further understand the 
concept of bioavailability, it is important to first explain the digestive process of the food 
products with OSVs encapsulation. Since OSVs are generally dissolved in oil medium to 
improve its solubility for incorporation into food products, fate of encapsulated OSVs 
during the upper gastrointestinal process is also highly correlated with lipid digestion 
process. In addition, the oil medium could act as protective barrier during storage against 
chemical loss, such as oxidation and isomerization. The digestion process of the foods 
includes several phases: mouth, stomach, small intestine and colon. Various physical 
(mechanical force, gastric emptying), chemical (pH, chemical composition) and 
biological (enzymes, biopolymers) reactions are involved during the gastrointestinal tract 
(GIT) to assist the digestion process. Therefore, the bioavailability of the OSVs in 
different food matrix might vary significantly under a chain of reactions after oral 
administration. 
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Mouth is the first part of the digestion process. Despite the fact that oral phase 
commonly last for a very short time from a few seconds to several minutes depending on 
the type of the foods, it contributes, sometimes huge impact, to the overall digestion 
process. Firstly, it is featured by a series of mechanical actions of mastication and 
swallowing, which is much more prominent in the breakdown of solid products 78. For 
liquid systems like emulsions, the mechanical force involves mainly swallowing, which 
might induce shearing to change their rheological properties. Besides, during the mouth 
phase, the food product is mixed with the secreted saliva which contains minerals, 
enzymes, protein, mucin and others 79. This further leads to changes of the pH, ionic 
strength, temperature, aggregation and flow properties of the foods 80. For example, the 
acidic emulsions containing chitosan is unstable with severe flocculation after mixing 
with neutral saliva solution since chitosan is highly unstable and insoluble at neutral pH 
value 81. For fat droplets stabilized by electrostatic repulsion from anionic particles, the 
surface potential might reduce under the mouth phase through adsorption of mucin 
molecules, which might induce flocculation and reduce emulsion stability 82, 83.  
Though passage of the esophagus after oral phase, the foods are further incubated in 
the stomach to form gastric chyme for a period ranging from 30 min to 4 hr. Mechanical 
forces involved are mainly peristaltic movement, which contribute to continuously 
mixing of the food with gastric juice for structure breakdown. At the end of the gastric 
phase, gastric chyme is passed to the intestinal phase through gastric emptying 84. The 
gastric juice is highly acidic with a pH value of 0.9 to 1.5, and consequently the pH of the 
gastric chyme decreases significantly in the span of 1 to 7 depending on the meals 85. In 
most cases, emulsions stabilized by acidic sensitive emulsifiers undergo severe creaming 
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destabilization on top of the gastric chyme, and consequently extended digestion time 82, 
86. These properties could be used for product design with tailored digestion process 87. 
Another important feature of the gastric juice is the presence of gastric lipase which could 
trigger lipid digestion in the gastric phase 85. In fact, the gastric stage might account for 
10–30% of the overall lipolysis 88. Carriere et al. showed that the lipolysis activity of 
gastric lipase and pancreatic lipases were similar but there was higher secretory amount 
of the pancreatic lipase 89. Currently, more research has highlighted the importance of 
gastric phase on the lipid digestion reaction 3, 88. Similar to the pancreatic lipase which is 
explained later, the lipid digestion reaction takes place mostly in the interface of the oil 
droplets. Expect that gastric lipase is sn-3 stereo-specific, intestinal lipase shows sn-1 and 
3 specificity 90. Nevertheless, low lipid digestion degree could be due to the accumulation 
of fatty acids, especially long chain fatty acids, since there is lacking of calcium, bile salts 
for removal of the free fatty acids 88. Besides, the lipid digestion process in the gastric 
phase might not be favorable for OSVs bioavailability. For example, Nguyen et al. 
observed a slight fraction of β-carotene release (about 20%) in the gastric phase with 
involvement of pepsin and gastric lipase, which might expose β-carotene for degradation 
91. 
Lipid digestion process takes place mostly in the intestinal phase, and therefore the 
encapsulated nutrients could be released and absorbed by the epithelium cells. When 
entering intestinal phase, the pH was gradually elevated to neutral conditions. The digesta 
was moving forward the intestinal phase though peristaltic motions and fluid mechanism. 
The pancreatic lipase catalyzes the lipid digestion process in the intestinal phase. Most of 
the lipid in the foods could be digested by the pancreatic lipase and be absorbed in the 
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forms of free fatty acids and monoglyceride. However, in some cases when lipid 
digestion was incomplete, the liberation of OSVs from the oil medium could be limiting 
step for the bioaccessibility and overall bioavailability 92. Lipases are interfacial enzymes, 
and the lipolysis reaction requires lipase absorption on the oil interface 90. The lipid 
digestion process requires assistance of other components in the digestive fluids. Firstly, 
several components in the intestinal juices play a positive role in contributing the affinity 
of the lipase onto the oil interface, and consequently promote lipid digestion. Before lipid 
digestion, bile salts interact with lipase/colipase, and then adsorb on the oil droplet 
interface by displacement of the emulsifier due to its strong surface activity 93, 94. 
Secondly, calcium and bile salts, as mention previously, are essential for removal of the 
free fatty acids, especially long chain ones, that accumulate on the surface of the oil 
droplets and inhibit further absorption of lipase on the oil interface 93, 95, 96. Besides, 
calcium is crucial for optimal enzyme activity 97. However, the role of calcium is 
complex which could also induce flocculation as well as precipitate the released OSVs in 
the form of calcium soaps 98, 99. Actually, there are attempts to modify nutraceutical 
bioavailability through controlling lipid digestion via these minor components 100, 101. 
After liberation from the oil medium, the esterification form of the OSVs is sensitive for 
hydrolyzation by the enzymes. However, due to high hydrophobicity, these OSVs are 
generally dissolved in the mixed micelles formed by free fatty acids, monoglycerides, 
bile salts and other. The mixed micelles components could migrate in the intestinal lumen 
and become bioaccessible to the epithelium cells 92. On one hand, the mixed micelle 
structure could be influenced by its compositions. On the other hand, the structure might 
change during evolution of the digestion process from spherical in several nanometer to 
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disk-like intermediate micelles, and to large vesicles less than 1 μm 102, 103. For example, 
calcium could modify the amount and structure of the mixed micelles through interaction 
with the lipolytic products and bile salts, promote the formation of calcium soaps, and 
therefore reduced the bioaccessibility of β-carotene 16, 95, 100. Consequently, the amount of 
OSVs that are dissolved in the mixed micelles could further be accessible for cell 
absorption, which is also referred as bioaccessibility. These mixed micelles particles then 
pass both the intestinal lumen and the mucus layer to reach the intestinal cell membrane. 
The mucus layer might be a great obstacle for the mixed micelles during the 
transportation process. First of all, the mucin pore size allows free diffusion at 100 nm 
and limits diffusion of 500 nm particles 104. Besides, the permeation through mucus layer 
could be reduced when there is interaction between each other, such as charge, surface 
functional groups 105. Nevertheless, the small intestine phase is also merited by thinnest 
mucus layer, which might further explain the highest absorption of OSVs and other 
digestion products 106. After crossing the mucus layer, the OSVs are ready to be absorbed 
by the mucus cells. The absorption mechanism of OSVs is not thoughtfully investigated, 
and more research is needed in this area. Generally, three main routes are involved in the 
absorption process, such as transcellular, paracellular, and persorption 12. Most absorption 
takes place via the transcellular route, which could be achieved by either diffusion or 
endocytosis–transcytosis–exocytosis processes. Vitamin D, vitamin E, vitamin K and 
carotenoid are mostly characterized by passive diffusion and protein mediated absorption 
via cholesterol transporters such as SRBI, NPC1L1, CD36 64. There are still unidentified 
protein transporters responsible for the absorption process. The route for Vitamin A is 
reported as passive diffusion with high absorption efficiency, but the specific route 
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remains unknown 107. Then, most of the OSVs (Vitamin D, vitamin E, vitamin K and 
carotenoid) are incorporated into chylomicrons and released into the lymph. 
Alternatively, they could also be secreted to the blood circulation in the form of high-
density lipoproteins (HDL) vit a non-apoB route. On the other hand, most of the retinol is 
directly secreted into the portal vein 107. Afterward, OSVs in the circulation systems 
might be transferred to different organs (i.e. liver or kidney) so as to transform into active 
forms (i.e. 1,25(OH)2D for vitamin D), or storage forms if excess OSVs are available (i.e. 
retinol ester) 22, 49. Then, when needed, OSVs in the hepatocytes are secreted to the blood 
cells for circulation. 
There is little research on the fate of OSVs in the colon. The colon is characterized 
by anaerobic environment with rich population the gut microbiota. The pH conditions 
might vary from 5 to 7. The colon also contains reduced levels of lipase. Additionally, 
there are some studies showing the release and bioavailability of carotenoids (β-carotene, 
lycopene, lutein) in the colon or colon cells 108-110. In addition, there are rich studies on 
the correlation of carotenoids and colon cancer 111. More research might be needed in the 
investigation of potential release of nutraceutical in colon 112. 
In summary of the above process, the bioavailability of the lipophilic nutraceuticals 
such as OSVs could be further divided into several factors, such as liberation from the 
food medium, solubility into digestive fluids to be bioaccessible, transformation into 
active forms, transportation to the epithelium cells and, absorption by the cells 11. These 
concepts are further classified into bioaccessibility, transformation and absorption 11. 
Among these, for strongly hydrophobic bioactives, like OSVs, the bioaccessibility, which 
include factors such as nutraceutical liberation and solubilization in the mixed micelles, is 
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often a critical step that determines their overall bioavailability 12. A comparison study 
showed that the in vitro bioaccessibility of carotenoids is positively correlated with that 
of in vivo bioavailability despite higher absolute value 113. 
2.4 Gastrointestinal simulation 
So far, human models are ideal for measurement of gastrointestinal fate of foods. 
However, there are many issues ethically as well as financially regarding the use of 
human models for digestion experiments. The use of in vitro models is widely 
appreciated due to its numerous benefits such as low cost, fast preliminary screening, 
insight into the mechanism 114-116. Besides, more studies have shown that in vitro 
digestion experiments are good reference to the human digestion process, especially 
copied with some animal and cell experiments 117-121.  
There are many in vitro simulations designed for different research purposes. Recently, 
there is more interest in development of dynamic in vitro digestion model. These models 
show higher reproduction of the dynamic human digestion systems through inclusion 
some of the following steps, such as vivid mechanical forces, gradual digestive fluids 
secretion, pH monitoring and separation of the digestive products 121. Another research 
interest lies in the development of unique digestion model for targeting populations 122. 
The complex GIT systems could greatly vary by causes such as age, genetic profile, GIT 
dysfunction illness, health, as well as time of the day, mood, and weather, and 
consequently lead to boost or loss of the digestion and absorption efficiency. Recently, 
the microfluidic techniques were applied into digestion models for in situ investigation on 
lipid digestion and nutraceutical bioavailability with tunable environmental conditions 91, 
123. Nguyen et al. showed that the β-carotene release rate as evolution of the lipid 
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digestion process was slowed at first and then increased overtime, and consequently the 
β-carotene accumulated in the oil droplets at first and then decreased in the end 91. 
Besides, Garcia-Campayo et al. developed an in vitro digestion model by mucosal 
enzyme inclusion, and this system is also useful for investigation of carbohydrate, protein 
and lipid hydrolysis simultaneously 115. Most recently, the use the harmonized 
INFOGEST method has attracted great interest, which is designed based on physiological 
condition of fed state 3, 124. This INFOGEST group formed by an international network, 
continuously works on improvement of the in vitro digestion model and recently they 
further updated the static digestion model to a semi-dynamic one through inclusion of 
some basic kinetic aspects (i.e. gradual acidification, fluid and enzyme secretion and 
gastric emptying) 125. They further highlighted this model for investigation of structural 
change during digestion process instead of end-point characterization. Although the use 
of different in vitro digestion models could lead to different absolute value of the 
bioaccessibility and bioavailability, the conclusions are the same in the most cases 126. 
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CHAPTER 3 
FACTORS IMPACTING LIPID DIGESTION AND Β-
CAROTENE BIOACCESSIBILITY ASSESSED BY 
STANDARDIZED GASTROINTESTINAL MODEL 
(INFOGEST): OIL DROPLET CONCENTRATION 
3.1 Abstract 
 Food, nutrition, and pharmaceutical scientists are trying to elucidate the major 
factors impacting the bioavailability of macronutrients (e.g., lipids) and micronutrients 
(e.g., vitamins) so as to improve their efficacy. Currently, there is still a limited 
understanding of how food matrix effects impact digestion and bioaccessibility 
determined under the INFOGEST model, which is currently the most widely used 
standardized in vitro gastrointestinal model. Therefore, we examined the impact of corn 
oil concentration on lipid digestion and β-carotene bioaccessibility using model food 
emulsions. For all oil concentrations tested (2.5 to 20%), complete lipid digestion was 
achieved using fed-state gastrointestinal conditions, which could only be seen if a back-
titration was performed. The particle size and negative surface potential on the mixed 
micelles formed at the end of the small intestine phase both increased with increasing oil 
concentration, which was attributed to the generation of more free fatty acids. The β-
carotene bioaccessibility increased when the oil concentration was raised from 2.5 to 
10% due to the increased solubilization capacity of the mixed micelles, but then it 
decreased when the oil concentration was raised further to 20% due to precipitation and 
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sedimentation of some of the β-carotene. The maximum β-carotene bioaccessibility 
(93.2%) was measured at 10% oil. These results indicate that the oil concentration of 
emulsions influences β-carotene bioaccessibility by altering digestion, solubilization, and 
precipitation processes. This knowledge is important when designing more effective 
functional or medical food products. 
Keywords: Oil concentration; β-carotene; emulsion; bioaccessibility; INFOGEST 
method. 
3.2 Introduction 
 Historically, a number of commonly consumed food products have been fortified 
with essential micronutrients (vitamins and minerals) to prevent nutritional deficiencies 
in the general population, including milk, juice, cereal, and bread 127, 128. More recently, 
there has been great interest in the fabrication and development of a new generation of 
fortified food products containing nutraceuticals 129. These bioactive food components 
are claimed to exert beneficial health effects when consumed at sufficiently high levels 
over extended periods 77. In particular, many nutraceuticals have been claimed to protect 
against chronic conditions such as cardiovascular disease, eye disease, brain disease, 
diabetes, hypertension, and cancer 130. A growing number of consumers are therefore 
purchasing nutraceutical-fortified functional foods to improve their health and wellbeing, 
with the aim of increasing their lifespan and quality of life 131, 132. In the future, it is 
hoped that functional foods may play an important role in reducing the incidences of 
chronic diseases, thereby reducing the need for pharmaceutical or surgical interventions 
133, 134. The efficacy of functional foods depends on the bioavailability of the 
nutraceuticals they contain, which depends on the composition and structure of the 
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surrounding food matrix 84, 135. As a result, there has been a major research effort to 
elucidate the key factors affecting nutraceutical bioavailability so that more efficacious 
functional food products can be designed 1, 136.  
 Many nutraceuticals are strongly hydrophobic substances that are challenging to 
incorporate into functional foods because of their poor water-solubility and 
bioaccessibility 2, 84. For this reason, hydrophobic nutraceuticals are typically loaded into 
colloidal particles that have hydrophobic interiors and hydrophilic exteriors before being 
incorporated into functional foods 136-138. Oil-in-water emulsions are one of the most 
commonly used colloidal systems for encapsulating and delivering hydrophobic 
nutraceuticals because they can be economically fabricated using existing 
homogenization technologies 2, 139. Nevertheless, the composition and structure of these 
delivery systems, as well as the surrounding food matrix, must be carefully designed to 
ensure good nutraceutical bioaccessibility 140, 141. Indeed, a variety of food matrix effects 
impact nutraceutical bioaccessibility. For instance, multivalent cations (such as calcium 
and magnesium) reduced carotenoid bioaccessibility, which was due to their ability to 
form insoluble soaps with long-chain fatty acids thereby reducing the number of mixed 
micelles present 142. Whey proteins have been shown to either increase or decrease β-
carotene bioaccessibility, depending on the extent of digestion 143. The presence of plant-
based oils and dietary fibers has also been shown to either increase or decrease the 
carotenoids bioaccessibility vegetables depending of the nature of the meal they are 
included in 144. An improved understanding of the impact of food matrix effects on 
nutraceutical bioaccessibility may therefore contribute to the formulation of functional 
food products with higher and more consistent biological activities 145.  
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 The impact of food matrix effects on the bioaccessibility of nutraceuticals is 
usually explored using gastrointestinal tract (GIT) models 3, 146. These models are 
designed to simulate the conditions present within the different parts of the human GIT 
(mouth, stomach, and small intestine), such as incubation times, mechanical actions, pH, 
mineral compositions, enzyme activities, and other factors 3. These in vitro models 
cannot account for the dynamic complexity of the real human GIT, but they can provide 
valuable insights into the physicochemical phenomenon involved since samples can 
easily be collected and characterized 147, 148. Moreover, they can be used to rapidly screen 
formulations with different compositions and structures, which cannot be easily achieved 
using in vivo testing methods, due to cost, time, and ethical reasons. One of the most 
widely used simulated GIT models was developed by the INFOGEST international 
consortium 3, 148. The conditions used in this model have been standardized so that 
researchers from different laboratories can compare their results under similar conditions. 
At present, however, there is still a relatively lacking understanding of how different food 
matrix effects impact the bioaccessibility of nutraceuticals determined using this new 
simulated GIT model. 
 In this article, we use the updated INFOGEST method to study the impact of oil 
concentration on the bioaccessibility of β-carotene encapsulated within a model food 
emulsion. This carotenoid has an extremely low water-solubility and poor 
bioaccessibility in its pure crystalline form, which makes it a good candidate for 
encapsulation 1. In addition, it exhibits provitamin A activity and is a natural antioxidant, 
which means that enhancing its bioaccessibility may have health benefits 149. Moreover, 
β-carotene is a strongly pigmented substance so that is concentration can easily be 
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quantified using simple UV-visible spectroscopy methods. This carotenoid has also been 
used extensively in previous GIT studies, which has led to a good understanding of the 
major factors impacting its bioaccessibility 2, 36, 150. As a result, β-carotene serves as a 
useful model hydrophobic nutraceutical for comparing the efficacy of different 
approaches for increasing nutraceutical bioaccessibility.  
 The bioaccessibility of carotenoids depends on several factors: liberation from the 
food matrix; solubilization within mixed micelles; and interaction with other food 
ingredients 80. Typically, the lipid phase surrounding the carotenoids must be digested 
before they are released. The products generated from lipid digestion, namely 
monoacylglycerols (MGs) and free fatty acids (FFAs) interact with bile salts, 
phospholipids and other lipophilic components to form mixed micelles that incorporate 
the carotenoids within their hydrophobic interiors. These carotenoid-loaded mixed 
micelles then travel through the gastrointestinal fluids and across the mucus layer before 
reaching the epithelium cells where they are absorbed. It should be noted, however, that 
some food components (such as chitosan) may interact with the mixed micelles and cause 
them to precipitate, thereby preventing the carotenoids from reaching the epithelium cells 
151.  
 In vitro studies have shown that oil concentration can impact the bioaccessibility 
of carotenoids encapsulated in or ingested with oil-in-water emulsions 152. For instance, 
increasing the oil content of emulsions has been shown to enhance the bioaccessibility of 
carotenoids, which was due to the formation of a higher number of mixed micelles that 
could solubilize the carotenoids 153. Nevertheless, only a limited range of fat contents has 
been examined from previous literatures. In practice, emulsion-based functional foods 
 
   27 
fortified with nutraceuticals, such as beverages, creams, sauces, and dressings may 
contain a wide range of fat contents. Consequently, it is important to understand how β-
carotene behaves in the gastrointestinal tract when it is present within food matrices with 
different oil contents. For this reason, the goal of the current paper was to determine the 
impact of oil droplet concentration on b-carotene bioaccessibility in model food 
emulsions using the standardized INFOGEST method 3. We hypothesized that the 
concentration of oil droplets initially present would alter the bioaccessibility of the 
carotenoids by altering lipid digestion, micelle solubilization, and/or micelle 
precipitation. The knowledge gained from this study should aid in the design of more 
effective functional food products. 
3.3 Materials and methods 
3.3.1 Materials 
 Corn oil (Mazola, ACH Food Companies, Memphis, TN, USA) was purchased 
from a supermarket. Tween 20 was purchased from ACROS Organic (Pittsburgh, PA, 
USA). Chemicals purchased from the Sigma-Aldrich Company (St. Louis, MO, USA) 
included β-carotene (synthetic, ≥93% in UV); porcine gastric mucin; pepsin from porcine 
gastric mucosa (≥250 units/mg); pancreatin from porcine pancreas; porcine lipase (100-
400 units/mg); and, porcine bile extract. Information about the methods used to measure 
enzyme activity are included in the supplier’s website.  Ethyl alcohol (ACS/USP grade) 
was obtained from Pharmco Products, Inc. (Shelbyville, KY, USA). All other chemicals 
and reagents (analytical grade or higher) were purchased from either Sigma-Aldrich or 
Fisher Scientific (Pittsburgh, PA, USA). All solutions and emulsions were prepared using 
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double distilled water (18 MOhm·cm) obtained from a water-purification system 
(Nanopure Infinity, Barnstaeas International, Dubuque, IA, USA). 
3.3.2 Preparation of emulsion-based delivery systems 
 Carotenoid-fortified delivery systems were fabricated according to a method 
described previously 154. An aqueous phase was prepared by dispersing non-ionic 
surfactant (2.0 wt% Tween 20) in phosphate buffer solution (5 mM, pH 7.0). The oil 
phase was prepared by dispersing β-carotene (0.1 wt%) in warmed corn oil (50 ºC) by 
repeated sonication (40 kHz, 1 min) and stirring (5 min) cycles until fully dissolved (clear 
solution). The oil phase (20 wt%) and aqueous phase (80 wt%) were combined together 
using a high-speed blender (M133/1281-0, Biospec Products, Inc., ESGC, Switzerland) 
(10,000 rpm, 2 min), and then homogenized using a microfluidizer (M110Y, 
Microfluidics, Newton, MA) (12000 psi, 3 passes). Emulsions with lower oil 
concentrations (2.5, 5 and 10%) were then prepared by dilution of the stock emulsion 
with phosphate buffer solution. 
3.3.3 Measurement of particle size 
 The dimensions of relatively large particles (initial emulsions and digested 
emulsions) were determined using a static light scattering particle size analyzer 
(Mastersizer 2000, Malvern Instruments Ltd., Malvern, Worcestershire, UK). Before 
measurement, samples were diluted with buffer solution (same pH) and stirred (1200 
rpm) to ensure they were homogeneous, the light scattering signal was high enough to 
obtain reliable results, and any multiple scattering effects were minimum.  A phosphate 
buffer solution with an appropriate pH was used to dilute the samples: initial, oral and 
small intestine (pH 7); stomach (pH 3). Appropriate refractive indices were used for the 
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oil phase (1.472) and aqueous phase (1.33) when converting the light scattering pattern 
into a particle size distribution. The results were then reported as the surface-weighted 
mean particle diameter (D3,2) calculated from the full particle size distribution. 
 The dimensions of relatively small particles (mixed micelles) were determined 
using a dynamic light scattering particle size analyzer (Zetasizer Nano ZS, Malvern 
Instruments Ltd., Malvern, Worcestershire, UK). The samples were diluted with 
phosphate buffer solution (pH 7) before analysis to obtain an appropriate signal intensity 
for reliable measurements. The same refractive indices were used in the analysis as for 
the static light scattering measurements. The results are reported as the Z-average 
diameter. 
3.3.4 Surface potential characterization 
 The surface potential (ζ-potential) of the particles in the emulsions and digested 
emulsions was measured using a dedicated microelectrophoresis instrument (Zetasizer 
Nano ZS, Malvern Instruments). Sample dilutions were performed using the same 
phosphate buffer solutions described for the particle size measurements. 
3.3.5 Microstructural analysis 
 Confocal microscopy analysis was performed according to a method described 
previously 155. Briefly, the oil phase was dyed with Nile red solution and then the 
resulting samples were imaged using a confocal laser scanning microscope (Nikon D-
Eclipse C1 80i, Nikon, Melville, NY, USA).  
3.3.6 In vitro digestion 
 In vitro digestion of the emulsion samples was performed using the recently 
updated INFOGEST gastrointestinal tract simulation method 3, with some slight 
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modifications. Initially, enzyme characterization assays were performed to establish the 
optimum enzyme activities required as described in the INFOGEST method. The 
temperature was maintained at 37 °C for the whole digestion process, and preheated 
solutions were used throughout the procedure to avoid any temperature fluctuations 
(which might impact enzyme activity). 
 Oral phase: Simulated saliva fluids containing 0.00375 g/ml mucin were mixed 
with emulsion samples at a ratio of 1:1 w/w. The mechanical forces experienced by foods 
in the human mouth were simulated using a mechanical shaking device (Model 4080, 
New Brunswick Scientific, New Brunswick, NJ, USA) operating at a speed of 100 rpm. 
The samples were maintained in the oral phase for 2 min. 
 Gastric phase: The sample exiting the oral phase was mixed 1:1 (v/v) with 
simulated gastric fluids containing pepsin (2000 U/ml in the final digestion mixture), and 
then the system was adjusted to pH 3.0 to trigger gastric digestion. The mechanical forces 
applied to the sample were the same as those employed in the oral phase.  The sample 
was maintained under simulated gastric conditions for 2 h. 
 Intestine phase: The sample exiting the gastric phase was further diluted 1:1 
(v/v) with simulated small intestinal fluids containing pancreatic enzymes and 10 mM 
bile salts. Pancreatin and pancreatic lipase were added to reach a trypsin activity of 100 
U/ml and a lipase activity of 2000 U/ml in the final mixture. An automatic titration 
device (857 Titrando, Metrohm USA Inc., Hillsborough, FL, USA) was used to maintain 
the sample at pH 7.0. The sample was maintained under simulated small intestinal 
conditions for 2 h. After this time, the intestinal sample was centrifuged (Sorvall Lynx 
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4000 centrifuge, Thermo Scientific, Waltham, MA, USA) at 46,285 ×g (18,000 rpm, 
4 °C) for 50 min to separate the mixed micelle and sediment phases. 
3.3.7 Measurement of lipid digestion 
 Lipid digestion was quantified by converting the volume of NaOH titrated into the 
reaction vessel into the fraction of free fatty acids released. The titration process was 
separated into two steps. In the first step, the volume of NaOH solution required to 
maintain the system at pH 7.0 throughout the small intestine phase was recorded. In the 
second step, the volume of NaOH solution required to titrate the solution to pH 9.0 was 
recorded.  This second step is required because not all of the free fatty acids generated 
during lipid digestion are fully deprotonated at neutral pH. The total volume of NaOH 
from these two steps was then used to calculate the total amount of FFAs released. The 
effect of any non-lipid components (the “blank” test) that might have contributed to the 
measured volume was accounted for by subtracting the volume of NaOH required to 
titrate a sample containing no oil (but otherwise the same as the test sample). The 
mathematical calculation was performed according to a method described previously 156, 
157.  
3.3.8 Extraction and analysis of β-carotene 
 The β-carotene in the digested samples was extracted and analyzed according to a 
method described in a previous study 158 with slight modifications. Briefly, an organic 
solvent consisting of 2:3 (v/v) hexane/isopropanol was used to carry out the extraction of 
the carotenoids. An aliquot of 0.5 ml sample was mixed with 1.2 ml of organic solvent. 
This mixture was then centrifuged (Minispin centrifuge, Eppendorf North America, Inc., 
Hauppauge, NY, USA) at 6000 rpm for 2 min, the supernatant was collected, and then its 
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absorbance at 450 nm was measured using a UV-visible spectrophotometer (Genesys 
150, Thermo Scientific, Waltham, MA, USA).  The bioaccessibility, release, and stability 
(%) of the β-carotene were calculated using the following equations: 












Here, Cmicelle, Csediment, Cdigesta, and Cinitial are the concentrations of β-carotene in 
samples collected from the mixed micelle, sediment, total intestine digesta, and initial 
emulsion, respectively.  Also, DF is the dilution factor for the gastrointestinal 
experiments (= 8). 
3.3.9 Statistical analysis 
 The emulsion preparation was carried out in duplicate, and the digestion process 
and other characterization assays were carried out in triplicate. The means and standard 
deviations of these measurements were then calculated. The statistical differences among 
samples were calculated at a confidence level of 95% using ANOVA with Tukey test. 
SPSS software (IBM Corp., Armonk, NY, USA) was used to perform all statistical 
calculations. 
3.4 Results and discussion 
3.4.1 Physical and structural properties of emulsions during digestion 
 Initially, the impact of oil droplet concentration (2.5, 5, 10 and 20%, w/w) on the 
gastrointestinal behavior of carotenoid-fortified emulsions was examined. These 
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emulsions all had a fixed surfactant-to-oil ratio of 1:10 (w/w) and a fixed carotenoid-to-
oil ratio of 1:1000 (w/w).  
 The surface weighted mean particle diameter (D3,2) of the initial stock emulsion 
was 0.158 ± 0.001 μm, indicating that the combination of surfactant and homogenization 
conditions used in our study were efficient at creating small oil droplets. Tween 20 is a 
relatively hydrophilic non-ionic surfactant (HLB = 16.7) that can rapidly absorb to oil 
droplet surfaces and stabilize them against aggregation 159. The surface potential of the 
Tween 20-coated oil droplets in the initial emulsion was -18.0 ± 0.8 mV. This relatively 
high negative charge may be ascribed from preferential adsorption of anionic hydroxyl 
ions (OH-) from the water or from the presence of anionic impurities in the surfactant, 
such as free fatty acids 160.  
 The in vitro gastrointestinal fate of the emulsions was established by passing them 
through the INFOGEST model 3. Changes in the physical and structural properties of 
different emulsion samples were determined after each digestion step to provide some 
insights into the key factors imparting lipid digestion and carotenoid bioaccessibility.  
 After the oral phase, the D3,2 values of all the samples remained relatively small, 
ranging from about 0.158 to 0.170 μm (Figure 3.1a). This result suggests that the 
surfactant-coated oil droplets were relatively stable against aggregation within the oral 
phase. The ζ-potential of the oil droplets was also fairly similar before (-18 mV) and after 
(-18 to -19 mV) exposure to the oral phase (Figure 3.1b), suggesting that there was not a 
major change in interfacial composition 161. The presence of the non-ionic surfactant 
would be expected to inhibit the attachment of other substances to the droplet surfaces, 
such as mucin. 
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Figure 3.1 The effect of different oil concentration on (a) the surface weighted mean 
particle diameter (D3,2) measured by static light scattering and (b) ζ-potential measured 
by electrophoresis of the corn oil in water emulsion during in vitro gastrointestinal 
digestion. Different capital letters (A, B, C) were used to designate significant difference 
(p < 0.05) among oil concentration (same stage), and lower-case letter (a, b, c) for 
different stage (same oil concentration). SI is abbreviated for small intestine. Data is 
reported as mean ± SD (n=6). 
 After the stomach phase, the D3,2 values of all the emulsions were fairly similar to 
those obtained in the oral phase, ranging from around 0.159 to 0.196 μm (Figure 3.1a), 
indicating that the oil droplets were relatively stable to aggregation in the simulated 
gastric solution conditions. However, the magnitude of the surface potential on the oil 
droplets decreased significantly (p < 0.05) after exposure to the stomach phase, reaching 
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values between about -1.9 and -1.2 mV (Figure 3.1b). Similar results have also been 
reported by other researchers monitoring the behavior of Tween 20-stabilized emulsions 
in a simulated gastric environment 162. In other words, these results indicate that the 
surfactant-coated oil droplets were resistant to aggregation when exposed to the highly 
acidic conditions in the stomach 163, presumably because they were primarily stabilized 
by steric repulsion between the hydrophilic polyoxyethylene head-groups of the 
surfactant molecules, rather than by electrostatic repulsion. The reduction in the negative 
charge on the droplet surfaces may have been due to protonation of any anionic 
impurities (such as free fatty acids) or due to a reduction in the adsorption of OH- groups 
under acidic conditions. 
 
Figure 3.2 The average diameter of the particles in mixed micelle samples obtained after 
intestinal digestion of emulsions with different oil concentration. These measurements 
were carried out using dynamic light scattering. Capital letters (A, B, C) were used to 
indicate significant difference (p < 0.05) among samples. Data is reported as mean ± SD 
(n=6). 
 A number of researchers have shown that the digestion of lipids within the small 
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For this reason, the gastric samples were initially adjusted to pH 7 (without lipase and 
bile salt addition) to represent the small intestine phase before lipid digestion (“SI-
Initial”). The size of the droplets remained relatively small when the condition was 
elevated to pH 7, again showing that they were stable in maintaining the oil droplet size 
under neutral conditions. Moreover, the magnitude of the ζ-potential became strongly 
negative again, around -17.2 to -22.3 mV (Figure 3.1b), suggesting that the oil droplet 
surfaces once again contained some anionic substances, such as fatty acids or hydroxyl 
ions. It should be noted that oil droplet concentration did not have a major impact on the 
size, surface charge and microscopic properties of the emulsions in the oral, gastric, or 
initial small intestine phases. 
 There was, however, a pronounced change in the properties of the oil droplets by 
the end of the small intestine phase, after bile salts and lipase was added. Moreover, the 
extent of this change depended on oil concentration. At the end of the small intestine 
digestion, the mean size value (D3,2) increased with increasing oil concentration, from 
0.273 μm for 2.5% oil to 0.549 μm for 20% oil (Figure 3.1a). These observations 
corresponded with the confocal microscopy images, which also showed an increase in the 
size of colloidal lipid particles with higher oil concentration (Figure 3.3a). Interestingly, 
the particle size (measured by dynamic light scattering) and turbidity (measured by UV-
visible spectroscopy) of the mixed micelles produced by lipid digestion also increased 
with increasing oil concentration (Figures 3.2 and 3.3b). In general, these samples may 
contain undigested oil droplets, micelles, vesicles, and/or insoluble calcium soaps, whose 
size could all change depending on the initial oil concentration in the emulsions. Simple 
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micelles typically have diameters around 10 nm or less, but the vesicles and other 
components in the mixed micelle phase lead to much higher particle sizes 167. 
 
Figure 3.3 The effect of different oil concentration on the (a) confocal photos of intestine 
samples, (b) optical photos of mixed micelle samples, and (c) the appearance of 
centrifugation separation of the intestinal samples (note the sediment at the bottom of the 
tubes). From left to right, the data correspond to the emulsions of increasing oil 
concentration from 2.5% to 20%. 
 β-carotene bioaccessibility would be expected to increase as the amount of mixed 
micelles formed by lipid digestion increased 168. Consequently, one would expect the 
bioaccessibility to increase as the oil concentration increased. Conversely, the 
bioaccessibility would be expected to decrease as the amount of insoluble sediment from 
the samples increased. In this study, we observed that the quantity of sediment formed 
increased as the oil concentration increased (Figure 3.3c). 
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 After the intestinal phase, the absolute value of the negative surface potential 
increased as the oil concentration increased, rising from -30.5 mV for 2.5% oil to -59.4 
mV for 20% oil (Figure 3.1b). This effect can be ascribed to the generation of more 
anionic fatty acids during lipid digestion, which were present at the surfaces of the 
colloidal particles in the digested samples. The ζ-potential of the mixed micelle phase 
also increased as the oil concentration increased, rising from -30.4 mV for 2.5% oil to -
68.0 mV for 20% oil (Figure 3.1b). Again, this effect can be explained by the presence of 
a higher level of anionic fatty acids after lipid digestion, which would be incorporated 
into the mixed micelles. The average size of the mixed micelles also increased with 
increasing oil concentration (Figure 3.2). This suggests that there may have been larger 
micelles or vesicles formed at higher FFA levels, or that there was an increase in the 
vesicle-to-micelle ratio. At high oil concentrations, the fatty acids appeared to be 
incorporated into insoluble calcium soaps rather than into mixed micelles, based on the 
fact that more sediment was observed at the bottom of the samples (Figure 3.3c). 
3.4.2 Lipid digestion in the intestinal digestion 
 The amount of FFAs released from the lipid phase in the different emulsions was 
monitored using the pH-sat method (Figure 3.4). The FFAs released was measured using 
a two-step procedure: (i) at pH 7 during digestion, which only detects the ionized fatty 
acids formed under neutral conditions; (ii) by back-titrating to pH 9, which also detects 
any fatty acids that were not ionized under neutral conditions. At pH 7, the fraction of 
FFAs released during digestion decreased significantly (p < 0.05) with increasing oil 
concentration, changing from 79.0% for 2.5% oil to 47.7% for 20% oil (Figure 3.4a). 
Thus, the percentage of fatty acids measured by the end of lipid digestion was 
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considerably less than 100%. Previous studies have shown that a fraction of the FFAs 
released during lipid digestion are not ionized at pH 7, so they are not titrated by NaOH 
during pH stat measurements 157, 169. A back titration was therefore carried to measure 
these non-ionized fatty acids. 
 After titration to pH 9, the percentage of FFAs produced still tended to decrease 
with increasing oil concentration (Figure 3.4a). Interestingly, though, the amount of FFAs 
produced was considerably higher than 100% (assuming two fatty acids formed per 
triacylglycerol). For instance, the final amount of FFAs released was calculated to be 
around 127% for the emulsions initially containing 2.5% oil. The reason for the higher 
amount of lipid digestion than expected may be that some of the monoacylglycerols were 
converted into a glycerol molecule and a fatty acid under alkaline conditions 170. This 
phenomenon appears to be an important limitation of the INFOGEST method for 
monitoring lipid digestion 170. Overall, our results suggest that the majority of the fat 
droplets was digested in all systems.  
 It should be noted that the dependence of the final FFAs released on oil 
concentration was different at pH 7 and pH 9. This suggests that the ratio of ionized-to-
non-ionized FFAs in the digested emulsions depended on their initial oil concentration. 
For this reason, the ratio of final FFA levels at pH 7 to pH 9 was calculated: 0.62, 0.51, 
0.46 and 0.48 at 2.5, 5, 10, and 20% oil, respectively. Thus, when there is more oil phase 
present the FFAs have a greater tendency to be in the non-ionized state. Previous studies 
have reported that the pKa values of fatty acids increases as their concentration increases,  
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Figure 3.4 The effect of different oil concentration on (a) final free fatty acid (FFA) 
released, (b) corrected FFA released profile, and (c) corrected FFA concentration profile 
of the corn oil in water emulsion during intestinal digestion. The significant difference 
among different oil concentration for final FFA released at pH 7 and pH 9 were labeled 
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as lower-case letters (a, b, c) and capital letters (A, B, C) respectively. Data is reported as 
mean ± SD (n=6). 
especially for long-chain ones 171. Indeed, the pKa values of long-chain fatty acids have 
been shown to be highly dependent on their local environment 170. This phenomenon was 
mainly attributed to interactions between the polar head-groups of fatty acids when they 
are in close proximity. 
The generation of FFAs during the course of lipid digestion was calculated using the 
measured NaOH volumes and a correction factor: CF = Final FFAs(pH 9)/Final FFAs(pH 
7) (Figure 3.4b). In addition, the molar concentration of FFAs produced during digestion 
was calculated (Figure 3.4c). For all oil concentrations, the amount of FFAs generated 
increased steeply during the first 500 s and then more gradually afterward. These results 
suggest that the lipase rapidly adsorbed to the surfaces of the oil droplets and initiated 
digestion of the underlying triacylglycerols 172. At the end of the small intestine period, 
there appeared to be a fairly similar total amount of lipid digestion for the emulsions 
containing 2.5 to 10% oil, but a reduced amount for the emulsions containing 20% oil 
(Figure 3.4b). This result suggests that some of the lipids may not have been digested at 
the highest oil concentrations used, which may have been due to the limited amount of 
lipase, bile salts, and calcium present in the in vitro GIT model. Conversely, the absolute 
amount of FFAs produced during lipid digestion increased as the oil concentration 
increased (Figure 3.4c), which should be expected because there were more 
triacylglycerol molecules present to convert into fatty acids. 
3.4.3 Stability, release, and bioaccessibility of β-carotene 
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Figure 3.5 The effect of different oil concentration on (a) stability and release, (b) 
bioaccessibility and sedimentation, and (c) β-carotene concentration in each phase of the 
corn oil in water emulsion after intestinal digestion. Capital letters (A, B, C), lower-case 
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letters (a, b, c) and the Greek letters (α, β, γ) were used to designate significant difference 
among different oil concentration. “Intestine” indicated the total digest obtained after 
intestinal digestion. Data is reported as mean ± SD (n=6). 
 After passing through the full INFOGEST digestion method, the β-carotene 
concentration was measured in the mixed micelle phase, the sediment phase, the total 
digest and the initial emulsions. These values were then used to determine the stability, 
release, and bioaccessibility of the carotenoid. 
 Stability: The stability of the carotenoids was calculated by comparing the total β-
carotene concentration from the small intestine samples with that in the original 
emulsion, accounting for the dilution steps (Figure 3.5a). Carotenoid stability was fairly 
similar for all oil concentrations used (2.5 to 20%), ranging from around 70 to 80%. 
These values agree with those published previously for related systems 173. We postulate 
that the observed reduction in total β-carotene concentration by the end of the 
INFOGEST model was mainly due to chemical degradation of the carotenoids. The 
highly acidic gastric fluids within the simulated stomach, as well as the slightly elevated 
temperature that the samples were exposed to during the whole digestion (37 oC), would 
have accelerated any acid-induced chemical degradation of the carotenoids 174. Moreover, 
the samples were exposed to light for short periods during the experimental operation 
(e.g., when transferring samples between digestion phases), which may also have 
accelerated the chemical degradation of the carotenoids. In addition, some of the 
carotenoids may also have adhered to the surfaces of the containers or other apparatus 
used in the simulated digestion method, which would also have reduced their 
concentration in the small intestine phase. Overall, our results suggest that the oil droplet 
concentration did not strongly impact the chemical stability of the β-carotene in the 
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emulsions. This may have been because the initial concentration of the carotenoids in the 
oil droplets (0.1%) was the same in all systems. 
 Release: The release of the carotenoids was calculated as the sum of β-carotene in 
the micelle and sediment phases divided by the total β-carotene in the digest. The release 
rate was only around 80.5% for the emulsions containing 2.5% oil, but close to 100% for 
all the other emulsions (Figure 3.5b). This result suggests that it is harder to efficiently 
extract the carotenoids from the samples when the initial oil concentration (and therefore 
final mixed micelle concentration) is relatively low. Thus, in future studies on food 
matrix effects, a higher oil concentration is recommended. 
 Bioaccessibility: The bioaccessibility of the carotenoid was the fraction of β-
carotene from the total digest that was dissolved in the mixed micelle phase. Similarly, 
the fraction of carotenoids in the sediment was calculated by comparing the concentration 
of β-carotene in the sediment with that in the total digest. As the oil concentration 
increased from 2.5 to 10%, the bioaccessibility of carotenoids in the mixed micelle phase 
increased from 60.5% to 93.2%, whereas that in the sediment phase decreased from 20.4 
to 7.9% (Figure 3.5b). The initial increase in bioaccessibility with increasing oil 
concentration can be attributed to the generation of more mixed micelles available of 
solubilizing the carotenoids. When reported as an absolute β-carotene concentration, the 
quantity of carotenoids in the mixed micelle phase increased from 1.20 to 6.77 μg/ml 
when the oil concentration was raised from 2.5% to 10%, while the total quantity of 
carotenoids in the small intestine phase increased from 2.02 to 7.24 μg/ml, respectively 
(Figure 3.5c). This result highlights the fact that it is necessary to use a higher oil 
concentration to increase the total amount of carotenoids available for absorption in the 
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small intestine. As expected, the β-carotene concentration in the sediment phase slightly 
increased when the oil concentration was raised being 0.357, 0.432, and 0.543 μg/ml for 
2.5, 5.0, and 10% oil, respectively (Figure 3.5c). The β-carotene in the sediment phase is 
probably trapped within insoluble calcium soaps formed by bile salts, free fatty acids and 
calcium ions. 
 Interestingly, increasing the oil concentration in the emulsions from 10 to 20% led 
to an inhibition in β-carotene bioaccessibility from 93.2% to 80.3% (Figure 3.5b). This 
effect can be due to an increase in the quantity of carotenoids within the sediment phase 
at the highest oil concentration, i.e., 1.20 μg/ml or 14.3% (Figures 3.5b and 3.5c). We 
hypothesize that this effect is due to the formation of a greater amount of sediment at 
higher oil concentrations, as seen by visual appearance of the samples (Figure 3.3c). The 
origin of this effect may be due to the increase in the pKa values of the long-chain FFAs 
at higher oil concentrations 171. As a result, a lower fraction of these fatty acids would be 
ionized at neutral pH, making them less water-soluble and more prone to forming 
insoluble sediments. Consequently, some of the carotenoids would be trapped within 
these sediments. Researchers have suggested that hydrophobic nutraceuticals trapped 
within fatty acid-rich sediments are unavailable for absorption and so end up within the 
feces 95. These results suggest that it is important to design functional foods that can 
prevent carotenoids being trapped within the insoluble precipitates formed from fatty 
acids during lipid digestion. 
 In a previous study on closely related systems, it was reported that the 
bioaccessibility of β-carotene decreased from around 84% to 39% when the oil droplet 
concentration was increased from 4% to 20% 152, which was a much bigger reduction 
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than observed in the current study. Indeed, the carotenoid bioaccessibility only decreased 
from around 82.5% to 80.3% when the oil concentration was increased from 5% to 20% 
oil in our study. This large difference in results can be attributed to the fact that different 
in vitro digestion methods were used. In the previous study, the lipid droplets were not 
completely digested exiting the small intestine phase because the lipase concentrations 
used were much lower than those employed in the INFOGEST method. As a result, the 
b-carotene was not fully released from the lipid phase, as well as there were less mixed 
micelles available to solubilize it. 
3.5 Conclusions 
In this study, the impact of oil concentration (2.5 to 20%) on the bioaccessibility of 
β-carotene vehiculated within model food emulsions was investigated using the updated 
standardized INFOGEST gastrointestinal simulation. At the beginning of the small 
intestine digestion, the size and surface potential of the oil droplets in the emulsions was 
independent of oil concentration. At the end of the small intestine phase, almost complete 
lipid digestion was observed in all of the emulsions after a back titration was carried out. 
Even so, the measured degree of lipid digestion decreased with increasing oil 
concentration. Interestingly, the fraction of the fatty acids released was much higher than 
expected in some of the samples (>120%), which was attributed to conversion of some of 
the monoacylglycerols into fatty acids and glycerol, which is obviously a limitation of the 
INFOGEST method. The bioaccessibility of the β-carotene increased from 60.5% to 
93.2% when the oil concentration was raised from 2.5% to 10 %, but then decreased to 
80.3% when the oil concentration was further raised to 20%. This effect was ascribed 
from the precipitation of some of the long-chain fatty acids at higher oil concentrations, 
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which caused some of the carotenoids to be trapped inside the sediment phase. These 
results suggest that the oil concentration in functional foods should be optimized to 
obtain the highest bioaccessibility. On the other hand, the total amount of carotenoids 
actually available for absorption does increase with increasing oil concentration, which 
means that it may be necessary to include a certain amount of oil to reach a desired target 
dose of the carotenoids. 
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CHAPTER 4 
FACTORS IMPACTING LIPID DIGESTION AND 
NUTRACEUTICAL BIOACCESSIBILITY ASSESSED BY 
STANDARDIZED GASTROINTESTINAL MODEL 
(INFOGEST): OIL DROPLET SIZE 
 
4.1 Abstract 
The oil droplets in commercial emulsified foods have dimensions that vary widely, 
from hundreds of nanometers to tens of micrometers. Previously, the size of the droplets 
in oil-in-water emulsions has been shown to impact their gastrointestinal behavior, which 
may influence their physiological effects. In this study, we analyzed the impact of oil 
droplet diameter (0.16, 1.1 and 8.2 μm) on lipid digestion and nutraceutical 
bioaccessibility using a widely used standardized gastrointestinal tract model: the 
INFOGEST method. The emulsions used consisted of corn oil droplets stabilized using a 
food-grade non-ionic surfactant (Tween 20), and the droplet size was controlled by 
preparing them with a microfluidizer (small), sonicator (medium), or high-shear blender 
(large). The surfactant-coated oil droplets were relatively resistant to size changes in the 
mouth and stomach, due to the strong surface activity and steric stabilization mechanism 
of the non-ionic surfactant used. As expected, the kinetics of lipid digestion were 
enhanced for smaller droplets because of their greater specific surface area. The degree of 
lipid digestion fell from 117% to 78% (p < 0.001) as the initial droplet diameter was 
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raised from 0.16 to 8.2 µm. In addition, there was a reduction in β-carotene 
bioaccessibility from 83 to 15% (p < 0.001) with increasing droplet diameter. This result 
was ascribed to several effects: (i) some carotenoids were trapped inside the undigested 
oil phase; (ii) fewer mixed micelles were produced to internalize the carotenoids; and, 
(iii) a fraction of the carotenoids crystallized and sedimented. Our results underline the 
critical importance of considering droplet size when developing emulsified foods loaded 
with carotenoids. The results obtained by the INFOGEST method are consistent with 
those found using other in vitro methods in earlier studies. 
Keywords: Oil droplet size; β-carotene; emulsion; bioaccessibility; INFOGEST method. 
4.2 Introduction 
Many food products are colloidal systems consisting of tiny oil droplets distributed 
throughout an aqueous medium, such as milk, cream, soft drinks, mayonnaise, dressings, 
sauces, and toppings 175. The oil droplet size in these products varies greatly due to 
different ingredients and processing operations used in their creation 176-178. For instance, 
the mean droplet diameter is only a few hundred nanometers in soft drinks and 
homogenized milk, but tens of micrometers in dressings and mayonnaise, which 
corresponds to a three-orders of magnitude difference 160, 179. The size of the droplets in 
an emulsified food product impacts its appearance, rheology, flavor release profile, 
physical stability, and chemical stability. Consequently, each product must be carefully 
designed to have a particle size distribution that provides the required quality attributes 
and shelf-life for the particular application. 
Emulsion droplet dimensions also influence the behavior of food products within the 
human gut,2 which can have important nutritional and health implications. Studies using 
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in vitro digestion models demonstrate that droplet dimensions influence lipid hydrolysis 
kinetics and nutraceutical bioaccessibility 18, 156, 180-182. Typically, these studies 
demonstrate that smaller droplets are digested faster and more fully than larger droplets, 
mainly because the lipase molecules have more surface area per unit volume of oil to 
attach to. Moreover, the bioaccessibility of non-polar substances present in the oil phase 
of emulsions, such as hydrophobic nutraceuticals or vitamins, usually increases as the oil 
droplets become smaller. This bioaccessibility enhancement is attributed to the fact that 
more of the bioactives are liberated from the oil droplets and more mixed micelles are 
formed to solubilize them when the lipid phase is digested faster and more extensively 2. 
Overall, these results demonstrate that emulsions with ultrafine droplets are more suitable 
in applications where rapid release and/or high bioavailability of a bioactive agent are 
required 14, 183-185. These in vitro results are consistent with in vivo animal studies that 
have also demonstrated the oral bioavailability and absorption rate of hydrophobic 
bioactives increase when they are encapsulated in very small lipid droplets 186-188.  
Globally, there are numerous research groups developing emulsion-based delivery 
systems for various kinds of hydrophobic bioactive agents. Many of these researchers use 
different in vitro gastrointestinal models to assess the potential efficacy of their 
formulations. These in vitro models differ in the types and amounts of enzymes, minerals, 
bile salts, and minerals they contain, which makes direct comparisons difficult. For this 
reason, a team of international researchers developed a standardized simulated 
gastrointestinal tract (GIT) model, known as the INFOGEST method, which has been 
widely adopted in the field 3, 148. This model has already been used to study lipid 
digestion and/or bioactive bioavailability in various emulsion systems 151, 189. For 
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instance, our group recently showed that it could be used to study the impact of calcium 
on carotenoid bioaccessibility 16 and chitosan on vitamin D bioaccessibility 151. Other 
researchers have used it to study the influence of mayonnaise on the bioaccessibility of 
carotenoids in fruits 190.  
Our objective in this study was to establish the impact of oil droplet size (100 nm to 
10 μm) on oil phase hydrolysis and nutraceutical bioaccessibility in model food 
emulsions using the INFOGEST method 3. A carotenoid (b-carotene) was used in this 
study as a model of a strongly hydrophobic nutraceutical. Results using earlier (non-
standardized) in vitro gastrointestinal models have shown that oil phase hydrolysis and 
carotenoid bioaccessibility increase as the droplet dimensions are reduced 18, 182. These 
models use different GIT conditions (such as bile salt, calcium, and enzyme levels) than 
the harmonized INFOGEST model. For this reason, we wanted to determine whether the 
results obtained using the INFOGEST model were consistent with those obtained using 
these earlier in vitro models. Based on previous results, we hypothesized that oil phase 
hydrolysis and carotenoid bioaccessibility would still increase as the droplet size was 
decreased, but the magnitude of this effect was unknown. The knowledge gained through 
this research on the impact of oil droplet size should enrich our understanding of the 
impact of food matrix effects on the biological activity of hydrophobic nutraceuticals, as 
well as providing insights into the differences between gastrointestinal models. It should 
be noted that this study is part of a series where we are using the INFOGEST method to 
systematically examine the impact of key factors on the gastrointestinal fate of emulsified 
foods, such as oil droplet concentration and emulsifier type 191, 192. The aim of these 
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studies is to provide some fundamental insights into the major factors impacting the 
gastrointestinal behavior of more complex real food systems. 
4.3 Materials and methods 
4.3.1 Materials 
See details in 3.3.1. 
4.3.2 Preparation of emulsion-based delivery systems 
The preparation of the aqueous and oil phases was carried according to 3.3.2. The 
oil phase (5%, w/w) and aqueous phase (95%, w/w) were mixed together using different 
homogenization methods to prepare emulsions containing different-sized droplets. 
Emulsions with large-sized droplets (“large emulsion”) were prepared by a high-shear 
blender (M133/1281-0, Biospec Products, Inc., ESGC, Switzerland) at 10,000 rpm, for 6 
min. Emulsions with medium-sized droplets (“medium emulsion”) were prepared by 
sonicating a portion of the large emulsion (Sonicator FB505, Thermo Fisher Scientific, 
Waltham, MA, USA). The sonication conditions used were as follows: diameter of tip 
probe = 13 mm, bottom gap = 10 mm, frequency = 20 kHz, power = 500 W, amplitude = 
20%, sonication on/off duration = 2/2 s, total sonication time = 3 min. An emulsion 
containing small oil droplets (“fine emulsion”) was prepared by microfluidizing a portion 
of the large emulsion (M110Y, Microfluidics, Newton, MA) at 12000 psi for 3 
circulations. 
4.3.3 Droplet size, charge, and microstructure 
The size, charge, and spatial location of the particles in the samples was carried out 
according to 3.3.3, 3.3.4 and 3.3.5. 
4.3.4 In vitro digestion 
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In vitro digestion of carotenoid-loaded emulsions was performed using the recently 
updated harmonized INFOGEST method 3. The experimental details were described in 
3.3.6 and 3.3.7. 
4.3.5 Extraction and analysis of β-carotene 
The extraction and analysis of β-carotene was carried out according to 3.3.8. 
4.3.6 Statistical analysis 
 See details in 3.3.9 
4.4 Results and discussion 
4.4.1 Structural and physical properties in simulated gastrointestinal tract 
In this study, the initial emulsion compositions were fixed as 0.005% β-carotene, 
5.0% corn oil, 0.5% Tween 20, and 94.5% phosphate buffer solution (pH 7, 5 mM). This 
surfactant is known to be a good emulsifier because it rapidly adsorbs to oil-water 
interfaces, reduces the interfacial tension appreciably, and forms a steric barrier 193. 
Emulsions with a range of different target average particle diameters (» 0.1, 1 and 10 μm) 
were prepared using a microfluidizer, sonicator, and blender respectively. The actual 
measured D3,2 values of these emulsions were 0.158, 1.09 and 8.20 μm respectively 
(Figure 4.1a). For clarity and concision, these samples are called “fine”, “medium” and 
“large” emulsions in the following discussion. The particle size distributions of all the 
initial emulsions were roughly monomodal (Figure 4.2a). The microscopy analysis 
indicated a similar general trend in particle size with homogenization conditions (Figure 
4.3). 
With increasing oil droplet size, more creaming occurred in the emulsions when 
they were left to stand under quiescent conditions for 24 hours (Figure 4.4a). This 
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phenomenon is expected since the gravitational force operating on an individual oil 
droplet is proportional to the square of its diameter 160. Hence, larger droplets should 
move upwards much more quickly than smaller ones, which would influence the storage 
stability and shelf life of commercial products 194.  
 
Figure 4.1 The effect of oil droplet size on: (a) mean particle diameter (D3,2) and (b) ζ-
potential of the corn oil-in-water emulsions during in vitro gastrointestinal digestion. 
Different capital letters (A, B, C) were used to designate significant difference (p < 0.05) 
among different oil droplet size (same stage), and lower-case letter (a, b, c) for different 
stage (same oil droplet size). SI is used as an abbreviation for small intestine. Micelle 
indicates the mixed micelle phase (supernatant fraction) of the intestinal samples. 
The surfactant-coated oil droplets all had negative surface potentials (-23.9 to -18.0 
mV) (Figure 4.1b). Tween 20 is supposed to be a non-ionic surfactant and so the negative 
charge may arise from other anionic species present at the oil droplet surfaces, e.g., 
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hydroxyl ions or free fatty acids 160. This result suggests that the oil droplets may be 
stabilized by both steric and electrostatic repulsive forces. 
 
Figure 4.2 The effect of oil droplet size on the particle size distribution of the corn oil-in-
water emulsions (initial) and at the end of gastrointestinal digestion (SI-end). Note: the 
volume fraction was stacked up the y-axis for comparison (using an increment of 10%). 
The different-sized emulsions were then passed through the INFOGEST model to 
understand their gastrointestinal fate. The physical and structural properties of samples 
were analyzed at the end of the sequential stages of this digestion model. In addition, they 
were measured at the start of the small intestine (“SI-initial”). We carried this out by 
taking the emulsions collected from the end of the gastric phase and then adjusting them 
to pH 7. Their properties were then measured before introducing the bile salts and 
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digestive enzymes. This procedure was carried out because the aggregation state of oil 
droplets entering the small intestine impacts their subsequent digestion 166, 195, 196. 
 
Figure 4.3 The effect of oil droplet size on the confocal microscopy images of the corn 
oil-in-water emulsions during in vitro digestion. SI is used as an abbreviation for small 
intestine. 
In the mouth, stomach, and SI-initial phases, the oil droplet size in all emulsions 
remained approximately the same as those in the initial emulsions (Figures 4.1a and 4.3). 
Thus, the Tween 20-coated oil droplets were resistant to aggregation and disruption in the 
early stages of the INFOGEST model irrespective of their initial size. Tween 20 has a 
high surface-activity so it attaches strongly to droplet surfaces and is difficult to displace. 
Moreover, it generates strong steric repulsive forces that prevent droplets from coming 
 
   57 
together and aggregating. In contrast, protein- or phospholipid-coated oil droplets often 
become aggregated under mouth or stomach conditions because of the reduction in 
electrostatic repulsive forces operating between them 197, 198. In addition, the non-ionic 
head groups of Tween 20 mean that it is difficult for mucin to adsorb to the droplet 
surfaces in the mouth and stomach phases. 
 
Figure 4.4 The effect of oil droplet size on: (a) the appearance of the initial emulsions and 
the mixed micelle samples (supernatant fraction of the intestinal samples) collected after 
digestion; (b) the appearance of centrifugation separation of the emulsions after intestinal 
digestion (note the sediment at the bottom of the tubes). 
The droplets in all the emulsions were strongly negative (-26.0 to -16.7 mV) when 
they were dispersed in neutral pH solutions, such as those present in the initial emulsions, 
oral, and SI-initial phases. Conversely, they were only weakly negative (-1.9 to -1.7 mV) 
under the acidic solution conditions in the gastric phase (Figure 4.1b). Interestingly, the 
surface potential of the oil droplets did not depend on their size. The reduced negative 
charge of the surfactant-coated oil droplets in the stomach phase is most likely due to the 
protonation of free fatty acid impurities or the reduced adsorption of hydroxyl ions from 
the water under acidic conditions. 
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After intestinal digestion in the presence of lipase, the physical and structural 
properties of all the emulsions changed considerably. A significant (p < 0.05) increase in 
the average size of the particles in the fine emulsions was observed (Figure 4.1a), as well 
as evidence for a wide range of different-sized particles in the samples (Figure 4.2b). On 
the other hand, the average size of the particles in the medium and large emulsions 
significantly (p < 0.05) decreased, due to the presence of a substantial fraction of small 
particles (< 1 μm) in the particle size distribution after digestion (Figures 4.1a and 4.2b). 
During the intestinal phase, the triglycerides inside the oil droplets are hydrolyzed to fatty 
acids and monoglycerides through a hydrolysis reaction. These lipid digestion products 
then interact with constituents within the gastrointestinal fluids (such as calcium, bile 
salts, and enzymes) to form a range of differently-sized colloidal assemblies, e.g., 
micelles, vesicles, liquid crystals, aggregated proteins, and fatty acid/calcium soaps 199, 
200. Electron microscopy and light scattering methods have shown that most of the 
colloidal particles present in the digest are smaller than about 1000 nm, such as spherical 
micelles (up to 10 nm), vesicles (up to 100 nm) and multivesicular liposomes (up to 1000 
nm) 196, 199. These colloidal particles are therefore larger than the oil droplets in the initial 
fine emulsions, but smaller than those in the medium and large emulsions. Similar size 
changes after intestinal digestion have also been noted in whey protein-stabilized 
emulsions 197. The mean diameters of the particles remaining within the intestinal fluids 
after digestion were 0.364, 0.410, and 0.825 μm for the fine, medium, and large 
emulsions, respectively (Figure 4.1a). Conversely, the Z-average values of the micelle 
samples (collected by centrifugation) were similar for all samples, being 195, 200, and 
202 nm for fine, medium, and large emulsions, respectively (Figure 4.5).  This suggests 
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that some of the larger and denser colloidal particles formed during lipid digestion, such 
as calcium soaps and/or large multivesicular liposomes, may have been at least partially 
removed by centrifugation. 
 
Figure 4.5 The average diameter of the particles in mixed micelle samples (supernatant 
fraction of the intestinal samples) obtained after intestinal digestion of emulsions with 
different initial oil droplet sizes. Capital letters (A, B, C) were used to indicate significant 
difference (p < 0.05) among samples. 
Our results suggest there were some undigested lipid droplets within the small 
intestine phase collected from the larger emulsions. Indeed, the confocal microscopy 
images and visual appearance of the samples showed numerous large undigested oil 
droplets in the large emulsions, as well as several smaller undigested oil droplets in the 
medium emulsions (Figures 4.3 and 4.4b). The results of the INFOGEST method are 
therefore consistent with those obtained with other in vitro digestion methods, where 
researchers also reported some undigested oil phase in emulsions containing relatively 
large oil droplets 156, 201. The fine and medium emulsions appeared much more turbid than 
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the large emulsions after digestion under small intestine conditions (Figure 4.4a). This 
suggests that they contained more sub-micron particles that scattered light strongly. 
The absolute value of the negative z-potential of all the emulsions increased 
significantly (p < 0.05) after intestinal digestion (Figure 4.1b), which is probably due to 
the generation of anionic fatty acids. Interestingly, the absolute value of the surface 
charge was similar for the fine and medium emulsions but significantly (p < 0.05) low for 
the large emulsions (Figure 4.1b). This is probably because the large oil droplets were not 
fully digested (see next section), and so less anionic fatty acids were generated. 
4.4.2 Lipid digestion in the intestinal digestion 
The production of free fatty acids (FFAs) during the intestinal phase was followed 
using a pH stat method. Initially, the volume of alkaline titrant needed to neutralize the 
FFAs produced during digestion was continuously recorded. However, a fraction of the 
FFAs released during lipid digestion from long chain triglycerides (like those in corn oil) 
are not ionized at pH 7, so they are not titrated by NaOH during pH stat measurements 
157, 169. Therefore, after digestion was completed, a back-titration was performed to pH 9 
to determine the total fraction of FFAs released by the various emulsions: 117, 113 and 
78% for the fine, medium, and large emulsions, respectively (Figure 4.6a). The 
INFOGEST method uses relatively high enzyme levels to simulate fed conditions in the 
human gut, which would account for the high degree of lipid digestion observed in the 
emulsions after back titration. It should be noted that these values are considerably higher 
than the total fraction of FFAs calculated without the back-titration for the same 
emulsions: 60, 52, 37%, respectively (Figure 4.6a). Again, this difference indicates that 
not all of the free fatty acids were fully ionized under neutral small intestine conditions, 
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and so they are not titrated by the alkaline solution at pH 7. For this reason, a correction 
factor (CF) was employed to determine the actual level of FFAs produced during lipid 
hydrolysis. The correction factor was calculated as: CF = Final FFAs (pH 9)/Final FFAs 
(pH 7). 
 
Figure 4.6 The effect of oil droplet size on: (a) final free fatty acid (FFA) released; (b) 
corrected FFA released profile during small intestine digestion. Significant differences (p 
< 0.05) among samples with different oil droplet size in terms of the final FFA released at 
pH 7 and pH 9 were labeled as lower-case letters (a, b, c) and capital letters (A, B, C), 
respectively. 
The kinetics of lipid digestion clearly depended on the size of the oil droplets in the 
emulsions entering the small intestine (Figure 4.6b). For all samples, the percentage of 
FFAs produced increased rapidly during the initial stages and then more slowly later. 
Nevertheless, the initial rate of FFAs released became faster as the droplet size was 
reduced, and the total amount of fatty acids released by the end of digestion was 
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appreciably higher for the small and medium emulsions than the large emulsions. The 
results of the INFOGEST method are therefore consistent with those found by previous 
researchers using simpler in vitro digestion models 18, 156, 182, 201. This effect occurs 
because the specific surface area (AS) of the oil droplets in an emulsion is inversely 
proportional to their average diameter (D3,2). Consequently, there is more lipid surface 
available for the lipase molecules to attach to for emulsions containing smaller droplets. 
The initial lipid digestion rates calculated from the free fatty acid release profiles (first 5 
minutes) were 21.1, 15.2, and 7.0 FFA/min for the small, medium, and large emulsions, 
respectively. This suggests that there was a positive, though not direct, correlation 
between the lipid digestion rate and the droplet surface area. 
Interestingly, the total fraction of FFAs produced by the final stages of lipid 
digestion exceeded 100% for the small and medium emulsions (Figure 4.6b). The 
calculation of the percentage of FFAs released using the pH stat method is based on the 
assumption that only two FFAs and one monoglyceride are generated per triglyceride 
molecule due to the action of pancreatic lipase 2. In practice, some of the monoglycerides 
may be further hydrolyzed into a glycerol molecule and another free fatty acid, thereby 
leading to values over 100%. Indeed, previous researchers have shown experimentally 
that monoglycerides can be degraded through this mechanism 18, 170.  
4.4.3 Stability, release, and bioaccessibility of β-carotene  
The bioaccessibility of hydrophobic nutraceuticals trapped inside oil droplets is 
known to depend on the digestion of the surrounding lipid phase 2. Consequently, we 
measured the influence of oil droplet size on the bioaccessibility of the β-carotene in the 
emulsions. The carotenoid concentration of the initial emulsions was measured, as well as 
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in various fractions collected after small intestinal digestion (sediment phase, micelle 
phase, total digested sample). The stability, release, and bioaccessibility of the β-carotene 
were then calculated from these values. 
 
Figure 4.7 The effect of oil droplet size on: (a) percentage of β-carotene that is stable and 
released; (b) percentage of β-carotene that is bioaccessible or sedimented; and (c) the 
concentration of β-carotene in different phases of corn oil-in-water emulsions after 
digestion in the small intestine. Capital letters (A, B, C), lower-case letters (a, b, c) and 
the Greek letters (α, β, γ) were used to designate significant difference (p < 0.05) among 
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different oil droplet sizes. “Micelle” indicates the mixed micelle phase (supernatant 
fraction) of the intestinal samples, which contains micelles and vesicles. 
Carotenoid stability: β-carotene stability in the samples to degradation and/or loss as 
they passed through the simulated GIT was defined as the total concentration measured in 
the small intestine divided by that measured in the initial emulsion. The stability of the β-
carotene was significantly (p < 0.05) higher in the fine and medium emulsions (75%) 
than in the large emulsions (65%) (Figure 4.7a). β-carotene is susceptible to chemical 
degradation when exposed to heat, light, or acidic conditions 202. Consequently, some of 
the β-carotene may have degraded within the acidic gastric environment (pH 3), 
especially since it was held there for two hours at a slightly elevated temperature (37 oC). 
In addition, some of the β-carotene-loaded oil droplets may have adhered to the sides of 
the containers used to hold or transfer the emulsions within the simulated GIT, and so 
were not detected in the small intestine. Typically, the attractive forces between colloidal 
particles and surfaces increase as the particle size increases 203, which may have led to 
more of the larger droplets being lost through this mechanism. 
Carotenoid release: The fraction of β-carotene released by the oil droplets was 
calculated as the sum of the concentrations measured in the sediment and micelle phases 
divided by the total concentration measured in the small intestine phase after digestion. 
We assumed that any non-released β-carotene was still associated with the oil phase 
(which formed a thin surface layer on some emulsions). Carotenoid release decreased 
significantly (p < 0.05) as the oil droplets became larger, being 94.7, 76.0 and 55.0% for 
the fine, medium, and large emulsions, respectively (Figure 4.7a). We attributed this 
effect to the reduction in lipid digestion as the droplets became bigger, which is 
supported by the lower level of free fatty acids produced during digestion (Figure 4.6), 
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the appearance of a thin surface layer on medium and large emulsions (Figure 4.4b), and 
the existence of large non-digested oil droplets in the microscopy results (Figure 4.3). It 
should be noted that this non-released fraction would be expected to reduce the 
bioaccessibility of the carotenoids in the small intestine phase. However, it is possible 
that any β-carotene remaining in the oil phase could travel to the colon and be released 
there, provided there are digestive enzymes available to break down the lipid phase. 
Moreover, this feature could be beneficial for the creation of emulsion delivery systems 
with extended release profiles for hydrophobic nutraceuticals. However, further 
experiments, both in vitro and in vivo, are needed to test these hypotheses. 
Carotenoid bioaccessibility: β-carotene bioaccessibility was calculated as the 
concentration measured in the micelle phase divided by the total concentration measured 
in the digested samples after the small intestine phase. After being released from the oil 
droplets, some of the β-carotene is incorporated into the mixed micelles in the aqueous 
phase that are typically formed from monoglycerides, free fatty acids, bile salts, and 
phospholipids. It is typically assumed that only β-carotene in this form can travel through 
the mucus layer and be internalized by the epithelium cells 204.  
In our study, the percentage of β-carotene in a bioaccessible form decreased 
significantly (p < 0.05) with increasing droplet size, being 82.5, 46.5, and 15.0% for the 
fine, medium, and large emulsions, respectively (Figure 4.7b). Conversely, the 
percentage of β-carotene within the sediment phase increased significantly (p < 0.05) 
with increasing droplet size, being 12.2, 29.5, and 44.4% for the corresponding 
emulsions. The same trends were observed in the measurements of the absolute 
concentrations of β-carotene in the micelle and sediment phases (Figure 4.7c). 
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Specifically, the carotenoid concentration in the micelles decreased significantly (p < 
0.05) as the droplet size increased, changing from 3.17 μg/ml for the fine emulsion to 
0.57 μg/ml for the large emulsion. At the same time, the carotenoid concentration in the 
sediment phase increased with increasing droplet size, changing from 0.43 μg/ml for the 
fine emulsion to 1.82 μg/ml for the large emulsion. On the other hand, the total 
concentration of carotenoids in the overall small intestine phase remained fairly constant 
(3.9 to 4.8 μg/ml). 
The high bioaccessibility and low sedimentation of the fine emulsions are attributed 
to complete lipid digestion, high micellization, and low precipitation of the carotenoids 
under the digestion conditions used in the INFOGEST method i.e., high lipase, high bile 
salts, and low calcium). Conversely, our results suggest that the lower β-carotene 
bioaccessibility observed for larger droplets is due to two main factors: (i) some of the 
carotenoids was not released from the oil phase because it was not fully digested (Figure 
4.7a); (ii) some of the carotenoids that were released from the oil droplets precipitated 
and were therefore incorporated into the sediment phase (Figure 4.7c). The fraction of 
non-digested oil was shown earlier to increase when the droplet size was reduced (Figure 
4.6), which would account for more of the carotenoids remaining within the oil phase at 
the end of digestion (Factor (i)). There are two potential causes for more precipitation of 
the β-carotene in emulsions containing larger oil droplets (Factor (ii)). First, it might be 
due to differences in the relative rates of lipid digestion, carotenoid release, carotenoid 
solubilization, and carotenoid crystallization 91. In relatively large droplets, which are 
only digested slowly, the release and solubilization of carotenoids are also relatively 
slow, so they tend to accumulate inside the oil droplets. As a result, their concentration in 
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the oil phase increases, until eventually it exceeds the saturation limit, and the 
carotenoids form water-insoluble crystals. Conversely, in relatively small droplets, which 
are digested rapidly, the carotenoids are quickly released and solubilized into the mixed 
micelles, which avoids the formation of large carotenoid crystals. A second reason may 
arise as a result of differences in the surface curvature of oil droplets with different 
dimensions, which leads to various types of colloidal particles being formed during lipid 
digestion. Large oil droplets have relatively low curvatures, thereby leading to the 
formation of larger vesicles at the oil droplet surfaces. Conversely, small oil droplets 
have relatively high curvatures, which may promote the formation of smaller micelles or 
vesicles at the droplet surfaces. Once formed, the larger vesicles may be more prone to 
precipitate due to their interactions with calcium ions in the gastrointestinal fluids, 
thereby leading to the production of more calcium soap precipitates. However, more 
experiments are clearly needed in this area to verify these hypotheses. 
In this study, carotenoid bioaccessibility increased as the fraction of FFAs released 
from the emulsions increased (Figure 4.8). There was a gradual increase in 
bioaccessibility when the percentage of FFAs released increased from 78% (large 
emulsion) to 113% (medium emulsion), followed by a steep increase when the 
percentage of FFAs released increased to 117% (fine emulsion). We hypothesize that this 
effect occurred because more and more β-carotene accumulated within the oil phase as 
lipid digestion proceeded, because lipid digestion was faster than carotenoid release 91. 
Consequently, any non-digested oil may have contained quite high levels of carotenoid. 
A layer of oil was clearly discernable on top of the medium and large emulsions after 
digestion, but not in the fine emulsions. This effect would therefore account for the large 
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increase in bioaccessibility observed when moving from the medium to fine emulsions 
(Figure 4.8). 
 
Figure 4.8 Relationship between the final free fatty acids released and β-carotene 
bioaccessibility after in vitro digestion of emulsions with different droplet size. From left-
to-right, the data correspond to large, medium, and fine emulsions. 
Overall, our results are consistent with earlier studies using non-standardized in vitro 
digestion models, which have also reported a decrease in bioaccessibility with increasing 
droplet size 18, 180, 182. This suggests that results from the new harmonized INFOGEST 
method can be compared to those obtained using these earlier in vitro digestion methods, 
at least qualitatively. In a series of recent studies, we have systematically examined a 
number of food matrix effects (oil droplet concentration, oil droplet size, and emulsifier 
type) on lipid digestion and carotenoid bioaccessibility in emulsions using the 
INFOGEST method 191, 192. Taken together, these studies show that oil droplet size is one 
of the most critical factors influencing the gastrointestinal fate of food emulsions, and 
that the impact of other factors (such as emulsifier type) can largely be accounted for by 
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4.5 Conclusions 
The impact of oil droplet size (0.1, 1 and 10 μm) on the bioaccessibility of β-
carotene encapsulated within model food emulsions was characterized using the 
standardized INFOGEST digestion model. These particle sizes were selected to cover a 
broad range of oil droplet sizes found in commercial food products. During the digestion 
process, the surfactant-coated oil droplets were stable to aggregation or dissociation prior 
to adding the pancreatic lipase in the small intestine phase. After adding the lipase, the 
triglycerides inside the oil droplets were broken down into monoglycerides and free fatty 
acids at a rate depending on their size. The initial rate of lipid digestion and the final 
concentration of free fatty acids released increased with decreasing droplet size, which 
was attributed to the increase in surface area available for lipase to attach to. The 
suppression of lipid digestion in emulsions containing large droplets had a pronounced 
impact on carotenoid bioaccessibility. As the droplet size increased, the amount of β-
carotene in the mixed micelles decreased, while that in the non-digested oil and sediment 
increased. The decrease in carotenoid bioaccessibility was mainly attributed to the fact 
that some of the carotenoids stayed within the non-digested oil droplets remaining after 
digestion of the large emulsions. Moreover, some of the carotenoids may have formed 
dense crystals that were trapped in the sediment phase. Overall, the results obtained using 
the standardized INFOGEST method were in good agreement with those obtained using 
earlier in vitro digestion methods. 
The results from this study should contribute to the design of food products with 
tunable biological effects, such as prolonging satiety or nutraceutical blood levels by 
delaying lipid hydrolysis and nutraceutical release. Nevertheless, in vivo experiments are 
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required to establish whether similar phenomena are observed in practice. Moreover, the 
impact of droplet size on the gastrointestinal fate of the emulsions is likely to depend on 
emulsifier type because this determines their resistance to size changes within the mouth 
and stomach prior to reaching the small intestine. In future studies, it will be important to 
investigate the impact of oil droplet size on the gastrointestinal fate of real emulsified 
food systems, such as beverages, dressings, sauces, dips, and desserts, as these are 
typically structurally and compositionally more complex than the simple model systems 
used in this study. Moreover, it will also be important to compare the results obtained 
with static in vitro methods (such as the INFOGEST one) with those obtained using more 
realistic dynamic digestion models, as well as in vivo feeding trials using animals or 
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CHAPTER 5 
FACTORS IMPACTING LIPID DIGESTION AND 
NUTRACEUTICAL BIOACCESSIBILITY ASSESSED BY 
STANDARDIZED GASTROINTESTINAL MODEL 
(INFOGEST): EMULSIFIER TYPE 
5.1 Abstract 
This paper is part of a series examining the impact of the main factors influencing 
lipid digestion and nutraceutical bioaccessibility in b-carotene-loaded oil-in-water 
emulsions using the harmonized INFOGEST simulated gastrointestinal model. Here, the 
impact of emulsifier type was examined since food emulsions and nutraceutical delivery 
systems are often stabilized by various types of emulsifier. The INFOGEST method was 
adopted to investigate the in vitro gastrointestinal fate of emulsions stabilized by five 
kinds of food-grade emulsifier representing different classes: synthetic surfactants 
(Tween 20); natural surfactants (quillaja saponin); proteins (caseinate); polysaccharides 
(gum arabic); and phospholipids (soy lysolecithin). Microfluidization produced 
emulsions with small droplet sizes for all emulsifiers, except soy lysolecithin. Within the 
gastrointestinal model, the caseinate-coated oil droplets had the worst gastric stability, 
with severe droplet flocculation and coalescence occurring in the stomach. The fraction 
of the lipid phase that had been digested by the end of the gastrointestinal model was 
considerably lower for the emulsions stabilized by soy lysolecithin (93%) or caseinate 
(93%), than those stabilized by gum arabic (99%), quillaja saponin (111%) or Tween 20 
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(117%). This effect was attributed to lower surface area of lipids available for lipase to 
attach to for the lysolecithin and caseinate emulsions. The overall bioaccessibility of the 
b-carotene increased in this order: lysolecithin (25%) < gum arabic (51%) < caseinate 
(55%) < quillaja saponin (56%) < Tween 20 (62%). The impact of emulsifier type on 
carotenoid bioaccessibility was ascribed to various factors: (i) some emulsifiers inhibited 
lipid digestion and so a fraction of the b-carotene remained inside the undigested droplets 
and the mixed micelle phase had less solubilization capacity, i.e., lysolecithin, and 
caseinate; (ii) some emulsifiers protected b-carotene from chemical degradation, i.e., 
lysolecithin and caseinate; and (iii) some emulsifiers promoted sedimentation of the β-
carotene-loaded micelles, i.e., lysolecithin. These results suggest that food emulsion 
behavior in the human gut may be influenced by the nature of the emulsifier employed, 
which is important knowledge when creating functional food and beverage products. 
Keywords: Emulsifier type; β-carotene; emulsion; bioaccessibility; INFOGEST method. 
5.2 Introduction 
The updated INFOGEST method has recently been introduced as a standardized in 
vitro gastrointestinal model to mimic the fate of foods inside the human gut 3. However, 
there is still limited knowledge of how different kinds of food behave within this in vitro 
digestion model. Previously, our research group has examined the impact of oil droplet 
concentration and size on emulsion behavior in a simulated gastrointestinal tract (GIT) 
environment using the INFOGEST method 205, 206. In this paper, our focus was on the 
impact of emulsifier type on the behavior of emulsified lipids within the GIT using the 
same method. Numerous kinds of emulsifiers can be employed by the food industry to 
formulate their products 207. These surface-active molecules become attached to the 
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surfaces of the oil droplets generated inside homogenizers, thereby depressing the 
interfacial tension and promoting droplet disruption, leading to the generation of smaller 
droplets. Moreover, they create a coating around each of the droplets, which inhibits their 
ability to aggregate with each other through strong steric and/or electrostatic repulsive 
forces 160. 
 The physicochemical characteristics of these coatings include thickness, charge, 
packing, and composition, which greatly influences emulsion performance. On one hand, 
coating properties influence the physical and chemical stability of emulsified lipids 
during storage 208. On the other hand, after being consumed, they impact the digestion of 
the oil droplets inside the human gut, as well as the release and solubilization of any 
hydrophobic nutraceuticals 140. Emulsifier properties may therefore affect the behavior of 
food emulsions within the GIT in numerous ways. Firstly, different kinds of emulsifier-
coated droplets are sensitive to different environmental stressors within the GIT, such as 
mineral ions, pH changes, bile salts, or enzyme activities. For instance, droplets coated 
with protein-based emulsifiers often flocculate in the stomach because of electrostatic 
and bridging effects 209. Droplet flocculation reduces the surface are available for bile 
salts and pancreatic lipases to attach to, which inhibits lipid digestion, as well as bioactive 
release and solubilization 198, 210. Secondly, the properties of interfacial coatings directly 
influence the adsorption of bile salts and pancreatic enzymes to the oil droplet surfaces, 
again inhibiting digestion and release 201. For example, some emulsifiers have been 
shown to reduce the adsorption of lipase on oil droplet surfaces under simulated GIT 
conditions, thereby retarding triglyceride digestion 98. Thirdly, some surface-active 
substances used as stabilizers in food emulsions can interact with digestive components, 
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thereby reducing macronutrient bioavailability, as well as bioactive release and 
solubilization. For instance, the addition of chitosan to emulsions can bind to mixed 
micelles formed during their digestion, thereby promoting their precipitation along with 
the solubilized nutraceuticals trapped inside them 81. 
Numerous types of emulsifiers are widely used for the formulation of food 
emulsions, such as phospholipids, proteins, polysaccharides, small molecule surfactants 
(synthetic and natural), nanoparticles, and their combinations 207. Therefore, these 
products display various emulsion performance in acid, alkaline, salt, cold, hot, or 
enzyme-rich environments during storage as well as during GIT. Here, we systematically 
studied the influence of five different food-grade emulsifiers on the GIT fate of 
emulsions loaded with b-carotene using the standardized INFOGEST in vitro 
gastrointestinal model. This carotenoid was selected as a model hydrophobic 
nutraceutical because it has widely been used in other studies. The emulsifiers used in 
this study were selected to represent a broad range of hydrophilic emulsifiers found in 
foods: Tween 20, quillaja saponin, caseinate, gum arabic, and soy lysolecithin. 
Tween 20 was selected as a representative small molecule synthetic surfactant. It 
consists of a non-polar saturated hydrocarbon (C12) tail and three polar polyoxyethylene 
heads, and primarily stabilizes emulsions through steric repulsion 159. Quillaja saponin 
was used as a representative small molecule natural surfactant. It has an ellipsoid-like 
structure with non-polar (quillaic acid groups) patches and polar (sugar groups) patches 
on its surfaces 211. This molecule is negatively charged in most solution conditions found 
in foods (pH > 3), which means it can stabilize emulsions by a combination of steric and 
electrostatic repulsive forces 212, 213. 
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Caseinate was selected as a representative amphiphilic protein-based emulsifier. 
This dairy ingredient contains a mixture of proteins (as1-, as2-, b-, and k-casein) that have 
a relatively adaptable structure with some regions that are predominantly hydrophobic 
and other regions that are predominantly hydrophilic 214. As a result, they can become 
attached onto the surfaces of the oil droplets inside a homogenizer and form coatings that 
stabilize them against aggregation through steric and electrostatic repulsion 215, 216. In 
addition, caseinate is interfacial antioxidant that can slow down the chemical degradation 
of encapsulated lipids or nutraceuticals 217. A potential disadvantage of using caseinate as 
emulsifier is that it is strongly affected by changes in pH and ionic strength, which 
adversely affects the ability to form and stabilize emulsions 218. 
Gum arabic was selected as a representative amphiphilic polysaccharide-based 
emulsifier. It is composed of non-polar polypeptide chains covalently linked to polar 
polysaccharide chains 219, which enables it to attach to the surfaces of oil droplets, 
thereby inhibiting their tendency to aggregate 220. Relatively high gum arabic-to-oil ratios 
are needed to produce small oil droplets during homogenization because of its relatively 
high surface load and low surface activity 221, 222. However, once attached to the surfaces 
of the oil droplets, gum arabic forms a thick interfacial layer that provides good 
resistance to aggregation over a wide range of conditions through steric repulsion 223. 
Soy lysolecithin was selected as a representative phospholipid-based emulsifier. 
Phospholipids are isolated from plants, animals, and microorganisms, where they are 
integral parts of biological membranes 224. In nature, they usually consist of a glycerol 
moiety with two fatty acids attached (sn-1 and sn-2), as well as a phosphate-based group 
(sn-3) 222. In lysolecithin, one of the fatty acids is removed, which makes the molecule 
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more polar and better at stabilizing oil-in-water emulsions 225. The remaining fatty acid 
chain provides the non-polar part, while the phosphate-based group provides the polar 
part, thereby leading to surface-activity. Nevertheless, the surface activity of lysolecithin 
is usually less than that of surfactants and proteins, and they are unstable to acidic 
conditions and high salt levels due to a reduction in electrostatic repulsion 226. 
Previous studies using other simulated GIT models demonstrate that emulsifier type 
influences lipid digestion and nutraceutical bioaccessibility 141, 198, 217. Here, we 
systematically explore the impact of emulsifier type in these factors using the newly 
harmonized INFOGEST digestion model 3, 124. This model is designed to simulate fed 
state physiological conditions within the human gut and is now the most widely 
employed in vitro digestion model for studying food systems. The knowledge acquired 
should help establish the suitability of the INFOGEST model for studying emulsions, as 
well as aid in the design of emulsion-based functional foods. 
5.3 Materials and methods 
5.3.1 Materials 
Sodium caseinate was purchased from the American Casein Company (Burlington, 
NJ). Gum arabic was kindly provided by TIC Gums (Belcamp, MD). Quillaja saponin 
(Q-Naturale 200 V) was kindly provided by Ingredion Inc. (Westchester, IL).	Soybean 
hydrogenated lysolecithin (LIPOID S LPC 20-3) was kindly provided by Phospholipid 
GmbH (Koln, Germany). The additional reagents and chemicals utilized in the present 
study were described in detail in 3.3.1.	
5.3.2 Preparation and characterization of emulsion-based delivery systems 
 
   77 
The oil phase and the homogenization techniques used were described in detail in 
3.3.2. Aqueous phases were prepared by dispersing emulsifiers in phosphate buffer 
solution (5 mM, pH 7.0): 0.5 wt% Tween 20, 0.5 wt% caseinate, 0.5 wt% quillaja 
saponin, 0.5 wt% lysolecithin, or 2.5 wt% gum arabic (based on final emulsion). 
The physical characterization of the samples was carried out according to 3.3.3, 
3.3.4 and 3.3.5. 
5.3.3 In vitro digestion 
In vitro digestion of carotenoid-loaded emulsions was performed using the recently 
updated harmonized INFOGEST method 3. The experimental details were described in 
3.3.6 and 3.3.7. 
5.3.4 Extraction and analysis of β-carotene 
The β-carotene was extracted from the samples and analyzed according to a method 
described in 3.3.8. 
5.3.5 Statistical analysis 
 See details in 3.3.9 
5.4 Results and discussion 
5.4.1 The physical and structural properties during in vitro gastrointestinal tract 
The initial oil-in-water emulsions contained β-carotene-loaded oil droplets coated 
with a series of representative food-grade emulsifiers: Tween 20; quillaja saponin; gum 
arabic; caseinate; and, lysolecithin. All these emulsions were produced under similar 
homogenization conditions. Tween 20, quillaja saponin, and caseinate all produced 
emulsions containing small mean particle diameters (D3,2): 0.16, 0.17, and 0.18 μm, 
respectively (Figure 5.1a). The particle size distributions and microscopy images also  
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Figure 5.1 The effect of different emulsifier type on (a) the surface weighted mean 
particle diameter (D3,2) during in vitro gastrointestinal digestion and (b) particle size 
distribution of the initial emulsion samples. Different capital letters (A, B, C) were used 
to designate significant difference (p < 0.05) among different emulsifier type (same 
stage), and lower-case letter (a, b, c) for different stage (same emulsifier type). SI is 
abbreviated for small intestine and GA is abbreviated for gum arabic. The volume 
fraction was stacked up the y-axis for comparison. 
showed the oil droplets were comparatively small in these emulsions and did not strongly 
aggregate with each other (Figures 5.1b and 5.2). The emulsions produced from 
lysolecithin contained significantly (p < 0.05) larger droplets (D3,2 = 0.33 μm) than these 
emulsions, and had a bimodal distribution (Figure 5.1). The microscopy images indicate 
the oil droplets had dimensions ranging from around 0.1 to 10 μm (Figure 5.2). The 
emulsions produced from gum arabic contained the largest mean particle diameter (D3,2 = 
0.48 μm), but had a monomodal distribution (Figures 5.1 and 5.2). Even though the light 
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scattering results suggested that the gum arabic emulsion contained larger oil droplets 
than the lysolecithin one, the microscopy images clearly showed that the lysolecithin 
emulsion contained a population of relatively large oil droplets. This suggests that the 
lysolecithin emulsion also contained another fraction of very small droplets that 
contributed to the overall light scattering signal. All the initial emulsions had a fairly 
uniform creamy yellow appearance, except the lysolecithin one, which had a thin layer of 
oil on top (Figure 5.3). The resistance of emulsions to coalescence and gravitational 
separation is known to be highly correlated to particle size, with faster creaming and 
phase separation occurring for larger oil droplets 178, 194. Differences in initial droplet size 
are typically due to differences in emulsifier surface activity and adsorption kinetics 
during homogenization 222. 
All emulsions had negative surface potentials when freshly prepared. The quillaja 
saponin emulsions contained the emulsifier-coated droplets with the highest absolute 
value of the z-potential, i.e., -71.9 mV (Figure 5.4). High negative charges on quillaja 
saponin-coated droplets have been shown in other studies which is due to the presence of 
carboxylic acid groups within the structure of quillaja saponin 212, 227. The absolute values 
of the z-potentials on the droplets in the caseinate, lysolecithin, and gum arabic 
emulsions were appreciably lower, ranging from -41.5 to -32.8 mV (Figure 5.4). The 
anionic nature of the caseinate- and gum arabic-coated droplets is mainly because the 
initial pH was above the isoelectric point of their polypeptide fractions 218. The anionic 
nature of lysolecithin-coated oil droplets is mainly linked to their negatively-charged 
phosphate-groups 226. Usually, a high surface charge improves emulsion stability by 
creating a strong electrostatic repulsive force amongst the droplets 194. The reason that  
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Figure 5.2 The effect of different emulsifier type on the confocal photos of corn oil in 
water emulsions during in vitro gastrointestinal digestion. 
the lysolecithin-coated oil droplets were unstable, even though they had a high z-
potential, may have been that some of the droplets formed during homogenization were 
relatively large as a consequence of the relatively high surface load and/or slow 
absorption of this emulsifier. As a result, they tended to cream upwards and form a 
densely packed cream layer where the droplets come into contact for long periods, 
leading them to merge together. The Tween 20-coated oil droplets had the lowest 
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absolute magnitude of the z-potential, which can mainly be attributed to the fact it is a 
non-ionic surfactant. The fact that Tween 20 does have some negative charge may be due 
to anionic surface-active substances within the oil or surfactant ingredients used to 
formulate them, or as a result of preferential adsorption of OH- ions from water 160. 
 
Figure 5.3 The effect of different emulsifier type on the optical photos of corn oil in 
water emulsions during in vitro gastrointestinal digestion. 
After preparation, the emulsions were subjected to the successive GIT phases of the 
harmonized INFOGEST in vitro digestion model 3. Samples were collected after the oral, 
stomach, and small intestinal phases to measure their physical and structural properties. 
In addition, a sample was collected at the start of the small intestine (“SI-initial phase”) 
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after adjusting the pH to neutral, but before adding the bile salts and digestive enzymes. 
Previously, it has been shown that the properties of an emulsion in the SI-initial and 
gastric phases, particularly the exposed surface area, are more important in determining 
its digestion in the small intestine phase than those of the original emulsion 81, 87. 
 
Figure 5.4 The effect of different emulsifier type on the ζ potential of corn oil in water 
emulsions during in vitro gastrointestinal digestion. Different capital letters (A, B, C) 
were used to designate significant difference (p < 0.05) among different emulsifier type 
(same stage), and lower-case letter (a, b, c) for different stage (same emulsifier type). 
The mean particle size of emulsions stabilized by Tween 20, quillaja saponin, and 
gum arabic remained the same from the initial samples to the SI-initial phase (Figure 
5.1a). Confocal microscopy images and digital photographs also showed that these 
emulsions were stable to aggregation throughout the first few steps of the INFOGEST 
method (Figures 5.2 and 5.3). These results agree with previous studies that have reported 
that emulsions stabilized by Tween 20, quillaja saponin, and gum Arabic are relatively 
stable in the mouth and stomach phases 228-230. Conversely, the charge on these emulsions 
did change appreciably depending on the GIT stage, due to alterations in solution pH and 
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interfacial composition (Figure 5.4). Under the neutral pH conditions found in the initial, 
oral and SI-initial samples, these emulsions had highly negative surface potentials. 
Having said that, the magnitude of the negative charge was somewhat lower in the GIT 
samples than in the initial samples, as a result of electrostatic screening, ion adsorption, 
or polyelectrolyte adsorption 231. Under the acidic environment (pH 3) of the gastric 
phase, the absolute value of the surface potential of these three emulsions decreased 
significantly (p < 0.05), ranging from -10.8 mV for quillaja saponin to -1.9 mV for 
Tween 20 (Figure 5.4). This phenomenon is due to protonation of carboxyl groups on the 
polar regions on the emulsifiers under highly acidic conditions. The fact that the droplets 
were still resistant to aggregation suggests that the oil droplets coated by the surfactants 
and polysaccharides were mostly protected by steric repulsion. 
The caseinate-coated oil droplets behaved very differently under simulated GIT 
conditions. They were highly unstable to droplet agglomeration within gastric fluids, as 
demonstrated by the much higher particle sizes (D3,2 = 15.6 μm), evidence of severe 
flocculation in the confocal images, and evidence of phase separation in the emulsion 
appearances (Figures 5.1-5.3). Caseinate-coated oil droplets have previously been 
reported to be extremely unstable to aggregation under gastric conditions 209. This effect 
is due to weak electrostatic repulsion between the droplets due to their low surface charge 
(Figure 5.4), as well as possibly bridging of the cationic caseinate-coated oil droplets by 
anionic mucin molecules from the saliva. The instability under gastric conditions has 
been reported in other kinds of protein-stabilized emulsions 16, 141, 232. When the pH was 
adjusted to neutral to attain the SI-initial phase, many of the large flocs seen in the 
caseinate emulsions dissociated leading to a smaller mean particle diameter (Figures 5.1a 
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and 5.2). This outcome is primarily a result of an increase in the absolute value of the 
surface potential (-37.9 mV), which strengthened the electrostatic repulsion amongst the 
droplets (Figure 5.4). Moreover, both the mucin and caseinate-coated droplets would be 
anionic at pH 7, which should prevent bridging flocculation. Interestingly, however, the 
average particle size was still greater than the initial emulsion (Figures 5.1a and 5.2), 
suggesting some irreversible flocculation and/or coalescence occurred after gastric 
digestion. Whereas, the good stability of the gum arabic emulsions in the first few stages 
of the simulated GIT can be attributed to a strong steric repulsion between the 
polysaccharide-coated oil droplets 233. 
 
Figure 5.5 The average size of the mixed micelle samples obtained after intestinal 
digestion of emulsions using different emulsifiers. Capital letters (A, B, C) were used to 
indicate significant difference (p < 0.05) among samples. 
For the lysolecithin-stabilized emulsions, particle dimensions increased appreciably 
in the mouth and then stayed large in the stomach, and SI-initial phases (Figures 5.1a and 
5.2). In addition, appreciable phase separation was seen in these samples, especially in 
the stomach (Figure 5.3). The surface potential was again strongly negative in the initial, 
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oral, and SI-initial phases, and close to zero in the stomach phase (Figure 5.4), which can 
be ascribed to similar reasons discussed earlier, pH-induced protonation/de-protonation 
of carboxyl groups. 
After the intestine, the majority of oil droplets appeared to be hydrolyzed by the 
pancreatic enzymes, as seen by the disappearance of most of the fat droplets in the 
confocal images (Figure 5.3). Lipid digestion produces anionic free fatty acids and 
neutral monoglycerides that become assimilated into the micelles, liposomes, calcium 
soaps, and other particles 234, 235. The formation of these different kinds of colloidal 
structures accounts for the fact that some particles were detected by light scattering 
(Figure 5.1a) and microscopy (Figure 5.3). Some differences in the particle sizes, 
microstructures, and appearances of the different digested samples were observed 
(Figures 5.1-5.3), suggesting that different kinds of colloidal structures were present. In 
particular, there were numerous large lipid-rich particles in the lysolecithin emulsions and 
some in the caseinate emulsions, which could be non-digested lipid droplets. 
The particle sizes of the mixed micelle samples were also measured. In general, the 
mean particle diameter of the mixed micelles produced from all the emulsions was quite 
similar i.e., from 135 to 223 nm (Figure 5.5), suggesting that fairly similar colloidal 
particles were available to solubilize the carotenoids. All of the mixed micelle phases also 
had high negative charges, which is due to the anionic fatty acids, bile salts, polypeptides, 
and emulsifiers present in the samples after digestion. 
5.4.2 Lipid digestion in the intestinal digestion 
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Figure 5.6 The effect of emulsifier type on (a) final free fatty acid (FFA) released; (b) 
corrected FFA released profile during intestinal digestion. The significant difference 
among samples with different emulsifiers for final FFA released at pH 7 and pH 9 was 
labeled as lower-case letters (a, b, c) and capital letters (A, B, C) respectively. 
The kinetics of lipid digestion were followed by titration of the free fatty acids 
(FFAs) released by the oil droplets using the pH stat approach. The fraction of FFAs 
released from the emulsions was corrected using a correction factor established by a back 
titration to pH 9, as described previously 16. The back-titration step was required because 
long chain FFAs are not completely ionized under neutral pH conditions. The results 
showed complete or almost complete lipid digestion for all samples, with the final FFAs 
released depending on emulsifier type: Tween 20 (117%) > quillaja saponin (111%) > 
gum arabic (99%) > caseinate (93%) » lysolecithin (93%) (Figure 5.6a). The excessive 
level of lipid digestion observed in some emulsions (>100%) may be due to the fact that 
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some of the monoacylglycerols were converted into a glycerol molecule and a fatty acid 
under alkaline conditions 170. Emulsifier type also impacted the initial rate of lipid 
digestion during the first 500 s (Figure 5.6b), which suggests that the nature of the 
emulsifier attached to the droplet surfaces influenced the ability of bile salts and/or lipase 
to adsorb to the oil-water interface when the droplets first reached the small intestine. 
In addition, emulsifier type may have influenced lipid digestion by altering the 
surface area of lipids available for the bile salts and lipase molecules to attach to. There 
appeared to be a correlation between the kinetics of lipolysis and the mean diameter of 
the particles (D3,2) entering the small intestine (SI-initial), which is inversely related to 
the specific surface area. The final extent of lipid digestion decreased as D3,2 in the SI-
initial phase increased (Figure 5.7). Tween 20, quillaja saponin, and gum arabic produced 
emulsifier-coated droplets that are relatively stable to aggregation in the oral, gastric, and 
initial small intestine phases. As a result, the lipase could easily attach to the droplet 
surfaces and rapidly induce complete lipid digestion. Previous researchers also showed 
high lipid digestion and nutraceutical bioaccessibility and/or bioavailability in emulsions 
systems, using different in vitro digestion models 227, 230, 236. Conversely, caseinate and 
lysolecithin produced emulsifier-coated droplets that were unstable to aggregation 
(flocculation and/or coalescence) in the oral, gastric, and initial small intestine phases, 
leading to an increase in particle size and decrease in exposed surface area for lipase 
molecules. A reduced level of lipid digestion in caseinate-stabilized emulsions has also 
been reported using other in vitro digestion models 237. The importance of oil droplet size 
(surface area) on lipid digestion and nutraceutical bioaccessibility has also been reported 
elsewhere 197, 238. It should be noted that our results highlight the importance of using the 
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size of the droplets entering the small intestine phase to predict the lipid digestion 
kinetics of emulsions, rather than that of the original samples. 
 
Figure 5.7 The correlation between the final FFA release after intestinal digestion and the 
D3,2 value at the beginning of the intestinal phase for the corn oil in water emulsions of 
different emulsifier. From left to right, data correspond to the Tween 20, quillaja saponin, 
gum arabic, caseinate and lysolecithin emulsions. 
Interestingly, some of the emulsions had quite different particle sizes, but gave 
similar digestion extents (Figure 5.7). For instance, the caseinate (D3,2 = 1.15 µm) and 
lysolecithin (D3,2 = 2.75 µm) emulsions had significantly (p <0.05) different mean 
particle diameters after entering the small intestine, but led to a similar lipid digestion 
degree as indicated by the FFAs released. This phenomenon may have occurred because 
caseinate formed a thicker more compact interfacial layer that was more difficult to 
displace. Alternatively, it might have occurred because soy lysolecithin increased lipase 
activity or the solubilization capacity of the mixed micelles 239. These results indicate that 
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interfacial layer. Consequently, emulsifier selection can be used as a tool to manipulate 
lipid digestion. 
5.4.3 Stability, release, and bioaccessibility of β-carotene  
 
Figure 5.8 The effect of different emulsifier type on the percentage of β-carotene from 
the corn oil in water emulsions after intestinal digestion (a) the stability and release, and 
(b) the bioaccessibility, sedimentation and overall bioaccessibility. Capital letters (A, B, 
C), lower-case letters (a, b, c) and the Greek letters (α, β, γ) were used to designate 
significant difference among different emulsifier type. 
After intestinal digestion, the stability, release, and bioaccessibility of β-carotene 
were analyzed to understand the impact of emulsifier type on its gastrointestinal fate. The 
precise meaning of these GIT terms was described in our earlier study 16. Briefly, the 
stability is the fraction of β-carotene added to the initial emulsion that actually reaches 
the small intestine, i.e., is not degraded or lost. The release is the fraction of β-carotene 
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that leaves the oil phase and is incorporated into either the mixed micelle or sediment 
phases. The bioaccessibility is the fraction of β-carotene within the small intestine that is 
present in the mixed micelle phase. 
Stability: The stability of the β-carotene in the emulsions decreased in the following 
order: caseinate (87%) > lysolecithin (85%) > Tween 20 (75%) > quillaja saponin 
(72%) > gum arabic (70%) (Figure 5.8a). This carotenoid is known to be unstable to 
chemical degradation when exposed to acidic conditions and high temperatures 202. 
Consequently, it may have degraded when the emulsions were incubated in the gastric 
fluids (pH 3, 37 oC). Our results suggest that the presence of caseinate or lysolecithin 
inhibited the chemical degradation of β-carotene. These findings are consistent with 
previous studies, which reported that some food-grade emulsifiers (e.g., caseinate and 
whey protein) can protect nutraceuticals (e.g., β-carotene and curcumin) from 
degradation during in vitro digestion 217. It may therefore be possible to improve the 
bioavailability of some nutraceuticals by utilizing antioxidant emulsifiers to protect them 
as they travel through the human gut. An alternative explanation for the observed results 
is that β-carotene trapped inside the non-digested oil phase is more stable to chemical 
degradation than that released into the mixed micelle phase. As mentioned earlier, both 
caseinate and lysolecithin inhibited lipid digestion, leading to more non-digested fat 
being present at the end of digestion. Consequently, there would have been a higher 
fraction of the b-carotene trapped inside the non-digested oil phase in these emulsions. 
Release: The release of β-carotene from the emulsions decreased in the following 
order: quillaja saponin (101%) > gum arabic (95%) » Tween 20 (95%) > caseinate 
(74%) > lysolecithin (67%) (Figure 5.8a). As just mentioned, the lower release of β-
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carotene from the caseinate and lysolecithin emulsions was probably due to their reduced 
lipid digestion degree as indicated by the FFA and confocal microscopy results (Figures 
5.2 and 5.6a). It should be noted that any β-carotene trapped inside non-digested fat 
droplets could be released and absorbed further down the GIT (i.e., within the large 
intestine), which may alter its biological effects. This phenomenon would have to be 
investigated utilizing a more sophisticated in vitro digestion model that included mouth, 
stomach, small intestine, and colon stages, or by using in vivo animal or human studies. 
Bioaccessibility: The β-carotene liberated from the oil droplets might be 
incorporated into mixed micelles, which can then transport it to the epithelium cells for 
absorption. Alternatively, it might precipitate and be incorporated into the sediment 
phase, where it would not be available for absorption. For this reason, we measured the 
bioaccessible fraction of β-carotene in the samples. The bioaccessibility of β-carotene in 
various emulsions decreased in the following order: Tween 20 (82%) > quillaja saponin 
(77%) > gum arabic (72%) > caseinate (62%) >> lysolecithin (32%) (Figure 5.8b). 
The caseinate and lysolecithin emulsions had the lowest carotenoid bioaccessibility, 
which is mainly because an appreciable fraction of the β-carotene was trapped within the 
non-digested lipid phase and was therefore not incorporated into the mixed micelles. In 
contrast, the quillaja saponin, gum arabic, and Tween 20 emulsions were fully or almost 
fully digested so that nearly all of the β-carotene was released. Other factors, however, 
may also have influenced the β-carotene bioaccessibility in different emulsions. For 
instance, some of the β-carotene released from the oil droplets may have been trapped 
within the sediment phase. Our results showed that the amount of β-carotene in the 
sediment phase was dependent on emulsifier type. The amount of sedimented β-carotene 
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decreased in the following order: lysolecithin (36%) > quillaja saponin (24%) > gum 
arabic (22%) > Tween 20 (12%) » caseinate (12%) (Figure 5.8b). These results suggest 
that the relatively low bioaccessibility of the carotenoid in the lysolecithin emulsions may 
have been partly because some of it was not liberated from the oil phase and partly 
because some of it sedimented. This may have occurred because the β-carotene 
molecules formed small dense crystals in the aqueous phase, which moved to the bottom 
of the sample during centrifugation. Alternatively, it may have occurred because the β-
carotene was successfully solubilized within mixed micelles, but then these micelles 
interacted with other components in the system causing them to precipitate. For instance, 
some of the emulsifiers might interact with calcium ions in the small intestine, and 
therefore mixed micelles containing the emulsifier may have been precipitated in the 
presence of calcium ions in the intestinal fluids, thereby leading to the formation of 
insoluble aggregates that sedimented. 
Overall bioaccessibility: The bioaccessibility provides a measure of the fraction of 
carotenoids in the small intestine that is available for absorption, but it does not account 
for the fraction that has been lost due to chemical degradation. As discussed earlier, the 
bioaccessibility and stability of carotenoids have different dependencies on emulsifier 
type. For example, Tween 20, quillaja saponin, and gum arabic had a high 
bioaccessibility but low stability. For this reason, the overall bioaccessibility was 
calculated by multiplying the bioaccessibility with the stability. The overall 
bioaccessibility decreased in the following order: Tween 20 (62%) > quillaja saponin 
(56%) > caseinate (55%) > gum arabic (51%) >> lysolecithin (25%) (Figure 5.8b). The 
overall bioaccessibility of the carotenoids in the caseinate emulsions is therefore higher in 
 
   93 
the order than the simple bioaccessibility, which is due to the ability of this protein to 
inhibit oxidation. In general, it is therefore important to account for both the 
bioaccessibility and stability of nutraceuticals when designing delivery systems. This 
phenomenon is likely to be especially important when the nutraceuticals used are highly 
unstable to chemical degradation, such as polyphenols. 
 
Figure 5.9 The correlation analysis between (a) the bioaccessibility and the final free fatty 
acid release and (b) the bioaccessibility and the D3,2 value at the beginning of the 
intestinal phase for the corn oil in water emulsions of different emulsifier type. From top 
to bottom, data correspond to the Tween 20, quillaja saponin, gum arabic, caseinate and 
lysolecithin emulsions. 
Further insights into the factors impacting carotenoid bioaccessibility were obtained 
by plotting the bioaccessibility versus either the final FFAs released by the end of the 
small intestinal phase or the D3,2 value at the beginning of the small intestine phase 
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(Figure 5.9). The bioaccessibility increases as the final amount of FFAs released 
increased, with an abrupt change for only a small increment in FFA value occurring 
between the caseinate and lysolecithin emulsions (Figure 5.9a). We postulate that the 
release of carotenoids from the lipid droplets during their hydrolysis occurred more 
slowly than the release of the lipid digestion products. Consequently, the highly 
hydrophobic carotenoids progressively accumulated within the oil phase, with their 
concentration gradually increasing as digestion proceeded. If the lipid phase is not fully 
hydrolyzed, then some of these carotenoids remain within the oil phase. In addition, these 
carotenoids may reach a concentration where they exceed their saturation limit, leading to 
the formation of dense crystals that end up in the sediment phase. 
The bioaccessibility of the carotenoids was inversely related to the size of the 
particles in the emulsions when they entered the initial stages of the small intestine 
(Figure 5.9b). The main reason for this phenomenon is that the rate of lipid digestion 
decreases with increasing particle size (decreasing surface area). As a result, there may be 
more carotenoids trapped within the non-digested oil and less mixed micelles available to 
solubilize the carotenoids released. On the other hand, the chemical degradation of 
carotenoids may be retarded in larger oil droplets because they have a smaller surface 
area and are therefore less exposed to any chemical reactants in the aqueous phase (such 
as acids). 
5.5 Conclusions 
In this paper, we focused on the impact of emulsifier type on the bioaccessibility and 
stability of a model nutraceutical present in food emulsions. We selected a number of 
food-grade emulsifiers to represent different categories, including synthetic surfactants 
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(Tween 20), natural surfactants (quillaja saponin), proteins (caseinate), polysaccharides 
(gum arabic), and phospholipids (lysolecithin). In addition, we used the recently 
harmonized INFOGEST in vitro digestion model to study the gastrointestinal fate of the 
emulsions, as this method has become the most widely used in the food area for this 
purpose. Our results show that many different factors contribute to the overall 
bioaccessibility of the carotenoids, including chemical degradation, lipid digestion, mixed 
micelle formation, carotenoid crystallization, and sedimentation processes. Emulsifier 
type impacts each of these processes differently, which impacts the final level of 
carotenoids present in a form suitable for absorption by the human body. Consequently, it 
is important to identify the most suitable emulsifier for formulating a particular 
carotenoid-loaded emulsion-delivery system. This research shows that the synthetic or 
natural surfactants (Tween 20 or quillaja saponin) gave the highest bioaccessibility 
because they made small lipid droplets (high surface area) that were stable to aggregation 
when they entered the small intestine. As a result, there was more surface area for the 
lipase molecules to attach, thereby digesting the lipids and releasing the carotenoids more 
effectively. Conversely, lysolecithin gave the lowest bioaccessibility because it formed 
large oil droplets (low surface area) that were digested more slowly. The knowledge 
gained from this study highlights the importance of selecting an appropriate emulsifier 
when designing functional foods. 
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CHAPTER 6 
IMPACT OF USING AN INDIGESTIBLE OIL PHASE 
(MINERAL OIL) ON THE BIOACCESSIBILITY OF 




These is some interest in replacing digestible fats with indigestible ones to decrease 
the energy-density of foods. The utilization of indigestible oils, however, may have 
unforeseen nutritional consequences, such as the reduction of vitamin bioavailability.  In 
this study, the impact of an indigestible oil on the bioaccessibility of emulsified vitamin 
D3 (VD) was examined. We prepared four kinds of nanoemulsions using different 
combinations of a digestible oil (DO) and an indigestible oil (IO): DO only; IO only; an 
oil mixture (OM) consisting of 1:1 DO:IO mixed before homogenization; and, an 
emulsion mixture (EM) consisting of 1:1 DO:IO nanoemulsions mixed after 
homogenization. A gastrointestinal tract (GIT) model was employed to elucidate the 
kinetics of VD bioaccessibility from the nanoemulsions. Both the lipid digestion rate and 
vitamin bioaccessibility decreased in the same order: DO > OM ≈ EM > IO. The change 
in vitamin bioaccessibility over time under simulated small intestine conditions was also 
measured. With the exception of the IO nanoemulsions, the vitamin bioaccessibility 
increased to a maximum value after around 30 minutes, but then decreased during the 
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following 24 h. This effect was attributed to an initial solubilization of the vitamin within 
the mixed micelles, followed by their precipitation during prolonged incubation. Our 
results show that lipid digestion, micelle solubilization, and micelle aggregation impact 
the in vitro bioaccessibility of vitamin D. This knowledge may be helpful for designing 
more efficacious nanoemulsion-based delivery systems for fat-soluble vitamins. 
Keywords: Indigestible oil; vitamin D; nanoemulsion; bioaccessibility; simulated GIT 
tract. 
6.2 Introduction 
Oil-in-water nanoemulsions are thermodynamically unstable colloidal dispersions 
consisting of tiny oil droplets distributed throughout an aqueous medium 240. This kind of 
nanoemulsion is commonly used as a delivery system for hydrophobic bioactive 
substances 241. Compared to conventional emulsions, the small dimensions of the oil 
droplets in nanoemulsions (d < 200 nm) may be beneficial because it leads to higher 
physical stability, lower opacity, and higher bioavailability and bioactivity 14, 183, 185. 
Moreover, nanoemulsions can be designed to meet specialized requirements for specific 
bioactive delivery applications: (1) rapid bioactive release for fast treatment 14; (2) 
enhanced potency for increased efficacy or reduced load 242; (3) sustained or targeted 
release 243, 244. 
Vitamin D is a fat-soluble micronutrient that plays an important role in skeletal 
functions such as calcium absorption and bone health, as well as non-skeletal functions 
such as inhibition of cancer, diabetes, and cardiovascular diseases 40, 41.  It comes in two 
major forms: ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), which differ in 
terms of their molecular structures, physicochemical properties, and biological effects 245.  
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In nature, vitamin D2 is mainly found in plant-based products such as mushrooms, while 
vitamin D3 is mainly found in animal-based ones such as fish, meat, and eggs. However, 
many foods are also fortified with vitamin D to enhance their nutritional profile, 
including milk, orange juice, butter, and yogurt. Vitamin D3 can also be synthesized 
naturally in human skin cells when they are exposed to UV radiation.  Even so, vitamin D 
deficiency is still prevalent in many countries because of poor diet and/or low sunlight 
exposure 41, 246.  Consequently, it is often important to ensure that people get sufficient 
vitamin D through their diet.  Food fortification with vitamin D is regarded as one of the 
most feasible and efficient solutions to this problem. For this purpose, vitamin D3 is 
better than vitamin D2 because it has a higher efficacy in raising blood serum levels of 
bioactive vitamin D metabolites 247. 
However, there are numerous challenges in designing effective food-based delivery 
systems for this micronutrient. Vitamin D has a low water-solubility and chemically 
degrades when exposed to light, oxidation, and elevated temperatures 54. Moreover, its 
bioavailability depends on the characteristics of the food matrix it is delivered in 248, 
although there is some debate about this 245. An effective oral delivery system should 
facilitate the incorporation of vitamin D in foods, protect it from degradation during 
storage, but release it in a bioaccessible form within the human gastrointestinal tract 
(GIT) after ingestion.  
Numerous types of colloidal systems have been developed as vitamin D delivery 
vehicles, including microemulsions, nanoemulsions, emulsions, protein nanoparticles, 
and filled microgels 249-252. Among these, nanoemulsions are particularly promising 
because of their ease of preparation, high stability, and rapid release properties. In vivo 
 
   99 
and in vitro studies have shown that nanoemulsions can improve the bioavailability 253, 254 
and bioactivity 255 of vitamin D. 
In some applications, it is desirable to have delivery systems that release vitamin D 
rapidly, whereas in others, a slow release is more advantageous. For this reason, it would 
be useful to create nanoemulsions with different vitamin release profiles. This might be 
achieved in a number of ways, including controlling the composition of the oil and water 
phases, altering the particle size distribution, or manipulating the interfacial 
characteristics of the droplets, such as the thickness, charge, or digestibility of their 
coatings 2. Previous researchers have shown that emulsifier type impacts both the lipid 
digestion profile and bioaccessibility of vitamin D within a simulated GIT 256. The nature 
of the oil phase has also been shown to play a critical role in determining mixed micelle 
formation and vitamin bioaccessibility 254. In particular, indigestible oils have been 
shown to reduce both lipid digestion and bioactive bioaccessibility 254, 257.  In this latter 
case, most of the bioactives remain trapped inside the indigestible fat droplets, which 
reduces their bioaccessibility. In addition, there are less free fatty acids (FFAs) and 
monoacylglycerols generated inside the small intestine, reducing the ability of the mixed 
micelles to solubilize hydrophobic bioactives.  
These previous studies suggest that encapsulation of fat-soluble vitamins in 
nanoemulsions made from indigestible oils may be a disadvantage because of the 
reduction in bioavailability in the upper small intestine. However, we hypothesized, that 
indigestible oils may also have some potential advantages. First, they may increase the 
chemical stability of vitamins during storage because they do not contain any unsaturated 
fatty acids that might promote vitamin degradation. Second, they may be used in 
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reduced-calorie products.  Finally, they may lead to a prolonged release of the vitamin D 
within the GIT, with the vitamins being released by simple diffusion from the indigestible 
oil droplets rather than by digestion. 
In this study, the impact of oil phase digestibility on the bioaccessibility of vitamin 
D3 (VD) loaded into oil-in-water nanoemulsions was therefore examined. This was 
achieved by encapsulating the vitamin in nanoemulsions formulated using oils with 
different digestibility: corn oil (digestible) and mineral oil (indigestible oil).  In addition, 
nanoemulsions were prepared containing different ratios of digestible and indigestible 
oils. A simulated GIT was then used to study the gastrointestinal fate of the 
nanoemulsions, including lipid digestion and vitamin bioaccessibility. The results of this 
study could lead to the formulation of vitamin-loaded nanoemulsions with novel release 
properties. 
6.3 Materials and methods 
6.3.1 Materials 
Vitamin D3 (VD) (1,0 Mill. I.U./g) was kindly donated by BASF (Ludwigshafen, 
Germany). Mineral oil (Crystal plus 70 FG) was purchased from STE Oil Company (San 
Marcos, Texas, USA). Whey protein isolate was donated by Agropur Inc. (Le Sueur, 
MN, USA). The additional reagents and chemicals utilized in the present study were 
described in detail in 3.3.1. 
6.3.2 Nanoemulsion preparation  
The aqueous phase and the homogenization techniques used were described in detail 
in 6.3.2 and 3.3.2. The oil phase was prepared by mixing 98 wt % carrier oil (corn or 
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mineral oil) with 2 wt % vitamin D3. Oil and aqueous phases (10:90 w/w) were then 
homogenized to form nanoemulsions. 
Four nanoemulsions were prepared using different combinations of a digestible oil 
(DO) and an indigestible oil (IO): 
(i) A nanoemulsion formed using digestible oil as the oil phase (DO); 
(ii) A nanoemulsion formed using indigestible oil as the oil phase (IO); 
(iii) A nanoemulsion formed by mixing equal masses of DO and IO together 
before homogenization to form an “oil mixture” (OM) system; 
(iv) A nanoemulsion formed by mixing equal masses of an IO-nanoemulsion 
with a DO-nanoemulsion to form an “emulsion mixture” (EM) system. 
6.3.3 Particle size characterization 
The particle size distribution of the samples was determined according to 3.3.3. 
Phosphate buffer solution (5 mM, pH 7.0) was used to dilute samples collected from the 
initial, mouth, and small intestine phases, whereas acidified distilled water (pH 2.5) was 
used to dilute samples collected form the stomach phase. The refractive index values for 
corn oil, mineral oil, and 1:1 DO:IO systems used in the light scattering calculations were 
1.472, 1.468 and 1.470, respectively. 
6.3.4 Surface potential 
The surface potential (ζ-potential) of the particles in the samples was measured 
according to 3.3.4. The initial nanoemulsions and the samples from the small intestine 
phase were diluted with phosphate buffer (5 mM, pH 7.0). The samples collected from 
the mouth phase were diluted with pH 6.8-adjusted simulated saliva fluid and the samples 
from the stomach phase were diluted with simulated gastric fluid (pH 2.5). 
 
   102 
6.3.5 Confocal microscopy 
Confocal microscopic images of the samples were measured according to 3.3.5. 
6.3.6 In vitro digestion 
The samples were passed through a simulated GIT model that has been described 
previously 80. This model is closely related to the standardized static in vitro digestion 
model developed by the INFOGEST consortium 148, but was optimized for emulsions.  
All solutions were preheated to 37 °C prior to use and the whole of the GIT procedure 
was carried out at this temperature by storing the samples in temperature-controlled 
shakers (mouth and stomach) or water baths (small intestine). 
Mouth Phase: Preheated simulated saliva fluid containing 0.003 g/mL mucin was 
mixed 1:1 (v/v) with diluted nanoemulsions to reach an oil concentration of 2 %. These 
mixtures were then adjusted to pH 6.8, followed by incubation in an incubator shaker 
(model 4080, New Brunswick Scientific, New Brunswick, NJ, USA) for 2 min at a 
shaking speed of 100 rpm. 
Stomach Phase: The sample from the mouth phase was mixed 1:1 (v/v) with 
simulated gastric fluids containing 0.0032 g/mL pepsin. After adjusted the pH to 2.5, this 
mixture was then incubated in the incubator shaker for 2 h at a shaking speed of 100 rpm. 
Small Intestine Phase: The samples from the stomach phase was adjusted to pH 
7.0, followed by inclusion of 1.5 mL salt solution (0.25 M CaCl2 and 3.75 M NaCl) and 
3.5 mL bile salt solution (0.0536 g/mL). The mixture was adjusted to pH 7.00 and then 
lipase solution (0.024 g/mL) was added to start the digestion reaction. An automatic 
titration unit (Metrohm, USA, Inc.) was used to monitor and maintain the pH at 7.0 
throughout the titration by adding 0.25 M NaOH solution. The standard intestine 
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digestion lasted for 2 h. The amount of free fatty acids released was calculated from the 
amount of NaOH needed for titration. An aliquot of intestine sample was centrifuged 
(Sorvall Lynx 4000 centrifuge, Thermo Scientific, Waltham, MA, USA) at 30,970 ×g 
(18,000 rpm) for 50 min at 4 °C to separate the micelle phase. A blank test was carried 
out without oil to determine the contribution of any non-lipid components to the digestion 
profiles. 
Extended intestine digestion: In some studies, a modified small intestine phase was 
used to monitor the release of the vitamin over an extended period of digestion (0, 0.5, 1, 
2, 5, 10 and 24 h).  In this case, the samples were subjected to the mouth and stomach 
phases before being placed in the extended small intestine phase. 
6.3.7 Bioaccessibility 
The VD concentrations in the total digest and mixed micelles were measured for 
calculation of the vitamin bioaccessibility. The extraction and measurement of VD were 
based on a published study 258. To extract VD, an aliquot of 3 ml sample was mixed with 
3 ml of a hexane:ethanol (1:1, v/v) mixture. The resulting system was then centrifuged 
(Sorvall ST 8 centrifuge, Thermo Scientific, Waltham, MA, USA) at 4000 rpm for 2 min 
to collect the supernatant layer. After triplication of the extraction process, the combined 
extracts were mixed with saturated sodium chloride solution, and then centrifuged again 
to remove any extra aqueous phase. The supernatant was collected and dried under a 
nitrogen atmosphere. An aliquot of HPLC grade methanol was added to dissolve the VD 
and then the system was passed through a 0.45 μm filter to remove any particles (VWR 
International, Philadelphia, PA, USA) prior to HPLC analysis. 
 
   104 
The VD concentration was measured by a reverse phase-HPLC system (Agilent 
1100 series, Agilent Technologies, Santa Clara, CA, USA) using a Zorbax SB-C18 
column (4.6×250 mm, 5 μm, Agilent Technologies, Santa Clara, CA, USA). A mixture 
of methanol:water (95:5, v/v) was used as the mobile phase at a flow rate of 1 mL/min. 
After injection of 20 μL sample, the absorbance of the eluent was monitored at 265 nm. 
Data analysis was carried out using the instrument software (Agilent ChemStation). 
The bioaccessibility (%) of VD was then calculated using the following equation: 




where Cmicelle and Cdigest are the concentrations of VD in the mixed micelle phase and 
in the total digest collected after the simulated small intestine phase, respectively. 
6.3.8 Statistical analysis 
See details in 3.3.9 
6.4 Results and discussion 
6.4.1 Gastrointestinal fate  
Changes in nanoemulsion properties were monitored as they travelled through each 
stage of the GIT model. As mentioned earlier, the oil phases of the four nanoemulsions 
consisted of digestible oil (DO) only, indigestible oil (IO) only, an oil mixture (OM) 
consisting of 50 % DO and 50 % IO inside each droplet, or an emulsion mixture (EM) 
consisting of 50 % DO-droplets and 50 % IO-droplets. 
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Figure 6.1 Influence of oil type on the physical and structural properties of four 
nanoemulsions encapsulated with vitamin D3 during simulated gastrointestinal tract 
(GIT) conditions. (a) surface-weighted mean particle diameter (D3,2); (b) surface 
potential; (c) confocal photos. For D3,2 values, samples designated with different letters 
were significantly different. For surface potential, different capital letters (A, B, C) were 
used to designated significant difference in samples between different GIT regions (same 
lipid type), while different lower-case letters (a, b, c) were used between different lipid 
types (same GIT region). Key: indigestible oil (IO), digestible oil (DO), oil mixture 
(OM), and emulsion mixture (EM). 
Initial: Initially, all four nanoemulsions had the same total oil, vitamin, and protein 
levels, but different oil phase compositions. The particle size, surface potential, and 
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microstructure of the nanoemulsions were measured. The surface-weighted mean particle 
diameters (D3,2) of all four nanoemulsions were 0.136 ± 0.003, 0.138 ± 0.001, 0.147 ± 
0.003, and 0.169 ± 0.004 μm for DO-, OM-, EM-, and IO- nanoemulsions, respectively 
(Figure 6.1a). The relatively small dimensions of the droplets suggest that the 
microfluidization protocol and emulsifier used were effective. The IO-nanoemulsion 
probably had a higher mean particle diameter than the DO-nanoemulsion because mineral 
oil has a higher viscosity than corn oil, and so is more difficult to disrupt during 
homogenization 259. The particle size distributions of all four nanoemulsions were 
monomodal (Figure 6.2), indicating that all the droplets had passed through the disruptive 
zone within the microfluidizer. All nanoemulsions were highly negatively charged (-49 to 
-46 mV) because the pH of the surrounding aqueous phase (pH 7) was considerably 
higher than the isoelectric point (pI) of the proteins coating the lipid droplets (Figure 
6.1b). 
Mouth: After the nanoemulsions were exposed to the mouth phase, their mean 
particle diameters (Figure 6.1a) and particle size distributions (Figure 6.2) measured by 
light scattering did not change much. A small amount of droplet flocculation was, 
however, detected in the microscopy images (Figure 6.1c). Even so, the oil droplets were 
still fairly evenly spread across the samples. Thus, the nanoemulsions appeared to be 
relatively stable to particle aggregation under simulated oral conditions, with only a few 
weak flocs being formed. Presumably, their good aggregation stability was the result of 
relatively strong electrostatic repulsive forces acting amongst the highly-negatively 
charged protein-coated oil droplets (Figure 6.1b). The small amount of floc formation 
observed was probably due to mucin-induced bridging or depletion flocculation under 
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oral conditions 231, 260, 261. The magnitude of the surface potential decreased from around -
48 mV initially to around -34 mV after incubation in the mouth phase (Figure 6.1b), 
presumably due to electrostatic screening by salts in the artificial saliva, as well as 
adsorption of mucin to the protein-coated droplet surfaces 261, 262. 
 
Figure 6.2 Influence of oil type on particle size distribution of four nanoemulsions 
encapsulated with vitamin D3 during simulated gastrointestinal tract conditions: (a) DO; 
(b) OM; (c) EM; (d) IO. Key: indigestible oil (IO), digestible oil (DO), oil mixture (OM), 
and emulsion mixture (EM).  Note: the volume fraction has been shifted up the y-axis to 
highlight differences in samples. 
Overall, all four types of nanoemulsions behaved fairly similarly within the oral 
phase, regardless of the nature of the oil phase inside the oil droplets. This kind of 
behavior might be expected for strongly hydrophobic water-insoluble oils because then 
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the emulsifier molecules should remain strongly attached to the droplet surfaces and no 
Ostwald ripening should occur. Under these circumstances, nanoemulsion behavior is 
mainly governed by the nature of the emulsifier coating the oil droplets rather than by the 
oil phase inside. 
Stomach: After the stomach phase, the mean particle diameter of all four 
nanoemulsions increased considerably, being 22.7, 17.9, 19.7 and 18.9 μm for DO-, 
OM-, EM-, and IO-nanoemulsions, respectively (Figure 6.1a). The particle size 
distribution data showed that all four nanoemulsions were monomodal, with particles 
ranging in diameter from around 10 to 100 μm (Figure 6.2). The light scattering results 
suggest that all the oil droplets in the nanoemulsions had undergone some kind of strong 
aggregation, which could have been due to flocculation and/or coalescence. The confocal 
microscopy images, however, suggest that aggregation was primarily the result of 
flocculation, since the individual oil droplets appeared to have clustered together into 
large clumps, and large single oil droplets were not seen (Figure 6.1c). 
There may be a number of factors contributing to droplet flocculation in the gastric 
fluids: reduction in pH; alteration in ionic environment; linking together of lipid droplets 
by mucin; and, hydrolysis of the interfacial protein layer 263, 264. In particular, the 
negatively charged mucin molecules from the artificial saliva could attach to the surfaces 
of numerous positively charged protein-coated oil droplets, leading to bridging 
flocculation. Moreover, the low surface potential on the oil droplets will have reduced the 
electrostatic repulsion between them. Finally, partial hydrolysis of the adsorbed protein 
molecules may have reduced their ability to protect the oil droplets from coming together. 
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After the stomach phase, the z-potential of all four nanoemulsions was relatively 
low and negative, ranging from -1.7 to -0.9 mV (Figure 6.1b). Under highly acidic gastric 
conditions, the pH is far below the pI of the adsorbed proteins. Consequently, one would 
expect the protein-coated oil droplets to have a strong positive charge 265. Our z-potential 
measurements therefore suggest that some anionic substances, for instance mucin from 
the artificial saliva, attached to the cationic protein-coated droplets and caused charge 
neutralization 266. Alternatively, some of the protein molecules may have been displaced 
from the droplet surfaces by other surface-active substances in the gastric fluids. 
Visible observation of the nanoemulsions showed that they had all undergone 
considerable droplet creaming by the end of the gastric phase. This may have occurred 
because the gravitational forces acting on the oil droplets increased when they were 
clustered together into large flocs: the creaming velocity increases with the square of the 
particle size in colloidal dispersions 265. 
Overall, all four nanoemulsions behaved fairly similarly in the stomach phase, 
irrespective of the nature of the oil phase inside the droplets, which can again be 
attributed to the same physicochemical phenomenon discussed for the mouth phase. 
Small Intestine: After the small intestine phase, the mean particle diameter 
decreased appreciably compared to that observed in the stomach phase (Figure 6.1a). 
There was also a considerable change in the shape of the particle size distributions, with a 
broader range of particle sizes existing after the small intestine phase (Figure 6.2). These 
effects are consistent with partial disruption of the flocs when the pH is increased, as well 
as with fat droplet digestion and mixed micelle formation in the case of the systems 
containing digestible oil 254. The triglycerides in corn oil are converted into free fatty 
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acids and monoglycerides due to hydrolysis by pancreatic lipase within the small 
intestine. These lipid digestion products then mix with endogenous bile acids and 
phospholipids from the intestinal fluids to create mixed micelles 181. 
The average particle diameters of the nanoemulsions containing some mineral oil 
(OM, EM and IO) were significantly (p < 0.05) higher than for the ones containing only 
corn oil (DO). This effect might be because the mineral oil was not digested under 
simulated small intestine conditions and thus some of the oil droplets remained intact. 
Also, the DO-nanoemulsions appeared to contain a broad population of relatively small 
particles (Figure 6.2a), which were probably mixed micelles. These small particles might 
not have been observed in the samples containing the indigestible oil because mixed 
micelles were not generated during lipid digestion.  Alternatively, they may not have 
been seen because the light scattering signal used to calculate the particle size distribution 
was dominated by the presence of the indigested oil droplets. 
All the nanoemulsions contained negatively charged particles after the small 
intestine phase was completed: -24.5, -20.7, -17.8 and -15.6 mV for DO-, OM-, EM-, and 
IO-nanoemulsions, respectively (Figure 6.1b). The neutral pH of the intestinal fluids 
would have led to ionization of anionic groups on proteins, peptides, mucin, bile salts, 
and fatty acids. Interestingly, the DO-nanoemulsion had the highest negative charge, 
whereas the IO-nanoemulsion had the lowest, which is probably because of the 
production of anionic fatty acids during the enzymatic hydrolysis of corn oil 267. 
Surprisingly, the z-potential of the OM-nanoemulsions was slightly lower than that 
of the EM-nanoemulsions, which may have been due to differences in the nature of the 
colloidal particles present in the small intestine phase after digestion. One would expect 
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that all the corn oil droplets in the EM-nanoemulsions would be fully digested, whereas 
all the mineral oil droplets would remain intact. Conversely, there may only have been 
partial digestion of all the droplets in the OM-nanoemulsions, leading to the formation of 
different kinds of colloidal particles. The electrical properties of the mixed micelle 
samples were very similar to those determined for the overall digest (Figure 6.1b), 
suggesting that they contained similar types of anionic species. 
These results show that the nanoemulsions do behave differently in the small 
intestine phase when they are formulated using different kinds of oil phase, which is 
presumably a result of the different levels of lipid digestion products generated. 
6.4.2 Lipid digestion kinetics  
In this series of experiments, we measured the kinetics of lipid digestion in the 
nanoemulsions. This was done soon after the nanoemulsions had been produced, as well 
as after 2 weeks of storage, so as to ascertain if there were any changes in the digestion 
behavior of the oil phase over time. Initially, we only focus on the results obtained after 
the nanoemulsions were stored for one day. 
The FFA versus time profiles for the four nanoemulsions were measured when they 
were incubated within the small intestine phase for two hours and the final amount of 
FFAs released was determined from these data (Figure 6.3). For the nanoemulsions 
containing some digestible oil (DO, EM, OM), the FFAs increased steeply initially but 
then increased more slowly at later times. Conversely, for the nanoemulsions containing 
only indigestible oil (IO), there was little increase in FFAs released over time. As 
anticipated, by the completion of the small intestine phase, the oil phase in the  
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Figure 6.3 Amount of free fatty acid (FFA) released from four nanoemulsions containing 
different oil types: (a) total FFA amount; (b) amount of FFA released during digestion 
(1st storage day). Samples designated with different letters were significantly different. 
Key: indigestible oil (IO), digestible oil (DO), oil mixture (OM), and emulsion mixture 
(EM). 
DO-nanoemulsions was fully digested (101 ± 9 %) but there was hardly any digestion of 
the oil phase in the IO-nanoemulsions (1 ± 1 %). The level of FFAs released for both the 
nanoemulsions containing equal amounts of corn and mineral oil (OM and EM) was 
similar, being around 56 %. These results suggest that the level of FFAs produced after 
digestion was linearly related to the amount of digestible oil initially present inside the oil 
droplets. Interestingly, the presence of the mineral oil did not appear to influence the 
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digestion of the corn oil. For the OM-nanoemulsions, this suggests that the lipase 
molecules were still able to access the triglyceride molecules inside the oil droplets, even 
in the presence of another oil that was non-digestible. 
Storing the nanoemulsions for 2 weeks had no impact on the extent of lipid digestion 
(Figure 6.3), which was probably because the nanoemulsions were stable to droplet 
aggregation throughout storage (Figure 6.1b).  As a result, there was no appreciable 
change in the surface area of lipids accessible to the digestive enzymes within the 
simulated GIT. 
6.4.3 Vitamin bioaccessibility  
The bioaccessibility of the oil-soluble vitamin D3 encapsulated within all four 
nanoemulsions was measured at the end of the small intestine phase. Vitamin 
bioaccessibility was clearly dependent on oil phase composition (Figure 6.4). The 
bioaccessibility was significantly (p < 0.05) higher for the nanoemulsions containing only 
digestible oil (75.2%) than for the ones containing only indigestible oil (20.7%). These 
results also suggest that a fraction of the vitamin was able to leave the indigestible oil 
droplets and became solubilized within micelles made up of simple bile salts (without the 
need of fatty acids or monoglycerides). The nanoemulsions containing both types of oils 
(OM and EM) had similar bioaccessibility values (35.6%) that were between those of the 
IO- and DO-nanoemulsions (Figure 6.4). The fact that the vitamin bioaccessibility was 
similar in both mixed systems suggests that the overall composition of the nanoemulsions 
was more important than the initial location of the two oils within the droplets. 
Interestingly, the vitamin bioaccessibility in the mixed nanoemulsions (35.6%) was 
appreciably less than would be expected from the average of the DO- and IO-
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nanoemulsions (47.9%). We hypothesize that some of the vitamin remained dissolved 
inside indigestible oil droplets and was therefore not released into the mixed micelle 
phase. Storing the nanoemulsions for 2 weeks had no impact on vitamin bioaccessibility 
(Figure 6.4), which can again be attributed to their good storage stability. 
 
Figure 6.4 Influence of oil type on bioaccessibility of four nanoemulsions encapsulated 
with vitamin D3 during storage. Samples designated with different letters were 
significantly different. Key: indigestible oil (IO), digestible oil (DO), oil mixture (OM), 
and emulsion mixture (EM). 
6.4.4 Impact of prolonged incubation  
Further insights into the impact of oil phase digestibility on vitamin bioaccessibility 
was obtained by measuring the fraction that had been solubilized in the micelle phase 
over time. The results discussed in the previous section suggest that vitamin D3 may be 
released from the oil droplets by two mechanisms: (i) digestion of the surrounding 
triglycerides and then release of the vitamin; (ii) direct diffusion of the vitamin out of the 
droplets, without digestion. We hypothesized that the latter mechanism would be 
considerably slower than the first and may be a means of prolonging the release of 
vitamin D3 in the human gut. In some cases, this may have beneficial effects. For 
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instance, it might be possible to deliver vitamin D3 to the colon, where it may have 
beneficial effects by inhibiting colorectal cancer 268. For this reason, we measured 
changes in vitamin bioaccessibility under simulated GIT conditions for all four 
nanoemulsions over a much longer period (24 h). This time-period was chosen because it 
is similar to the length of time a digested food may spend in the colon.  Changes in the 
physical and structural properties of selected nanoemulsions (IO and DO) were also 
measured to facilitate the interpretation of the bioaccessibility results. It should be noted 
that we did not include colonic microflora in these experiments, so these results should 
only be seen as a rough estimation of the behavior of nanoemulsions in the colon. In 
future studies, it would be informative to utilize a more realistic colonic model to study 
the potential behavior of the nanoemulsions in the colon. 
6.4.4.1 Physical and structural changes 
Initially, the mean particle diameters of the digests arising from the two samples 
were fairly similar, being 9.1 and 10.7 μm for the DO- and IO-nanoemulsions, 
respectively (Figure 6.5a). There were, however, great differences in the way the particle 
size changed over time for the two systems. For the DO-nanoemulsions, there was a 
significant (p < 0.05) decrease in the D3,2 value (0.92 μm) after 2 h incubation (Figure 
6.5a), which might be due to disruption of flocs, digestion of oil droplets, and assembly 
of mixed micelles. However, the D3,2 value then increased sharply after 5 h of incubation 
and remained large (Figure 6.5a). This effect is likely to have been due to mixed micelle 
aggregation and insoluble calcium soap formation 269. Confocal microscopy revealed that 
the size of the particles in the DO-nanoemulsions decreased from 0 to 2 h but then 
increased from 2 to 24 h (Figure 6.5c), which supports the light scattering results. 
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Figure 6.5 Changes in the physical and structural properties of vitamin D3-loaded 
nanoemulsions made from either digestible oil (DO) or indigestible oil (IO) during 
extended intestinal digestion: (a) surface-weighted mean particle diameter (D3,2); (b) 
surface potential; (c) confocal microscopy images. Different lower-case letters (a, b, c) 
were used to designate significant differences in samples from the DO nanoemulsion; 
while different capital letters (A, B, C) were used for the samples from the IO 
nanoemulsions. 
The nanoemulsions containing the indigestible oil behaved quite differently. The 
D3,2 value of the IO-nanoemulsion gradually decreased throughout the 24 h intestine 
digestion (Figure 6.5a). This phenomenon might be because of progressive disruption of 
the flocs in these nanoemulsions due to the mechanical action of stirring and the 
emulsifying activity of the bile salts. Confocal microscopy also indicated that the size of 
the particles in these nanoemulsions progressively decreased over time (Figure 6.5c). 
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Figure 6.6 Influence of digestion time on particle size distribution of four nanoemulsions 
encapsulated with vitamin D3 during extended digestion: (a) digestible oil (DO); (b) 
indigestible oil (IO). 
We hypothesized that micelle aggregation and calcium soap formation might have 
led to the formation of insoluble complexes that trapped the vitamin D3 and then 
sedimented to the bottom of the test tubes, thereby reducing the measured 
bioaccessibility. For this reason, the susceptibility of different samples to sedimentation 
was evaluated (Figure 6.7). Phase separation was observed in both the DO- and IO-
nanoemulsions during the initial stages of the small intestine phase (0 h), with an opaque 
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cream layer above a slightly turbid serum layer. This effect can be attributed to the 
relatively large size of the flocs formed by the oil droplets when they left the stomach 
phase. At later times, the appearance of the digested DO-nanoemulsions was obviously 
different from that of the IO-nanoemulsions. After 0.5 h digestion, the DO-nanoemulsion 
formed an opaque colloidal suspension with a small amount of cloudy sediment at the 
bottom. The thickness of the sediment layer increased from 2 to 5 h of digestion. After 24 
h digestion, a thick solid sediment was observed at the bottom of the test tubes. This layer 
is likely to have contained aggregated mixed micelles and insoluble calcium soaps that 
formed during extended digestion. 
 
Figure 6.7 Optical images of digesta samples of two nanoemulsions during extended 
intestine digestion: (a) digestible oil (DO); (b) indigestible oil (IO). 
For the IO-nanoemulsions, the overall appearance remained more similar throughout 
the 24 h digestion period, with a cream layer on top and a turbid liquid layer at the 
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bottom. This suggests that the flocculated indigestible oil droplets, which are less dense 
than water, moved upwards due to the effects of gravity. The cloudy appearance of the 
liquid phase at the bottom of the test tube may have been due to the presence of some 
non-flocculated indigestible oil droplets from the initial nanoemulsions and/or some bile 
salt micelles from the intestinal fluids. 
6.4.4.2 Surface potential changes 
The z-potential of these two nanoemulsions were similar at the beginning of the 
digestion period (Figure 6.5b). At later times, however, the electrical characteristics of 
the two systems diverged. The magnitude of the negative surface potential in the DO-
nanoemulsions increased from around -16.3 mV at 0 h to -26.2 mV at 5 h, which might 
be related to the release of anionic free fatty acids (Figure 6.5b). The magnitude of the 
surface potential then decreased (-16.6 mV) after 24 h digestion, which was probably due 
to calcium soap formation and sedimentation. Interestingly, the negative charge of the 
(soluble) mixed micelle phase remained relatively high (-26.5mV) after 24 h digestion. 
This result suggests that cationic calcium ions may have bound to anionic fatty acids or 
bile salts leading to charge neutralization and precipitation.  On the other hand, the 
surface potential of the IO-nanoemulsion remained fairly consistent throughout 
incubation (Figure 6.5b). This was probably because no free fatty acids were generated 
during digestion and so the electrical characteristics of this system remained fairly 
constant. 
6.4.4.3 Bioaccessibility Kinetics 
The vitamin bioaccessibility in the nanoemulsions was also measured throughout the 
extended digestion period (Figure 6.8a). For the IO-nanoemulsions, the bioaccessibility 
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remained relatively low and constant through the digestion period. This suggests that the 
vitamin did not continue to diffuse out of the indigestible oil droplets over time. Indeed, 
the fact that there was some bioaccessibility in this system at 0 h suggests that some of 
the vitamin may have leached out of the oil droplets during the mouth or stomach phases, 
or more likely, that some of the vitamin molecules were rapidly solubilized by bile acid 
micelles at the beginning of the small intestine phase.  The fact that there was no further 
increase in bioaccessibility at longer times may have been because the bile acid micelles 
had become saturated with vitamin.  In future studies, it would be interesting to elucidate 
the physicochemical mechanisms by which this fat-soluble vitamin moves out of 
indigestible oil droplets. 
Conversely, all of the nanoemulsions containing the digestible oil behaved very 
differently. For the DO-, OM-, and EM-nanoemulsions there was a steep increase in the 
amount of vitamin solubilized in the mixed micelle phase during the first 30 minutes of 
digestion until a maximum value was reached. Afterwards, the bioaccessibility decreased 
steeply until it reached a value that was fairly similar to the initial value. One possible 
reason for this observation is that the vitamin chemically degraded throughout storage. 
For this reason, we measured the change in the total concentration of vitamin D3 in the 
samples throughout the 24 h incubation period (Figure 6.8b). We found that the total 
vitamin content did not change appreciably during this time, which suggests that the 
vitamin was stable under neutral conditions, as has been reported previously 270. 
We therefore postulated that the change in vitamin bioaccessibility was due to 
physical changes in the nanoemulsions during incubation. Presumably, free fatty acids 
were formed during the initial stages of digestion that were incorporated into mixed  
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Figure 6.8 Influence of oil type on (a) bioaccessibility and (b) vitamin D3 content of four 
nanoemulsions during extended intestine digestion. Key: indigestible oil (IO), digestible 
oil (DO), oil mixture (OM), and emulsion mixture (EM). 
micelles and formed relatively stable colloidal dispersions. These mixed micelles were 
capable of solubilizing appreciably amounts of the vitamin D3. As a result, the vitamin 
bioaccessibility was relatively large during the early stages of incubation. However, when 
the samples were kept for extended periods the anionic mixed micelles interacted with 
the cationic calcium ions in the simulated intestinal fluids, which caused an increase in 
particle size and sedimentation. Consequently, some of the vitamin was lost from the 
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mixed micelle phase, leading to a lower bioaccessibility. This result has important 
implications for the measurement of bioaccessibility using in vitro digestion models – the 
value obtained may be highly sensitive to the digestion time used in the model.  In vivo, 
the mixed micelles would travel through the layer of mucus lining the GIT and then be 
taken in by the epithelium cells, which means that this effect may not be observed in 
practice. Moreover, any insoluble calcium soaps would travel to the colon where the bile 
salts would be absorbed, which may have released the vitamin. 
6.5 Conclusions 
In this study, the impact of the composition of the oil phase on the bioaccessibility 
of vitamin D3 loaded into oil-in-water nanoemulsions was examined. The oil phase 
composition was varied by using a digestible oil (corn oil), indigestible oil (mineral oil), 
or their mixtures. We hypothesized that the bioaccessibility of the vitamin would depend 
on the initial oil phase composition. We found that vitamin bioaccessibility was much 
lower when the oil phase was indigestible than when it was digestible. In mixed systems, 
the presence of the indigestible oil did not appear to impact the digestion of the 
triglycerides, but it did reduce the bioaccessibility of the vitamin. This latter effect may 
have been because some of the vitamin remained solubilized within the non-digested oil 
droplets and so was not incorporated into the mixed micelles. 
Measurements of changes in vitamin bioaccessibility throughout incubation under 
simulated intestinal conditions produced some interesting findings. In particular, the 
vitamin tended to remain trapped inside indigestible oil droplets even during prolonged 
incubation under gastrointestinal conditions. On the other hand, for digestible oil 
droplets, the bioaccessibility reached a maximum value and then decreased steeply. This 
 
   123 
phenomenon may have occurred because insoluble calcium soaps formed that trapped 
some of the vitamin. In future studies, the impact of digestible and indigestible oil 
droplets on the bioaccessibility of vitamin D3 should be studied under in vivo conditions. 
Overall, our results may be important for the design and fabrication of more efficacious 
delivery systems for oil-soluble vitamins and nutraceuticals.  In particular, they suggest 
that the bioavailability of vitamin D3 may be increased by encapsulating it within small 
lipid droplets containing digestible (rather than indigestible) oils. 
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CHAPTER 7 
IMPACT OF CALCIUM LEVELS ON LIPID DIGESTION 
AND NUTRACEUTICAL BIOACCESSIBILITY IN 
NANOEMULSION DELIVERY SYSTEMS STUDIED USING 
STANDARDIZED INFOGEST DIGESTION PROTOCOL 
 
7.1 Abstract 
Recently, the standardized in vitro digestion model (“INFOGEST method”) used to 
evaluate the gastrointestinal fate of foods has been updated and revised 3. Under fed state 
conditions, the calcium level used in this model is fixed and relatively low: 0.525 mM. In 
practice, the calcium concentration in the human gut depends on the nature of the food 
consumed and may vary from person-to-person. For this reason, we examined the impact 
of calcium concentration on the gastrointestinal fate of a model nutraceutical delivery 
system. The effect of calcium level (0.525-10 mM) on lipid digestion and β-carotene 
bioaccessibility in corn oil-in-water nanoemulsion was investigated using the INFOGEST 
method. At all calcium levels, the lipids were fully digested, but this could only be 
established by carrying out a back titration (to pH 9) at the end of the small intestine 
phase. Conversely, the bioaccessibility of β-carotene decreased with increasing calcium 
levels: from 65.5% at 0.525 mM Ca2+ to 23.7% at 10 mM Ca2+. This effect was attributed 
to the ability of the calcium ions to precipitate the β-carotene-loaded mixed micelles by 
forming insoluble calcium soaps. The ability of calcium ions to reduce carotenoid 
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bioaccessibility may have important nutritional implications. Our results show that the 
bioaccessibility of hydrophobic carotenoids measured using the INFOGEST method is 
highly dependent on the calcium levels employed, which may have important 
consequences for certain calcium-rich foods. Moreover, we have shown the importance 
of carrying out a back titration to accurately measure free fatty acid levels in the presence 
of low calcium levels. 
Keywords: Calcium; nanoemulsion; β-carotene; lipid digestion; bioaccessibility; 
INFOGEST method. 
7.2 Introduction 
Research on food fortification with nutraceuticals has increased recently in response 
to consumers’ growing interest in functional foods and beverages with potentially health-
promoting properties 135, 271. Many nutraceuticals cannot simply be incorporated into 
foods because of solubility, stability, or sensory issues. Various kinds of colloidal 
delivery systems have therefore been fabricated to overcome these problems 272. 
Moreover, these delivery systems are being designed to exhibit specific functional 
attributes, such as controlled release, enhanced bioavailability, increased potency, 
synergistic effects, or targeted release 14, 242, 244. To test the potential efficacy of these 
delivery systems, both in vitro and in vivo methods have been developed 80, 113. These 
methods are essential for identifying the physicochemical processes that occur as a 
delivery system passes through the gastrointestinal tract (GIT). This information can then 
be used to identify the optimum composition and structure of colloidal delivery systems 
for specific applications 272. In general, the bioavailability of nutraceuticals within the 
GIT depends on three main factors: bioaccessibility, absorption, and transformation 1. For 
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highly hydrophobic nutraceuticals, like carotenoids, the bioaccessibility is often the rate 
limiting step that determines the overall bioavailability. The bioaccessibility depends on 
the liberation of the nutraceutical from the food matrix and then its solubilization within 
the mixed micelle phase. The bioaccessibility of hydrophobic nutraceuticals is usually 
enhanced by increasing the fat content within the food matrix, as this leads to the 
formation of more mixed micelles to solubilize the nutraceuticals 2, 273. 
In vivo human feeding studies are the most accurate methods of determining the 
impact of specific colloidal delivery systems on the bioaccessibility and bioavailability of 
nutraceuticals 113. In these studies, the levels of nutraceuticals and their metabolites are 
typically measured in the bloodstream, urine, and/or feces over time. Despite their 
accuracy, however, human feeding studies are rarely used to test nutraceutical 
bioavailability because of their high cost, long time, potential safety issues, and ethical 
concerns 80, 274. Moreover, they do not provide any insights into the physicochemical 
mechanisms involved. For this reason, in vitro digestion models have been developed that 
are relatively simple and inexpensive to perform, and allow researchers to rapidly screen 
many different formulations during the early stages of delivery system development 3. A 
recent review article has highlighted that there is often a good qualitative correlation 
between the results obtained using in vivo and in vitro methods, which supports the 
utilization of the latter for testing nutraceutical bioaccessibility 113. 
A number of in vitro digestion protocols have been developed over the past decade 
to test the gastrointestinal fate of foods, which vary in their attempts to mimic the 
complex physiochemical and physiological processes occurring inside the human gut 3, 91. 
These models typically come to some compromise between accurately simulating the 
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complexity of the human gut and having a protocol that is inexpensive, simple, rapid, and 
repeatable. Recently, there have been attempts to standardize the in vitro digestion 
models used in both the food and pharmaceutical areas 124, 275. The advantage of having a 
standardized model is that results on different samples or from different laboratories can 
be compared. In the food industry, the most well-established and widely-used in vitro 
digestion model is that developed by the INFOGEST consortium 124. Despite its 
widespread use, this method often leads to widely differing results when studying lipid 
digestion in foods, ranging from almost complete digestion 276 to only modest digestion 
277. In reality, humans are known to digest and absorb the vast majority of the lipids 
(triacylglycerols) they consume. It is, therefore, important to establish the origin of the 
observed variations in lipid digestion determined using the INFOGEST method. 
Moreover, this static in vitro digestion procedure has recently been refined to improve its 
accuracy and reliability 3, and so it is useful to examine the efficacy of this refined 
method for studying lipid digestion. 
One factor that is known to play an important role in lipid digestion in foods is the 
level of calcium present 101, 278. Calcium may act as both a promoter or inhibitor of lipid 
digestion depending on the system 279. On one hand, cationic calcium ions can promote 
flocculation of oil droplets, especially in emulsions stabilized by anionic emulsifiers, 
resulting in less surface area for lipolysis reaction. On the other hand, calcium ions can 
facilitate lipid digestion due to their ability to act as co-factors for pancreatic lipase and 
the ability to precipitate free fatty acids generated at the lipid droplet surfaces. There 
have, therefore, been several attempts at understanding the impact of calcium ions on 
lipid digestion 101, 278.  
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The digestive conditions within the INFOGEST method are based on the fed state of 
human digestion. Nevertheless, the calcium level used in the simulated intestinal fluids 
(0.6 mM) is considerably below those reported in human intestinal fluids 280, 281. Besides, 
some foods contain high levels of calcium, such as cheeses and milk, which can lead to 
much higher calcium levels (up to 10 mM) in the small intestine during digestion 281-283. 
These relatively high calcium levels may interfere with the lipid digestion process. 
The objective of the current study was to examine the impact of calcium levels on 
the digestion of lipids in nanoemulsion-based delivery systems using the INFOGEST 
method. Moreover, we also examined the impact of calcium levels on the bioaccessibility 
of a model hydrophobic nutraceutical (β-carotene) encapsulated within the 
nanoemulsions. This carotenoid has been associated with several diet-related health 
benefits due to its pro-vitamin A and antioxidant activities 149. Structurally, β-carotene 
consists of two beta-rings held together by a long polyene chain, and hence it is a highly 
hydrophobic polyunsaturated molecule that has low water-solubility and is highly prone 
to oxidation. A considerable research effort has, therefore, been carried out to develop 
colloidal delivery systems to encapsulate and protect this carotenoid, as well as to boost 
its bioavailability 284, 285. Nevertheless, the fate of these systems within the INFOGEST 
method has rarely been examined.  
In summary, the main objective of this research is to investigate the effects of 
different calcium levels on lipid digestion and β-carotene bioaccessibility of a 
nanoemulsion-based delivery system using the INFOGEST method. The physical and 
structural properties of the nanoemulsion were measured during in vitro digestion to 
identify the possible underlying mechanisms involved. The information generated by this 
 
   129 
research should lead to a better understanding of the lipid digestion process, as well as to 
the creation of more efficacious nutraceutical delivery systems. Moreover, it provides 
valuable insights into the critical role that calcium ions play in the standardized 
INFOGEST model. 
7.3 Materials and methods 
7.3.1 Materials 
Whey protein isolate (WPI) was provided by Agropur Inc. (Le Sueur, MN, USA). 
The additional reagents and chemicals utilized in the present study were described in 
detail in 3.3.1. 
7.3.2 Preparation and characterization of nanoemulsion delivery system 
The oil phase and the homogenization techniques used were described in detail in 
3.3.2. The aqueous phase, was prepared by dissolving emulsifier (WPI) in phosphate 
buffer solution (5 mM, pH 7.0) to reach a level of 1.0 wt% in the final nanoemulsion. The 
oil and aqueous phases were homogenized (10:90 w/w) to form the carotenoid-enriched 
nanoemulsions. The physical characterization of the samples was carried out according to 
3.3.3, 3.3.4 and 3.3.5. 
7.3.3 In vitro digestion 
In vitro digestion of vitamin-loaded emulsions was performed using the recently 
updated harmonized INFOGEST method 3. The experimental details were described in 
3.3.6 and 3.3.7. 
Specifically, A test sample was obtained by diluting the nanoemulsion with 
phosphate buffer solution (5 mM, pH 7.0) to an oil concentration of 5%. According to the 
INFOGEST method, the calcium (CaCl2 (H2O)2) concentration is 1.5, 0.15 and 0.6 mM in 
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the digestive fluids of mouth, gastric and intestinal phases respectively, which results in 
0.525 mM in the final solution after mixing with the gastric chyme. The effect of calcium 
level was investigated by also using a series of other calcium concentrations (1.5, 5 ,7.5 
and 10 mM in the final mixture) in the intestinal phase. 
7.3.4 Extraction and measurement of β-carotene 
The β-carotene was extracted from the samples and analyzed according to a method 
described in 3.3.8. 
7.3.5 Statistical analysis 
See details in 3.3.9. 
7.4 Results and discussion 
7.4.1 Gastrointestinal fate 
The physical and structural properties of the β-carotene encapsulated nanoemulsions 
were measured during each stage of the in vitro GIT model using the INFOGEST 
method. The initial nanoemulsion consisted of 1% WPI and 10% corn oil with a β-
carotene level of 0.1% in the oil phase. The nanoemulsion had a monomodal particle size 
distribution with a mean particle diameter (D3,2) of 143.5 ± 1.3 nm (Figures 7.1a and 
7.1b). The confocal microscopy images showed that the nanoemulsion contained a 
dispersion of fine oil droplets that were evenly distributed throughout the sample (Figure 
7.1c). The protein-coated oil droplets had a high negative surface potential (-56.1±1.0 
mV) because the pH of the nanoemulsion (pH 7) was higher than the isoelectric point of 
the WPI (around pH 5) (Figure 7.2). The nanoemulsion formed was physically and 
structurally similar to that of our previous studies 173, 286. These results showed that the 
 
   131 
microfluidization protocol and emulsifier used were successful at forming β-carotene-
fortified nanoemulsions. 
 
Figure 7.1 Physical properties of corn oil nanoemulsion during simulated gastrointestinal 
tract (GIT) digestion: (a) surface-weighted mean particle diameter (D3,2); (b) particle size 
distribution; (c) confocal photos. Samples with significant differences in the D3,2 value 
were designated with different letters. Abbreviation: small intestine (SI). Note: the 
volume fraction was stacked up the y-axis for comparison. 
The nanoemulsion was then subjected to the simulated oral phase. The light 
scattering experiments suggested that the particle size of the nanoemulsions remained 
fairly similar after exposure to the simulated oral conditions (Figure 7.1a), but the 
confocal microscopy images showed that some of the oil droplets had flocculated (Figure 
7.1c). The magnitude of the negative surface potential on the protein-coated oil droplets 
decreased significantly (p < 0.05) (Figure 7.2). These effects might have occurred 
because the change in ionic strength altered the electrostatic interactions, or the presence 
of mucin promoted depletion or bridging flocculation 231. 
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Figure 7.2 Surface potential of corn oil nanoemulsion during simulated gastrointestinal 
tract (GIT) digestion. Samples with significant differences in the surface potential were 
designated with different letters. Abbreviation: small intestine (SI). 
The nanoemulsion was then exposed to simulated gastric conditions by adjusting the 
pH to 3.0 and adding pepsin to reach a level of 2000 U/mL in the final mixture. The 
physical properties of the nanoemulsion changed appreciably within this stage. The mean 
particle diameter increased to over 30 µm, and the position of the peak in the particle size 
distribution shifted upwards, with most of the particles being in the range from 1 to 300 
μm (Figures 7.1a and 7.1b). The confocal microscopy images indicated that excessive 
droplet flocculation occurred under simulated gastric conditions (Figure 7.1c). 
Additionally, the negative surface potential of the particles in the nanoemulsion 
decreased to around -1.9 mV. Moreover, visual observations showed that the 
nanoemulsions became unstable to phase separation, with a thin cream layer being seen 
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Figure 7.3 Photos of corn oil nanoemulsion during simulated gastrointestinal tract (GIT) 
digestion. Abbreviation: small intestine (SI). 
Previous studies suggest that the flocculation state of oil droplets when they first 
enter the small intestine phase impacts their digestion: when the droplets are highly 
flocculated, the lipase is unable to easily access the surfaces of all the oil droplets, 
thereby inhibiting digestion 86. For this reason, we adjusted the gastric chyme to pH 7.0 
before adding the other intestinal components (calcium, bile salt, and pancreatic 
enzymes) so as to focus on the impact of pH on the flocculation state of the oil droplets. 
The sample obtained by this process is referred to as the “SI-Initial phase”. The light 
scattering and microscopy measurements indicated that there was a pronounced decrease 
in droplet flocculation when the system was adjusted to pH 7 (Figure 7.1). This effect can 
mainly be attributed to an increase in the negative charge on the protein-coated oil 
droplets (Figure 7.2), which recovered to a value fairly similar to that of the oral phase. 
Thus, the increased electrostatic repulsion between the oil droplets in the emulsions 
reduced the degree of flocculation. Nevertheless, there was evidence of some large 
individual oil droplets present in the SI-initial phase, which suggests that droplet 
coalescence as well as flocculation had occurred during incubation in the gastric phase. 
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Visual observations of the nanoemulsions in the SI-initial phase showed that they 
consisted of homogenous nanoemulsions without any obvious phase separation (Figure 
7.3). The good stability of the nanoemulsions to gravitational separation can be attributed 
to the fact that most of the individual oil droplets were relatively small and not 
flocculated. 
The nanoemulsions were then exposed to the full intestinal phase by adding the 
appropriate levels of digestive enzymes, bile salts, and mineral ions. The confocal 
microscopy images (Figure 7.1c) and pH stat measurements (see later) indicated that the 
majority of the lipids had been digested by the end of the small intestine phase. Visually, 
the nanoemulsions had a watery-turbid appearance, with no cream layer at the top, again 
suggesting that most of the oil droplets had been fully digested (Figure 7.3). The particle 
size distribution measurements indicated that the digested samples contained a broad 
range of different sized particles, which were probably micelles, liposomes, insoluble 
calcium soaps, and protein aggregates (Figure 7.1b). The ζ-potential of the digested 
samples was highly negative, which can be attributed to the presence of various kinds of 
anionic species, such as proteins, peptides, bile salts, phospholipids, and free fatty acids 
(Figure 7.2) 267.  
The properties of the particles in the mixed micelle sample (0.525 mM calcium, pH 
7) were also measured (Figures 7.2 and 7.4). Micelles are too small to be detected by 
static light scattering and so dynamic light scattering was used instead. The mean particle 
diameter of the mixed micelle phase was around 208 nm (Figure 7.4a), which is 
considerably larger than the dimensions of individual micelles (< 10 nm) 287, 288. This 
phenomenon is probably because the samples also contained liposomes and calcium 
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soaps 102, 165, 199. The magnitude of the negative ζ-potential on the particles in the mixed 
micelle phase was relatively high (-59.4 mV), which can again be attributed to the 
presence of various anionic species (Figure 7.2). The mixed micelle solution was slightly 
turbid suggesting that it contained particles large enough to scatter light strongly (Figure 
7.3). Overall, the physical and structural properties of the nanoemulsions during passage 
through the INFOGEST GIT model were fairly similar to those found using other in vitro 
digestion models 286, 289. The main exception was that the micelle phase formed after lipid 
digestion was more turbid in the INFOGEST method. 
 
Figure 7.4 Effect of different pH values on physical properties of samples from the 
micelle phase: (a) Z-Average; (b) surface potential; (c) and (d) particle size distribution. 
For addition of 0.525 mM calcium salt, samples with significant differences were 
designated with different capital letters (A, B, C), whereas lower case letters (a, b, c) 
were used for 10 mM calcium salt. Note: the volume fraction was stacked up the y-axis 
for comparison. 
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Figure 7.5 Effect of different calcium concentrations on the release of free fatty acids 
(FFA) of samples from the small intestine phase: (a) FFA released value verse time at pH 
7; (b) final FFA released value at pH 7 and 9; (c) corrected FFA released value verse 
time. For Final FFA value, different capital letters (A, B, C) were used to designated 
significant difference among samples at pH 7, while different lower-case letters (a, b, c) 
were used at pH 9. 
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The release of FFAs over time was measured during the small intestine phase using 
the pH-stat method by adding enough alkaline solution to maintain a neutral pH (Figure 
7.5a). Similar to previous studies, the amount of FFA increased greatly during the first 
1000 s, then gradually increased afterwards 156. However, under the fed conditions used 
in the standardized INFOGEST method, which employed only 0.525 mM calcium, the 
fraction of FFAs released by the end of the small intestine phase was only 39.4% (Figure 
7.5b). This value is much lower than that reported (> 90%) for similar nanoemulsions 
tested using an alternative in vitro digestion method 286. This phenomenon may have 
occurred because most of the FFAs were non-ionized at neutral pH when low calcium 
levels were used 280. For this reason, we used an additional back-titration step to pH 9 to 
detect the total number of FFAs released. In this case, a much higher final FFA value was 
reached, i.e., around 128% (Figure 7.5b). Indeed, the final FFA value was considerably 
higher than the expected value of 100%, assuming that two FFAs were released per 
triacylglycerol molecule. Several other studies have reported FFA values >100% at the 
end of lipid digestion 100, 280. This effect might have been attributed to the production of 
more than two FFAs per triacylglycerol due to alkaline hydrolysis of the triacylglycerol 
molecules at high pH values 170. 
Overall, this study shows that a high proportion of the FFAs generated during the 
small intestine phase under neutral conditions are non-ionized, and so could not be 
titrated by sodium hydroxide. Interestingly, this effect is not seen in alternative in vitro 
digestion models that use much higher calcium levels, which may have been because the 
presence of the calcium ions altered the equilibrium between the ionized and non-ionized 
states of the FFAs. In summary, for the INFOGEST method, a back titration to pH 9 is 
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required to measure the faction of non-ionized FFAs present in the samples after 
digestion. 
 
Figure 7.6 Effect of calcium concentration on the β-carotene concentration (a) and 
percentage (b) of samples from different digest phases. For different indicators, capital 
letters (A, B, C), lower-case letters (a, b, c) and Greek letters (α, β, γ) were used to 
designated significant difference among samples of different calcium concentration. 
The β-carotene concentration in the intestinal samples, as well as its distribution in 
the mixed micelle and sediment phases, was also measured at the calcium level (0.525 
mM) normally used in the INFOGEST method (Figure 7.6a). Most of the β-carotene was 
solubilized in the mixed micelle phase after digestion, leading to a relatively high 
bioaccessibility (65.5%) (Figure 7.6b), which is in agreement with previous studies 289. 
The recovery rate of the carotenoid was around 97.9% (Figure 7.6b), which indicates that 
most of the β-carotene in the intestinal digesta was located in either the mixed micelle or 
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sediment phases. The stability of the β-carotene encapsulated within the nanoemulsions 
was relatively high (84.4%), which indicated that the carotenoid was relatively stable to 
chemical degradation within the simulated GIT. 
7.4.2 Effects of calcium levels 
The calcium level used in the INFOGEST method (0.525 mM) is at the low end of 
reported physiological levels 280. As mentioned earlier, in the fasted state, the calcium 
levels reported in human duodenal fluids range from about 0.5 to 3 mM. Moreover, the 
calcium levels in foods and individuals may vary considerably depending on their diet 
and physiology. For this reason, the effect of different calcium concentrations (0.525, 1.5, 
5, 7.5 and 10 mM) on lipid digestion and carotenoid bioaccessibility was investigated. It 
should be noted that we only altered the calcium concentration in the small intestine 
phase, while the level in the oral and gastric phases was kept constant. The impact of the 
calcium levels on the physical and structural properties of the intestinal samples were 
measured (Figure 7.7). 
At low calcium levels (0.525 and 1.5 mM), the D3,2 values were 0.424 and 0.499 µm 
respectively, and the particle size distributions were bimodal. The confocal microscopy 
images indicated that there were only a few relatively large oil-rich particles present in 
these samples after digestion. These particles may have been oil droplets formed by the 
non-ionized free fatty acids. When the calcium level was increased to 5 mM, the mean 
particle diameters increased significantly (p < 0.05) to 0.692 µm and the particle size 
distribution broadened. The confocal microscopy images indicated that there were some 
large spherical lipid-rich particles, as well as many smaller irregular lipid-rich particles. 
When the calcium level was increased further to 7.5 and 10 mM, the D3,2 values remained 
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fairly similar, but there was a change in the shape of the particle size distribution. 
Besides, there were more particles of a ring shape or an irregular shape in the confocal 
images at these high calcium levels. We hypothesize that the cationic calcium ions 
promoted the aggregation of some of the small anionic mixed micelles, leading to the 
production of calcium soaps. Previous studies have also reported that high levels of 
calcium can promote the formation of insoluble calcium soaps 100, 282. 
 
Figure 7.7 Effect of different calcium concentrations on physical properties of samples 
from the small intestine phase: (a) surface-weighted mean particle diameter (D3,2; solid 
circle) and surface potential (open circle); (b) particle size distribution; (c) confocal 
photos. Samples with significant differences in the D3,2 values were designated with 
different low-case letters (a, b, c), whereas different capital letters (A, B, C) were used for 
surface potential. Note: the volume fraction was stacked up the y-axis for comparison. 
The surface potential of the particles in the digesta became increasingly less 
negative as the calcium ion level was increased (Figure 7.7a). This effect is consistent 
with the binding of cationic calcium ions to the anionic mixed micelles. At sufficiently 
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high calcium levels, the formation of calcium soaps may have been promoted because of 
the decrease in surface potential on the mixed micelles and the tendency for bridging to 
occur.  
The release of FFAs during digestion in the small intestine phase (pH 7.0) was 
monitored by titration with sodium hydroxide using the pH stat method (Figure 7.5a). 
The FFA release profiles of the nanoemulsion all followed a fairly similar pattern 
irrespective of the calcium levels used: there was a sharp increase during the first 1000 s 
followed by a gradual increase later. The fraction of titrated FFAs by the end of the 
digestion period increased from around 39% to 95% as the calcium concentration was 
increased from 0.525 to 10 mM. Interestingly, the final FFA value measured at pH 7 was 
linearly related to the calcium concentration (Figure 7.5b). As discussed earlier, most 
FFAs generated during lipid digestion are not titratable at low calcium levels because 
they are in a non-ionized form 280. Therefore, a back titration to pH 9 was carried out 
after the small intestine phase to measure the total amount of FFAs produced. Under 
these conditions, all the samples were seen to be fully digested after the intestinal phase 
with a final FFA value ranging from 116 to 128%. This result highlights the critical 
importance of carrying out the back-titration step under the low calcium conditions used 
in the standardized INFOGEST method. The actual FFA release kinetics were determined 
by multiplying the measured values with a correction factor (C), which was defined as 
the ratio of the final FFA values measured at pH 9 and pH 7 (Figure 7.5c). The corrected 
FFA release profiles indicate that the calcium level used had little impact on the lipid 
digestion curve. The calcium concentration used in the in vitro digestion model therefore 
appears to impact the ionization state of the FFAs, rather than the total amount of FFAs 
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generated. We hypothesize that the calcium ions altered the ionization equilibrium of the 
carboxylic acid groups (2[-COOH] + Ca2+ « Ca(-COO)2 + 2H+), thereby releasing the 
titratable protons. Thus, most FFAs could be titrated when higher calcium levels are 
employed in an in vitro GIT model. Alternatively, this result suggests that the in vitro 
digestion model could be simplified (no back titration) if relatively high calcium levels 
(10 mM) are used in the small intestine phase.   
The β-carotene concentrations of the whole small intestine samples, as well as those 
of the micelle and sediment phases, were measured at different calcium levels (Figure 
7.6a). The β-carotene concentrations in the whole small intestinal samples did not change 
appreciably (4.3 to 4.8 μg/ml) when the calcium level was changed. Moreover, the β-
carotene remained relatively stable under different calcium level during the GIT (75.3 to 
84.4%) (Figure 7.6b), which suggests that calcium do not have a major impact on the 
chemical stability of the carotenoid during the in vitro GIT digestion. The recovery of the 
β-carotene from the micelle and sediment phases combined was between about 89.2 to 
98.2% of that of intestinal phase (Figure 7.6b), which indicated that most of the β-
carotene was released from the oil phase after digestion. 
Nevertheless, the bioaccessibility of β-carotene decreased from 65.5 to 23.7% as the 
calcium concentration was increased from 0.525 to 10 mM (Figure 7.6b). In particular, 
the β-carotene concentration in the micelle phase decreased from around 3.02 to 0.78 
μg/ml, what in the sediment phase increased from around 1.32 to 3.20 μg/ml (Figure 
7.6a). This result indicates that there was a change in the location of the carotenoids 
within the digesta at the end of the small intestine phase. During lipid digestion, most of 
the encapsulated β-carotene should be released from the oil droplets and solubilized 
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within the mixed micelles formed by bile salts and FFAs 274. In the presence of calcium 
ions, however, the micelles tend to aggregate and eventually form particles that are large 
enough to sediment to the bottom of the samples 286. Indeed, an increasing amount of 
sediment was observed in the samples as the calcium concentration was increased (Figure 
7.8a). As a result, some of the β-carotene-loaded mixed micelles are incorporated into 
insoluble calcium soaps, which decreases the measured bioaccessibility. These results 
show that the bioaccessibility of carotenoids is highly sensitive to the level of calcium 
present in the small intestine, which may have important practical applications. For 
instance, consumption of carotenoid-rich foods with calcium-rich foods could lead to a 
decrease in carotenoid bioaccessibility.  Even so, it will be important to establish whether 
a similar effect is observed in vivo using animal or human feeding studies. 
 
Figure 7.8 Photos of the samples from intestinal phase with different calcium levels: (a) 
sedimentation after centrifuge; (b) micelle phase. 
In addition, we also observed that the mixed micelle phase was highly turbid at 
lower calcium levels but became increasingly clear at higher calcium levels (Figure 7.8b). 
This phenomenon may have occurred because there were a lot of mixed micelles 
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(micelles and vesicles) present at low calcium levels, which scattered light strongly and 
made the mixed micelle phase looks turbid. Conversely, at high calcium levels, many 
mixed micelles precipitate and sediment to the bottom of the samples so the mixed 
micelle phase looks clearer. 
7.4.3 Effect of pH values 
If back titration is used, the intestine sample has to be adjusted to pH 9 at the end of 
the digestion stage, which may change the physical properties of the colloidal particles 
present, as well as the bioaccessibility of any nutraceuticals. This series of experiments 
therefore focusses on the effect of pH (from 6 to 9) on the physical and structural 
properties of the particles in the mixed micelle phase at both low and high calcium levels 
(0.525 and 10 mM), which is displayed in Figs. 4 and 9. At low calcium level (0.525 
mM), the mean particle diameter increased from around 183 to 250 nm when the pH was 
increased from 6 to 8, but then slightly decreased to 229 nm when the pH was further 
increased to 9 (Figure 7.4a). This effect was presumably due to increases in the ionization 
state of the FFAs as the pH was raised 290. Changes in the charge of the carboxylic acid 
groups may have altered their ability to pack into mixed micelle structures. At high 
calcium levels (10 mM), the mean particle diameter increased gradually from 113.1 to 
136.4 nm when the pH was raised from 6 to 8, but then increased more steeply to 253.4 
nm when the pH was further increased to 9 (Figure 7.4a). The mixed micelles were 
significantly (p < 0.05) smaller at the higher calcium level than the lower one. This is 
probably because many of the larger mixed micelles have been preferentially precipitated 
out of the system by binding to calcium ions, leaving the smaller ones. 
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The surface potential of the mixed micelle samples remained negative across the 
entire pH range (from 6 to 9), which is because all of the colloidal particles present are 
anionic. At pH 6, the ζ-potential of the low calcium sample (-32.3 mV) were similar to 
that of high calcium sample (-29.9 mV) (Figure 7.4b). This phenomenon may have 
occurred because there was a high fraction of non-ionized FFAs at pH 6, since the pKa 
value of the carboxylic acid groups is higher than this value 291. As a result, the 
magnitude of the negative surface potential was lower. On the other hand, calcium ions to 
bind to the surfaces of the mixed micelles in high calcium sample and thus reduced the 
negative potential. The impact of pH value on the surface potential depended on the 
calcium levels present. For low calcium levels, the magnitude of the ζ-potential increased 
significantly (p < 0.05) with increasing pH: from -32.3 mV at pH 6 to -63.6 mV at pH 9 
(Figure 7.4b). This effect can be attributed to the increasing ionization of the FFAs as the 
pH is increased over the pKa values of the carboxylic acid groups. For high calcium 
levels, increasing the pH had little effect on the surface potential (-25 to -34 mV), which 
may have been because the ionized FFAs were bound and precipitated by the calcium 
ions. 
The impact of pH and calcium levels on the turbidity of the mixed micelle samples 
was also investigated (Figure 7.9). In this case, control samples were also used, which 
were obtained by collecting the mixed micelle phase from samples containing no oil. For 
the control samples, the mixed micelle phase was cloudy at pH 6 but transparent from pH 
7 to 9, irrespective of calcium level. The turbidity of the control samples at pH 6 was 
presumably due to the fact that they contained proteins (whey protein, pancreatin, and 
pancreatic lipase) with isoelectric points close to this value. At pH 6, the turbidity of the 
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control samples containing 10 mM calcium was slightly less than those containing 0.525 
mM calcium, which might have occurred because the cationic calcium ions promoted 
some precipitation of the anionic proteins. 
 
Figure 7.9 Photos of samples from control sample (no lipid) and micelle phase of high 
and low calcium levels at different pH values. 
In the test (nanoemulsion) samples, the mixed micelle solutions were cloudy at pH 6 
and became increasingly clear as the system was raised to pH 9. This effect was observed 
at both calcium levels used, but the turbidity of the mixed micelle phase was less in the 
samples containing the higher calcium levels. This effect may have been because the 
cationic calcium ions promoted aggregation of the anionic proteins and mixed micelles. 
For the test samples, the pH-dependent change in turbidity of the mixed micelle phase 
might be due to both protein and mixed micelle aggregation. As the pH is increased, both 
the proteins and fatty acids become more negatively charged, which should increase the 
electrostatic repulsion between the colloidal particles, thereby opposing aggregation. 
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In summary, these results showed that the change of pH value in the micelles 
samples could modify the size and charge properties as well as the solubility of the 
components insides, and these effects are dependent on the calcium level applied. 
Consequently, it might place possible impacts on the bioaccessibility of the solubilized 
nutraceuticals. 
7.5 Conclusions 
In this study, the effect of calcium concentration on lipid digestion and carotenoid 
bioaccessibility was evaluated for β-carotene-fortified nanoemulsions using the 
standardized INFOGEST method. In the absence of a back-titration step, the extent of 
lipid digestion appeared to increase with increasing calcium level. When this step was 
included, however, the lipids were fully digested in all the nanoemulsions, regardless of 
the calcium levels used. This effect was attributed to the ability of the calcium ions to 
change the ionization state of the carboxylic acid groups on the free fatty acids. At neutral 
pH, the FFAs are not fully ionized and so they are not titrated by sodium hydroxide in the 
pH-stat method. In the presence of calcium, however, the FFAs form calcium soaps and 
release protons (H+) that can be titrated. This study therefore highlights the importance of 
including the back-titration step in the INFOGEST method in order to get accurate 
measurements. 
Interestingly, increasing the level of calcium in the small intestine phase decreased 
the bioaccessibility of the carotenoids, which was attributed to the ability of the cationic 
calcium ions to precipitate the anionic b-carotene-loaded mixed micelles.  As a result, the 
carotenoids were no longer present in the mixed micelle phase generated during lipid 
digestion. The ability of calcium ions to reduce carotenoid bioaccessibility may have 
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important implications for the nutritional benefits of these nutraceuticals. Consuming 
carotenoid-rich foods with calcium-rich foods could lead to a reduction in carotenoid 
bioavailability and efficacy. 
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CHAPTER 8 
CHITOSAN REDUCES VITAMIN D BIOACCESSIBILITY 




Consumption of sufficiently high quantities of dietary fibers has been linked to a 
range of health benefits. Recent research, however, has shown that some dietary fibers 
interfere with lipid digestion, which may reduce the bioavailability of oil-soluble 
vitamins and nutraceuticals. For this reason, we examined the impact of a cationic 
polysaccharide (chitosan) on the bioaccessibility of vitamin D using the standardized 
INFOGEST in vitro digestion model. The vitamin D was encapsulated within an 
emulsion-based delivery system that contained whey protein-coated corn oil droplets. 
Our results showed that chitosan promoted severe droplet flocculation in the small 
intestine and reduced the amount of free fatty acids detected using a pH-stat method. 
However, a back-titration of the digested sample showed that the lipids were fully 
digested at all chitosan levels used (0.1-0.5%), suggesting that chitosan may have bound 
some of the free fatty acids released during lipid digestion. The presence of the chitosan 
decreased the bioaccessibility of vitamin D by about 37%, but this effect did not depend 
strongly on chitosan concentration (0.1-0.5%). It was hypothesized that chitosan bound to 
the vitamin-loaded mixed micelles and promoted their precipitation. The knowledge 
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gained in this study might provide useful insights in designing emulsion-based delivery 
systems with high vitamin bioaccessibility. 
Keywords: chitosan; emulsion; nanoemulsion; vitamin D; bioaccessibility; in vitro 
digestion 
8.2 Introduction 
Recently, there has been considerable interest within the food industry in the design 
of functional foods and beverages that not only taste good, but also have specific health 
benefits 292. A number of approaches are being utilized to create these healthier versions 
of processed foods. One approach is to decrease the levels, or at least reduce the 
potentially negative effects, of food ingredients that have been linked to increased health 
risks, such as fat, sugar, and salt 292. Another approach is to control the structural 
organization of the constituents within foods so as to alter their behavior inside the 
gastrointestinal tract. An example of this approach is to create foods in which the 
macronutrients are digested more slowly, thereby inhibiting glucose or lipid spikes in the 
blood that may lead to diabetes or heart disease 293, 294. Yet another approach is to fortify 
foods with bioactive ingredients that have been linked to beneficial health effects, such as 
vitamins, minerals, and nutraceuticals 2, 133. For example, vitamin D is vital for bone 
health and other critical physiological functions 40, but in many countries, some segments 
of the population are deficient in this essential micronutrient 41. Nevertheless, the amount 
of fortification must be carefully controlled because excessive vitamin D intake can have 
adverse health outcomes, such as gastrointestinal disorders and kidney dysfunction 295, 296. 
A specialized design of food matrix systems using food macronutrients to regulate the 
adsorption of encapsulated micronutrients like vitamin D is of great interest 297. 
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The purpose of the current study was to examine the impact of a dietary fiber 
(chitosan) on the bioavailability of vitamin D encapsulated within emulsion-based 
delivery systems. In general, dietary fibers are claimed to have a number of potentially 
beneficial health effects 298-300. For instance, they can inhibit glucose absorption, promote 
satiety, and thereby reduce overall calorie consumption 301. Dietary fibers have also been 
shown to modulate the gut microflora 302, which is claimed to promote a healthy immune 
system and reduce the susceptibility to certain chronic diseases 303. Dietary fibers have 
also been shown to modulate the rate and extent of lipid digestion in emulsion-based 
delivery systems 304, 305, which may impact the bioavailability of encapsulated oil-soluble 
vitamins. Several possible mechanisms have been proposed to account for the ability of 
dietary fibers to interfere with lipid digestion: 
(1) some dietary fibers form coatings around oil droplets that restrict the ability of 
lipase to access the underlying lipids 306, 307; 
(2) some dietary fibers promote droplet flocculation, which decreases the surface 
area of the oil droplets available for lipase adsorption 308; 
(3) some dietary fibers thicken or gel the gastrointestinal fluids, which reduces 
mixing efficiency and retards enzyme diffusion, thereby inhibiting the ability of lipase to 
reach the oil droplet surfaces 309-311; 
(4) some dietary fibers bind to critical components in the lipid digestion process, 
such as bile salts, free fatty acids 93, 308, digestive enzymes 312, and, calcium ions 313, 
thereby altering the rate and extent of lipid digestion. 
(5) some dietary fibers bind to mixed micelles 314, which alters their availability for 
adsorption by the epithelium cells in the gastrointestinal tract (GIT). 
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The tendency for specific dietary fibers to be involved in these different mechanisms 
depends on their molecular and physicochemical characteristics (such as molecular 
weight, charge, conformation, and solubility), as well as food matrix properties (such as 
composition and structure). We hypothesized that chitosan could impact the 
bioaccessibility of vitamin D by interfering with the lipid digestion process by one or 
more of the above mechanisms. 
Food-grade chitosan is commonly produced by deacetylation of the chitin found in 
the shells of crustaceans, such as crabs and shrimps 315, 316. It is one of the few positively 
charged polysaccharides available and so has been widely used as a functional ingredient 
in foods and other commercial products for its binding, structure building, film forming, 
and other functional attributes 317. The U.S. Food and Drug Administration and European 
Union have approved chitosan as safe in application of dietary use and wound dressing. 
Chitosan has been used as food additives in many countries including Japan, USA, Korea 
etc. 318 The positive charge on chitosan molecules is due to aliphatic amino groups that 
are protonated (-NH3+) under acidic conditions: pKa ~ 6-7 319. The cationic nature of 
chitosan is believed to be responsible for many of its physiological effects in the human 
gut after digestion. Several studies have shown that chitosan can inhibit lipid digestion 
and reduce the bioaccessibility of hydrophobic bioactives (such as curcumin) 229, 320. 
These effects have been attributed to some of the physicochemical mechanisms listed 
earlier. For instance, cationic chitosan can form a protective coating around anionic oil 
droplets, or promote their flocculation, which inhibits lipid digestion by reducing the 
ability of lipase to reach the lipid phase 321. Besides, chitosan can bind to anionic free 
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fatty acids and bile salts 314, which might alter the number of nutraceutical-loaded mixed 
micelles available for adsorption in the upper gastrointestinal tract (GIT). 
The main objective of the current study was therefore to examine the impact of 
chitosan on the gastrointestinal fate of vitamin D-loaded oil droplets in emulsion-based 
delivery systems. In particular, we used the standardized INFOGEST simulated GIT 
model to examine the impact of chitosan on lipid digestion and vitamin bioaccessibility 3. 
The results obtained from this study may facilitate the design of more effective emulsion-
based delivery systems for oil-soluble vitamins and other non-polar bioactive agents. 
8.3 Materials and methods 
8.3.1 Materials 
Whey protein isolate (WPI) was provided by Agropur Inc (Eden Prairie, MN). 
Chitosan (Chitoclear cg 800, degree of deacetylation >75%, viscosity 600-1200 mPa·s) 
was provided by Primex ehf. (Siglufjordur, Iceland). Vitamin D3 (1,0 Mill. I.U./g) was 
supplied by BASF (Ludwigshafen, Germany). The additional reagents and chemicals 
utilized in the present study were described in detail in 3.3.1. 
8.3.2 Emulsion preparation 
The aqueous phase, oil phase and the homogenization techniques used were described 
in detail in 6.3.2, 7.3.2 and 3.3.2. The final composition of the emulsion was 10 wt% oil 
phase (2 wt% vitamin D in corn oil) and 90 wt% aqueous phase (1.11 wt% WPI in buffer 
solution). This led to a WPI concentration of 1 wt% in the final emulsion. 
8.3.3 Chitosan solution preparation 
A chitosan stock solution was prepared by dissolving 1 wt% chitosan in 0.5% (v/v) 
acetic acid solution and then storing at 4 °C overnight to ensure complete hydration. Any 
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insoluble matter was then removed from this solution by centrifugation (Sorvall Lynx 4000 
centrifuge, Thermo Scientific, Waltham, MA, USA) at 15,000 rpm for 30 min at room 
temperature. 
8.3.4 Emulsion and chitosan mixing method 
The chitosan stock solution was diluted with different amounts of 0.5% (v/v) acetic 
acid solution to obtain a series of solutions containing different chitosan levels (0%, 0.2%, 
0.4%, 0.6%, 0.8% and 1%). These solutions were then mixed with the emulsions at a 1:1 
(v/v) ratio by adding the emulsions dropwise into beakers containing the chitosan solutions. 
The resulting mixtures were then stirred for 5 min to ensure they were homogenous and 
then placed at room temperature overnight before in vitro digestion. 
8.3.5 Particle size measurements 
The particle size distribution of the samples was determined according to 3.3.3. A 1:1 
(v/v) mixture of 0.5% (v/v) acetic acid and phosphate buffer (5 mM, pH 7.0) was used to 
dilute the initial samples. Double distilled water with pH adjustment was used for the 
mouth (pH 4.8) and stomach (pH 3) samples. Phosphate buffer (5 mM, pH 7.0) was used 
to dilute the small intestine samples. Phosphate buffer (5 mM, pH 7.0) was used to dilute 
the samples prior to analysis to avoid multiple scattering effects. 
8.3.6 Particle surface potential measurements 
The surface potential (z-potential) of the particles in the emulsions was measured 
according to 3.3.4. The buffer solutions used for sample dilution were the same as 8.3.5. 
8.3.7 Confocal microscopy 
Confocal microscopy images were acquired according to 3.3.5. 
8.3.8. In vitro digestion 
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In vitro digestion of vitamin-loaded emulsions was performed using the recently 
updated harmonized INFOGEST method 3. The experimental details were described in 
3.3.6 and 3.3.7. 
8.3.9 Direct mixing of micelle and chitosan 
In one series of experiments, we aimed to determine the impact of adding chitosan 
to the mixed micelles formed during digestion. To achieve this, a corn oil-in-water 
emulsion (5% oil) was subjected to the above in vitro digestion procedure, and then the 
resulting mixed micelle phase was collected after centrifugation. Different amounts of 
chitosan stock solution (1 wt.%) was then mixed with the mixed micelle samples to reach 
0%, 0.0125%, 0.025%, 0.0375%, 0.05% and 0.0625% of chitosan, which is similar to the 
chitosan levels present in the chitosan-emulsion mixtures after in vitro digestion. The 
mixed micelle-chitosan mixtures were then placed in the incubated shaker at 37 °C at 100 
rpm for 2 h. Afterwards, the micelle-chitosan mixtures were centrifuged (Sorvall Lynx 
4000 centrifuge) at 30,970 ×g (18,000 rpm) for 30 min at 4 °C to precipitate the 
sediment. The vitamin D concentration in the micelle-chitosan mixtures and the 
supernatants formed after centrifugation were measured using the method described in 
the following section. The mass of the sediment was weighed after oven-drying at 37 °C 
overnight. The percentage of sediment formed was then calculated using the following 
expression: 




Here, mmixture and msediment are the mass of the micelle-chitosan mixture and the 
sediment, respectively. 
8.3.10 Vitamin D measurement 
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The extraction and analysis of the vitamin D concentration was carried out 
according to 7.3.7. 
8.3.11 Statistical analysis 
See details in 3.3.9. 
8.4 Results and discussion 
8.4.1 Physical and structural properties during in vitro gastrointestinal digestion 
Initially, corn oil-in-water emulsions containing different chitosan concentrations 
were prepared. These mixtures were then passed through the in vitro digestion model to 
obtain a better understanding of their potential gastrointestinal fate, especially the impact 
of the chitosan on lipid digestion and vitamin bioaccessibility. The particle size, surface 
charge, and microstructure of the emulsion-chitosan mixtures were measured in each 
stage of the GIT model. 
Initial: The emulsion-chitosan mixtures were prepared by adding the corn oil 
emulsion (in phosphate buffer, pH 7) drop-by-drop into the chitosan solution (in acetic 
acid solution, pH 3.7). The resulting solutions had pH values ranging from 3.9 to 4.6, 
increasing with decreasing chitosan concentration. The surface charge of the particles in 
all of the emulsions was highly positive. The pure emulsion (no chitosan) had a surface 
charge of +48.8 mV (Figure 8.3), because the final pH was below the isoelectric point of 
the adsorbed proteins (pI » 5). The pure emulsion had a monomodal distribution and a 
mean particle diameter of 148 nm, which is fairly similar to that of the original emulsion 
i.e., 139 nm (Figures 8.1 and 8.2a). The confocal microscopy images showed that these 
emulsions contained fine oil droplets that were evenly distributed throughout the samples 
(Figure 8.4). These results indicate that the pure emulsion was stable under these pH 
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conditions, which is probably due to the strong electrostatic repulsion between the highly 
cationic droplets. 
 
Figure 8.1 The effect of different chitosan concentrations on the surface-weighted mean 
particle diameter (D3,2) of the corn oil in water emulsion during stimulated 
gastrointestinal tract. Significant difference was labeled by different capital letters (A, B, 
C) for different chitosan concentrations (same phase), whereas lower-case letters (a, b, c) 
for different phases (same chitosan concentration). Abbreviation: small intestine (SI). 
In the presence of chitosan, the positive surface potential of the emulsions remained 
relatively high and positive (+41.7 to +47.3 mV) with increasing chitosan concentration 
(0.1-0.5 %) (Figure 8.3). This effect may have been because the chitosan did not bind 
strongly to the droplet surfaces under these acidic conditions because both the chitosan 
and lipid droplets had strong positive charges, leading to an electrostatic repulsion. In 
addition, as the pH increased from 4.1 to 4.6, and therefore moved closer to the 
isoelectric point of the adsorbed whey proteins, some of the cationic chitosan molecules 
could have bound to anionic patches formed on the protein-coated droplet surfaces 322. As 
a result, the net positive charge remained relatively high.  The confocal microscopy 









































0% 0.1% 0.2% 0.3% 0.4% 0.5%
 
   158 
chitosan levels used, which is most likely a result of bridging or depletion flocculation 94, 
322. The extent and nature of flocculation depended on the chitosan concentration. At low 
chitosan levels (0.1%), severe droplet flocculation occurred (Figure 8.4) and the 
emulsions visually separated into a cream layer on top and a serum layer at the bottom 
(Figure 8.5). Surprisingly, the measured mean particle diameter only increased slightly to 
156 nm in the presence of 0.1% chitosan (Figure 8.1), which suggests that either the 
flocculated droplets were only held together by relatively weak reversible attractive 
interactions, or that only a small fraction of the droplets were flocculated. 
 
Figure 8.2 The effect of different chitosan concentrations on the particle size distribution 
of the corn oil in water emulsion during stimulated gastrointestinal tract. Abbreviation: 
small intestine (SI). Note: the volume fraction was stacked up the y-axis for comparison. 
When the chitosan concentration was increased to 0.3%, the flocculated oil droplets 
appeared to be more evenly spread (less clumping) and the emulsions showed less phase 
separation (Figures 8.4 and 8.5). In this case, the mean particle diameter increased 
significantly (p < 0.05) to 286 nm (Figure 8.1) and the particle size distribution became 
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bimodal.  These results suggest that the oil droplets were more strongly aggregated to 
each other and formed a 3D-network that was more resistant to gravitational separation. 
At 0.4 and 0.5% chitosan, there was some evidence of clumping of the flocculated 
droplets, a steep increase in mean particle diameter, and a shift in the particle size 
distribution to higher values (Figures 8.1-8.3). These effects may have been due to 
increasing bridging and/or depletion flocculation as the chitosan level was increased 94, 
323. 
 
Figure 8.3 The effect of different chitosan concentrations on the ζ-potential of the corn oil 
in water emulsion during stimulated gastrointestinal tract. Capital letters (A, B, C) were 
used for distinguish significant difference of samples with different chitosan 
concentration (same phase). Abbreviation: small intestine (SI). 
Mouth: The physical and structural properties of the samples changed appreciably 
after exposure to the oral phase. After mixing with the simulated salivary fluids, the 
solutions had pH values from 4.5 to 5.1. The pure emulsion was unstable under mouth 
conditions with visible phase separation, an increase in mean particle diameter (D3,2 = 9.7 
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This effect may have been because of the relatively low surface potential (ζ = -0.17 mV) 
of the protein-coated oil droplets near the isoelectric point of the proteins, which led to a 
relatively weak electrostatic repulsion between them. 
 
Figure 8.4 The effect of different chitosan concentrations on the confocal microscopy of 
the corn oil in water emulsion during stimulated gastrointestinal tract. Abbreviation: 
small intestine (SI). 
The addition of chitosan improved the stability of the emulsions by an amount that 
depended on the concentration used (Figure 8.5). As the chitosan level was increased, the 
mean particle diameter decreased reaching a value of 331 nm at 0.3% chitosan level 
(Figure 8.1), but a broad particle size distribution was observed (Figure 8.2d). This effect 
may have been due to the ability of the chitosan molecules to adsorb to the surfaces of the 
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protein-coated oil droplets, increase their positive charge, and strengthen the electrostatic 
repulsion between them. This hypothesis is supported by the observation that the z-
potential of the droplets became increasingly positive as the chitosan level increased 
(Figure 8.3). Nevertheless, the confocal microscopy images showed that the protein-
coated oil droplets were still highly flocculated in the presence of chitosan (Figure 8.4). 
These results suggest that there were still some bridging and/or depletion flocculation at 
high polysaccharide levels, but the flocs formed were weak enough to dissociate when 
the samples were diluted for the particle size measurements. 
Stomach: In the stomach phase, the emulsion samples were exposed to highly acidic 
conditions (pH 3), as well as digestive enzymes (pepsin). All the samples were highly 
unstable to droplet aggregation (Figures 8.1, 8.2, and 8.4) and phase separation (Figure 
8.5). The mean particle diameter was relatively high (> 7 μm) at all chitosan levels (0 to 
0.5%) (Figure 8.1). Droplet aggregation was probably a result of changes in electrostatic 
interactions, bridging flocculation, and protein digestion. After exposure to the stomach 
phase, the ζ-potential of the particles was positive in all the samples, increasing from +5.3 
mV in the absence of chitosan to +23.2 mV in the presence of 0.5%, chitosan. One might 
have expected that this large increase in particle charge would have led to stronger 
electrostatic repulsion between the oil droplets, but there was not a major change in 
particle aggregation with increasing chitosan levels. This phenomenon might be 
explained by a number of factors: (1) the change in pH caused partial or full displacement 
of the chitosan from the oil droplet surfaces; (2) the dilution of the samples reduced the 
amount of chitosan coating the droplet surfaces, thereby promoting bridging; (3) the 
digestion of the adsorbed proteins by pepsin reduced the stabilizing effects of the 
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emulsifier; and (4) the higher ionic strength of the gastric fluids screened the electrostatic 
repulsion 324. 
SI-Initial: Since pH is known to play a critical role in determining the physical and 
structural properties of protein-stabilized emulsions 325, we measured the properties of the 
samples at the beginning of the small intestine phase before adding the digestive enzymes 
and bile salts. This was accomplished by adjusting the sample collected after the stomach 
phase to pH 7. The properties of all the samples changed appreciably when the pH was 
increased. The average mean particle diameter of the pure emulsion decreased steeply to 
281 nm (Figure 8.1), and populations of both small and large particles were seen in the 
particle size distribution (Figure 8.2a). This result matched with the confocal microscopy 
images, which showed most of the flocs were dispersed into small oil droplets with only a 
few large droplets (Figure 8.4). The breakdown of the flocs can mainly be attributed to an 
increase in the electrostatic repulsion between the droplets due to an increase in their 
surface potential to a high negative value (-37.5 mV) (Figure 8.3). The fact that there 
were large individual oil droplets present suggests that some coalescence occurred within 
the mouth and/or stomach phases. Visual observation of the pure emulsions indicated that 
they were stable at the beginning of the small intestine phase (Figure 8.5). Overall, these 
results suggest that most of the oil droplets stayed intact and were evenly dispersed 
throughout the samples. 
 
   163 
 
Figure 8.5 Appearance of emulsions containing different chitosan concentrations at 
different digestive stages. Abbreviation: SI-initial = the initial stages of the small intestine 
phase. 
In contrast, the emulsions containing chitosan became more unstable when they 
were moved from the stomach phase to the initial part of the small intestine phase. Visual 
observations showed that all these emulsions underwent phase separation, with a white 
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cream layer on top and a clear serum layer at the bottom (Figure 8.5). The addition of 
chitosan significantly (p < 0.05) increased the mean particle diameter of these samples, 
with the effect becoming more pronounced with increasing chitosan concentration 
(Figure 8.1). Extensive droplet flocculation was also observed in the confocal microscopy 
images (Figure 8.4). This effect can be attributed to at least two phenomena.  First, 
chitosan is slightly positively charged at pH 7 whereas the protein-coated droplets are 
strongly negatively charged, thereby promoting bridging flocculation.  Second, chitosan 
loses most of its positive charge under neutral conditions (pKa around 6.5), which causes 
it to precipitate. These two mechanisms are supported by the electrophoresis 
measurements, which show that the negative charge on the particles decreased with 
increasing chitosan concentration: from -37.5 mV in the absence of chitosan to -2.5 mV 
in the presence of 0.5% chitosan (Figure 8.3). In summary, the presence of the chitosan 
appears to promote the aggregation of the oil droplets. 
SI-End: The properties of the samples were measured again after bile salts and 
digestive enzymes were added and the samples were then incubated for 2 hours. At the 
end of the small intestinal phase, the mean particle diameter of the pure emulsions 
increased significantly (p < 0.05) to around 970 nm (Figure 8.1). This change might be 
brought about by the digestion of the lipid droplets and the formation of large colloidal 
structures like vesicles and insoluble calcium soaps 267. The magnitude of the surface 
potential in the pure emulsion sample increased slightly to -44.0 mV (Figure 8.3), which 
has been attributed to the presence of colloidal particles comprised of anionic 
constituents, such as free fatty acids, bile salts, and peptides 267. The confocal microscopy 
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images indicated that most of the oil droplets had been digested by the end of the small 
intestine phase (Figure 8.4).  
Compared to the beginning of the small intestinal phase, the mean particle diameters 
of the samples containing chitosan decreased greatly after the small intestine phase. Even 
so, the D3,2 value still increased with increasing chitosan concentration: from 0.97 μm in 
the absence of chitosan to 3.33 μm in the presence of 0.5% chitosan (Figure 8.1). The 
confocal microscopy images also indicated that most of the oil droplets were digested at 
all chitosan concentrations, but that there were slightly more lipid-rich particles 
remaining at higher chitosan levels (Figure 8.4). Interestingly, these results show that 
even though the emulsions containing chitosan were highly flocculated at the beginning 
of the small intestine phase, most of the oil droplets were still digested by the end. Unlike 
at the beginning of the small intestine phase, the surface potential of the samples 
containing chitosan was highly negative and did not change much at different chitosan 
levels ranging from -32.0 to -40.6 mV. This effect can be attributed to the relatively high 
level of anionic components in the small intestine phase, such as free fatty acids and bile 
salts. Presumably, these components bound to the positively charged chitosan molecules 
and neutralized their charge. 
The surface potential of the mixed micelles collected after centrifugation of the 
digest were also measured (Figure 8.4). The z-potential of the mixed micelle samples 
were fairly similar to those of the equivalent whole intestinal samples, suggesting that the 
mixed micelles dominated the overall charge characteristics. 
8.4.2 Release of free fatty acids during intestinal digestion 
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Figure 8.6 Impact of chitosan concentration on the release of free fatty acids (FFA) from 
corn oil-in-water emulsions during simulated digestion. (a) FFA profile at pH 7, (b) final 
FFA value at pH 7 and pH 9. Capital (A, B, C) and lower-case (a, b, c) letters were used 
to designate significant difference among different chitosan concentrations for final FFA 
value at pH 7 and pH 9 respectively. 
The release of free fatty acids (FFA) from the emulsions within the small intestine 
phase was recorded using a pH stat method by adding increasing volumes of alkaline 
solution to maintain a neutral pH. The FFA-time release profiles are shown in Figure 8.6a 
and the final FFA values are shown in Figure 8.6b. The measured FFA values increased 
rapidly during the first few minutes of digestion but then increased more steadily at 
longer times. In general, the level of FFAs detected in the pure emulsions was higher than 
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that detected in the emulsions containing chitosan. For instance, the final FFA value was 
around 65% for the pure emulsion, whereas it was around 47% to 53% for the emulsions 
containing chitosan. These results appear to be inconsistent with the confocal microscopy 
images, which showed that most of the oil droplets had been fully digested by the end of 
the small intestine phase (Figure 8.4). This apparent inconsistency might be due to the 
fact that a fraction of the FFAs were not ionized at pH 7 and so could not be titrated. To 
test this hypothesis, a back titration to pH 9 was carried out, since this protocol has 
previously been shown to be capable of measuring all of the FFAs present 280. After back 
titration, the final FFA values of all the samples (102% to 115%) suggested that full lipid 
digestion had occurred. This result suggests that chitosan did not inhibit lipid digestion, 
but instead altered the amount of FFAs that could be detected by the pH stat method at 
pH 7. Presumably, the cationic chitosan molecules bind to any anionic free fatty acids at 
neutral pH thereby reducing the number of titratable protons (H+) released. 
In previous studies, it has been suggested that chitosan can inhibit lipid digestion 
through a number of mechanisms, including inducing oil droplet flocculation, forming 
coatings around oil droplets, or binding to digestive components (like enzymes or bile 
salts) 326. Our current results suggest that some of these earlier observations might have 
been because a back-titration step was not carried out. As a result, not all of the FFAs 
released during lipid digestion were measured.  In addition, most of the earlier studies 
were carried out using an in vitro digestion method that contained different levels of 
digestive enzymes, calcium, and other components to the standardized INFOGEST 
digestion method used in the current study 3. In particular, the INFOGEST method uses 
higher levels of pancreatic enzymes and lower levels of calcium, which may alter the rate 
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and extent of lipid digestion.  Having said this, our results still show that chitosan does 
interfere with the lipid digestion process under neutral conditions. 
8.4.3 Vitamin bioaccessibility 
 
Figure 8.7 The effect of different chitosan concentrations on the vitamin D 
bioaccessibility of the corn oil in water emulsion during stimulated gastrointestinal tract. 
Samples with significant difference were labeled with different capital letters (A, B, C). 
The vitamin D bioaccessibility in the emulsion-chitosan mixtures was measured 
after they had been passed through the entire in vitro simulated digestion model (Figure 
8.7). The pure emulsion had the highest bioaccessibility (68.5%), which is quite similar 
to the value published previously (75.2%) for a fairly similar system 286. The addition of 
chitosan significantly (p < 0.05) reduced the bioaccessibility of the vitamin in the 
emulsion (37.5% to 47.0%), but the decrease did not depend strongly on chitosan 
concentration. There have been few previous studies on the impact of chitosan on the 
bioaccessibility of lipophilic bioactives. One study showed that chitosan enhanced the 
bioaccessibility of curcumin 308, while others showed that it reduced the bioaccessibility 
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bioactive agents, food matrices, and in vitro digestion models used by different 
researchers. 
In general, the bioaccessibility of oil-soluble vitamins in emulsion-based delivery 
systems is governed by two processes: (1) their release from the oil droplets due to 
digestion of the triglycerides; (2) their solubilization within the mixed micelles. Several 
previous studies have suggested that there is a relationship between the extent of lipid 
digestion and the bioaccessibility of hydrophobic bioactives 229, 308, 326. As shown by 
Figures 8.4 and 8.6, however, the majority of the oil phase was fully digested by the 
enzymes in this study, so all of the vitamin D should have been released from the oil 
droplets. Thus, the decrease in vitamin bioaccessibility observed in the presence of 
chitosan was probably not due to its impact on lipid digestion. Instead, we hypothesized 
that it was related to the micellization process. This process may be altered through a 
number of physicochemical mechanisms: (1) modification of the properties of the mixed 
micelles formed, such as the size of their hydrophobic domains 273; (2) reduction of the 
total amount of mixed micelles formed during digestion 76; and, (3) precipitation of some 
of the mixed micelles 100. In this study, we believe that the cationic chitosan molecules 
bound to the anionic vitamin-loaded mixed micelles, which led to the formation of large 
insoluble aggregates. These aggregates would be removed from the digest during the 
centrifugation process and so would not be detected as part of the mixed micelle phase. 
This hypothesis is supported by visual observations of the samples, which showed that an 
increasing amount of sediment was formed at the bottom of the tubes as the chitosan 
concentration was increased (Figure 8.5). It should be noted, however, that these 
precipitated mixed micelles might be liberated when the chitosan is digested by the gut 
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microbiota in the colon, and so the vitamin may be released and become bioaccessible 
again. This might be a good strategy for controlling the release of vitamin D in the human 
body, but further in vivo studies are needed to test this. 
8.3.4 Interaction between micelle and chitosan 
Finally, we carried out an additional experiment to examine the potential 
interactions between chitosan and mixed micelles.  In this case, chitosan was directly 
mixed with the mixed micelle phase formed by digestion of a pure emulsion sample.  In 
the absence of chitosan, the mean particle diameter of the mixed micelle solution was 218 
nm (Figure 8.8a), which is higher than that reported for simple micelles (< 10 nm). This 
was probably because a variety of other colloidal structures were formed during digestion 
under fed state conditions, including vesicles, calcium soaps, and protein aggregates 102, 
199. The addition of 0% chitosan solution (just acetic acid solution), significantly (p < 
0.05) increased the mean particle size of the mixed micelles to 380 nm. It is possible that 
the acetic acid changed the ionic equilibration of the free fatty acids thereby altering the 
mixed micelle structure. The addition of 0.1 to 0.5% chitosan solutions reduced the mean 
particle size, which was similar to that of the pure micelle samples. Interestingly, the 
chitosan level did not appear to alter the particle size. 
We hypothesize that the cationic chitosan bound to some of the anionic mixed 
micelles and caused them to precipitate. As a result, only the properties of the mixed 
micelles remaining in the aqueous phase would be measured by the dynamic light 
scattering instrument. This hypothesis was supported by measurements of the percentage 
of sediment formed, with the amount increasing from 0.09% at 0% chitosan to 0.4% at 
0.5% chitosan (Figure 8.8b). This hypothesis is also supported by the surface potential 
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measurements, which showed that the colloidal particles in the mixed micelle phase were 
strongly negatively charged at all chitosan levels (Figure 8.8c). Any mixed micelles that 
bind to the chitosan are neutralized and precipitate, and are therefore not measured by the 
z-potential instrument. 
 
Figure 8.8 The effect of different chitosan concentrations on the physical properties and 
vitamin D distribution of mixed micelles prepared from corn oil-in-water emulsions after 
exposure to the simulated gastrointestinal tract: (a) mean particle diameter; (b) percentage 
of sediment formed; (c) ζ-potential; (d) vitamin D percentage in supernatant or sediment. 
Samples with significant differences were labeled with different capital letters (A, B, C), 
whereas samples with different lower-case letters (a, b, c) were used for vitamin D 
percentage of sediment. 
The sedimentation of the mixed micelles in the presence of chitosan also influenced 
the location of the vitamin D in the system (Figure 8.8d). The addition of chitosan 
significantly (p < 0.05) reduced the amount of vitamin D in the supernatant phase from 
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93.3% at 0% chitosan to 65.9% at 0.1% chitosan (Figure 8.8d). Further addition of 
chitosan led to a further slight decrease in the percentage of vitamin D in the supernatant 
phase, reaching 63.3%. These results therefore support the bioaccessibility data discussed 
above. They suggest that chitosan binds to the vitamin-D loaded mixed micelles causing 
them to sediment, thereby reducing their bioaccessibility. 
8.5 Conclusions 
In this study, the impact of chitosan addition (0-0.5%) on the gastrointestinal fate of 
vitamin-loaded oil-in-water emulsions was examined. In particular, the effects of chitosan 
on the extent of lipid digestion and the bioaccessibility of vitamin D3 were investigated. 
The recently updated standardized INFOGEST protocol was used to simulate the 
conditions in the upper regions of the human gastrointestinal tract.  Chitosan induced 
severe droplet flocculation in the small intestine phase but this did not reduce the total 
amount of free fatty acids released by the end of digestion. Indeed, the oil droplets in all 
the emulsions were fully digested, regardless of the amount of chitosan present. It is 
important to note that a fraction of the free fatty acids released were not completely 
ionized under neutral pH conditions, and so a back titration was required to measure the 
total amount of free fatty acids released. Comparison of the results with and without the 
back-titration suggested that chitosan altered the ionization state of the free fatty acids. 
The presence of chitosan (0.1 to 0.5%) decreased the bioaccessibility of vitamin D3 by 
about 40% when compared to the samples containing no chitosan, with the chitosan level 
used not having a major effect.  As the triglycerides in all the samples were fully 
digested, we attribute the reduction in vitamin bioaccessibility to the ability of chitosan to 
modulate the micellization process. Cationic chitosan molecules bind to anionic vitamin-
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loaded mixed micelles, leading to the formation of insoluble precipitates that are removed 
from the mixed micelle phase. Our results therefore suggest that incorporating chitosan 
into foods as a functional ingredient could have a negative impact on vitamin 
bioaccessibility. However, in vivo experiments are required to determine whether the 
same effect occurs under more realistic gastrointestinal conditions. 
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CHAPTER 9 
BIOACCESSIBILITY OF OIL-SOLUBLE VITAMINS (A, D, 




Foods and beverages are commonly fortified with oil-soluble vitamins to tackle 
micronutrient deficiencies and their related diseases. The bioavailability of this type of 
vitamin is known to depend on the composition and structure of the food matrix. In this 
study, we systematically investigated the impact of oil droplet diameter (≈ 0.1, 1, or 10 
µm) on the bioaccessibility of three important oil-soluble vitamins (vitamin A palmitate, 
vitamin D, and vitamin E acetate) encapsulated in model food emulsions. Oil-in-water 
emulsions were used for this purpose, which consisted of saponin-coated soybean oil 
droplets dispersed in water, with the vitamins being dissolved in the oil phase prior to 
homogenization.  The gastrointestinal fate and bioaccessibility of the vitamin-fortified 
emulsions were monitored using a standardized (INFOGEST) in vitro digestion model. 
Large oil droplets inhibited lipid digestion and reduced vitamin release and solubilization. 
For instance, as the oil droplet diameter was increased from around 0.1 to 10 µm, the 
bioaccessibility of vitamin A decreased from 87 to 39%, vitamin D from 76 to 44%, and 
vitamin E from 77 to 21%. The bioaccessibility of the vitamins tended to decrease as 
their hydrophobicity and molecular weight increased, which was attributed to their 
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tendency to remain inside the oil droplets and/or be poorly solubilized within the mixed 
micelles.  We also showed that the esterified vitamins were hydrolyzed by the enzymes 
used in the in vitro digestion model: almost complete hydrolysis was observed for 
vitamin A palmitate (~90%) but only slight hydrolysis for vitamin E acetate (~3%). Our 
results show that both vitamin type and droplet size have a strong impact on vitamin 
bioaccessibility. Consequently, the composition and structure of emulsion-based delivery 
systems should be carefully designed when creating vitamin-fortified functional food or 
beverage products. 
Keywords: droplet size; vitamin type; nanoemulsion; bioaccessibility; INFOGEST 
method. 
9.1 Introduction 
Vitamins are a group of organic molecules that play a critical role in many 
physiological functions important to human health so deficiencies in these micronutrients 
leads to severe diseases. For example, lack of vitamin A leads to night blindness 20, lack 
of vitamin D leads to bone fractures and rickets 37, 38, and lack of vitamin E leads to 
anemia and stunted growth 328. In addition to their role as micronutrients, oil-soluble 
vitamins may also have other therapeutic effects e.g., by reducing the incidences of 
cancer, cardiovascular disease, and other chronic conditions 4-7. Despite their beneficial 
health effects, many people do not get sufficient quantities of oil-soluble vitamins in their 
diet. Moreover, many individuals suffer from conditions that reduce the level of these 
vitamins that are actually absorbed from their foods, including the elderly and patients 
suffering from certain gastrointestinal conditions, or they have greater micronutrient 
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demands than the general population, including babies, children, adolescents, pregnant 
women, and athletes 26.  
Several strategies have been developed to tackle vitamin deficiencies or 
insufficiency, including food fortification and vitamin supplementation 329. These 
strategies have been shown to be effective at maintaining vitamin levels, as well as at 
preventing or curing chronic diseases 330, 331. For this reason, many food and supplement 
companies have developed products containing oil-soluble vitamins, which are designed 
to reduce deficiencies and/or improve health 332. For example, milk is usually fortified 
with vitamin D, while many plant-based milk analogs are fortified with vitamins A, D, 
and E 333, 334. Oil-soluble vitamins cannot simply be mixed with fluid beverages because 
they are immiscible with water and would therefore separate. For this reason, they are 
usually mixed with an oil phase first, which is then homogenized to form vitamin-loaded 
lipid droplets that can be dispersed within an aqueous environment 333.   
The nutritional efficacy of oil-soluble vitamins also depends on their absorption and 
utilization by the body in a bioactive form after ingestion 2. This process is determined by 
their bioavailability, which depends on their bioaccessibility, transformation, and 
absorption within the gastrointestinal tract (GIT) 1, 335. The understanding of the 
physicochemical basis of the bioavailability of oil-soluble vitamins is critical for 
improving the nutritional impact of fortified foods. In general, vitamin bioavailability is 
governed by the gastrointestinal conditions within the individual consuming the food, as 
well as by the precise nature of the food consumed 12. As an example, the bioavailability 
of vitamin E has been reported to vary from around 10% to 80% for different food 
matrices 73. Similar food matrix effects have also been reported for the bioavailability of 
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vitamins A and D 17, 18. These results point out the importance of well designing the 
composition and structure of fortified foods so as to increase the bioavailability of 
encapsulated vitamins 12, 140, 336, 337. 
The size of the oil droplets in emulsified foods can easily be varied by modification 
on the homogenization conditions or emulsifier properties 2.  Droplet size greatly 
influences the physicochemical properties, stability, sensory attributes, and 
bioavailability of vitamin-fortified emulsions. For instance, reducing the droplet size in 
emulsions reduces creaming, inhibit coalescences, increases creaminess perception, and 
enhances bioaccessibility 160, 338, 339. However, producing emulsions with smaller droplet 
sizes is typically more expensive because specialized homogenization equipment is 
required, such as microfluidizers, high-pressure valve homogenizers, or sonicators 160. 
Consequently, it is vital to optimize the droplet size for specific applications. For oil-
soluble vitamins, the impact of droplet size on vitamin bioavailability is particularly 
important.  Previous publications have shown that the bioaccessibility of encapsulated 
pro-vitamin A (β-carotene) increases as the oil droplet size decreases, which was 
attributed to faster and more extensive lipid digestion and mixed micelle formation 182. 
Moreover, a recent study showed there was a reduction in the level of crystalline β-
carotene present within the sediment phase formed after lipid digestion as the oil droplet 
size decreased, which was attributed to the same causes 339. These results indicate that oil 
droplet size plays a critical role in determining the bioaccessibility of hydrophobic 
bioactives. 
There is also strong evidence that the bioaccessibility of hydrophobic bioactives 
depends on their molecular dimensions relative to the dimensions of the hydrophobic 
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regions inside mixed micelles. In particular, the hydrophobic bioactives must be small 
enough to be accommodated within these hydrophobic domains.  For example, small 
bioactives can easily be incorporated into mixed micelles formed from fatty acids with 
chain lengths varying from medium to long, leading to a high bioaccessibility 340. 
Conversely, large bioactives can only be incorporated into mixed micelles formed from 
long chain fatty acids, otherwise they tend to precipitate, leading to a low bioaccessibility 
341. The bioaccessibility also depends on the hydrophobicity of the bioactives: the transfer 
of a bioactive substance from the oil droplets to the mixed micelles tends to decrease as 
its hydrophobicity increases, thereby reducing the bioaccessibility 18, 92. These results 
indicate that the molecular characteristics of hydrophobic bioactives also play a major 
role in determining their bioaccessibility. 
In this study, we focus on the impact of oil droplet size on the gastrointestinal fate of 
three important oil soluble vitamins (vitamins A, D, E) encapsulated within model food 
emulsions. A standardized in vitro digestion model (INFOGEST) was used to evaluate 
the hydrolysis and bioaccessibility of the vitamins and lipid phase, as well as the physical 
and structural changes in the emulsions during gastrointestinal tract (GIT) passage. Based 
on the findings of previous studies, we hypothesized that the bioaccessibility of the 
vitamins would increase with decreasing droplet size, but by an amount that depended on 
their molecular characteristics. In particular, we hypothesized that the release of the 
vitamins from the oil droplets would decrease as their hydrophobicity increased, whereas 
their solubilization in the mixed micelles would decrease as their molecular dimensions 
increased. Vitamins A, D, and E are widely used in commercial fortified foods and 
supplements and so the results of this study have practical relevance in the design for 
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these products. For this reason, we used retinyl palmitate and tocopheryl acetate versions 
of vitamin A and E, respectively, since these esterified forms are widely used to prevent 
their oxidation during storage, thereby increasing their bioactivity 33, 73. The results of this 
study should advance the understanding of food matrix effects on vitamin bioavailability, 
which may lead to the development of more effective functional foods and supplements. 
9.2 Materials and methods 
9.2.1 Materials 
Soybean oil (Wesson, Conagra Brands, Inc., Chicago, IL, USA) was purchased from 
a local supermarket. Vitamin A palmitate (1.7 Mio IU/G, stabilized with tocopherol), 
vitamin D3 (1.0 Mio IU/G) and vitamin E acetate (98%) were kindly supplied by BASF 
corporation (Ludwigshafen, Germany). The additional reagents and chemicals utilized in 
the present study were described in detail in 3.3.1. 
9.2.2 Emulsion preparation 
The aqueous phase, oil phase and the homogenization techniques used were 
described in detail in 3.3.2, 4.3.2, 5.3.2 with slight modifications. In this study, two sets 
of oil phases were used for different research purposes. First, pure oil phase (soy oil) was 
used for the analysis of oil droplet size on the physicochemical properties, structure, and 
digestion of the emulsion samples within the simulated GIT. Second, vitamin-loaded oil 
phase was used to study the bioaccessibility and transformation of the vitamins in the 
simulated GIT. The vitamin concentration used was 10-times higher than the 
recommended daily allowance (RDA) for each type of oil-soluble vitamin. Information 
about the properties of the different vitamins is included in Table 9.1 and Figure 9.1. 
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Table 9.1 Molecular and physicochemical characteristics of the oil-soluble vitamins used 
in this study, as well as information about the amount of vitamin in the oil phase1. Key: 
RDA = recommended daily allowance. 




RDA3 Vitamin in oil 
phase2 (wt. %) 
Vitamin A-palmitate 524.9 14.8 800 μg/d 0.63 
Vitamin A (retinol) 286.5 5.7 - - 
Vitamin D 384.6 7.5 15 μg/d 2.4 
Vitamin E-acetate 472.7 10.9 15 mg/d 2.43 
Vitamin E (α-tocopherol) 430.7 10.7 - - 
1 The data were obtained from National Center for Biotechnology Information, U.S. 
National Library of Medicine, and ChemSpider, Royal Society of Chemistry. 
2 The vitamins were supplemented at 10-times of the RDA in this study. 
3 Average of recommended daily allowances for male and female. 
 
 
Figure 9.1 The chemical structure of oil soluble vitamins. The data were obtained from 
National Center for Biotechnology Information, U.S. National Library of Medicine. 
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Emulsions with different oil droplet sizes were prepared by using different 
homogenization approaches. Specifically, the large emulsions were prepared using a 
high-speed blender operated at 10,000 rpm for 4 min. The medium emulsions were 
prepared by further homogenization of the large emulsions using ultrasonication for a 
total sonication time of 3.5 min. The fine emulsions were prepared by microfluidization 
of the large emulsions at 12,000 psi for 3 circulations. 
9.2.3 In vitro digestion 
In vitro digestion of vitamin-loaded emulsions was performed using the recently 
updated harmonized INFOGEST method 3. The experimental details were described in 
3.3.6 and 3.3.7. The fraction of sediment formed was then calculated: 




Here Wsediment and Wintestine are the weights of the whole intestinal sample and of the 
sediment collected after centrifugation, respectively. 
9.2.4 Average size, charge, and microstructure characterization 
The physical characterization of the samples was carried out according to 3.3.3, 
3.3.4 and 3.3.5. Before size and surface potential measurements, all samples were diluted 
with phosphate buffer solutions with pH values corresponding to the sample: initial and 
oral (pH 6), stomach (pH 3), and small intestine (pH 7). The refractive index values used 
in the calculations of particle size and surface potential were 1.475 for the oil phase and 
1.33 for the aqueous phase, respectively. 
9.2.5 Extraction and measurement of vitamin A, D, E 
The same solvent extraction and quantification protocol was used for all the oil-
soluble vitamins according to 7.3.7. The operating conditions of the HPLC measurement 
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was tailored for each vitamin type. Specifically, the mobile phase for vitamin A palmitate 
and vitamin A was pure methanol solution at 40 °C, and the detection wavelength used 
was 325 nm 35. For vitamin D, a mixture of methanol:water (95:5, v/v) was used as the 
mobile phase at 25 °C for vitamin D, and the detection wavelength used was 265 nm 258. 
For vitamin E acetate and vitamin E, a mixture of methanol and water (97:3 v/v) was 
used as the mobile phase at 30 °C, and the detection wavelength used was 286 nm. These 
conditions were based on a previous publication 76, with slight modifications.  
The transformation of the esterified vitamin A and E to the non-esterified forms was 
calculated using the following equation:  




Here Cvitamin and Cvitamin-ester are the molar concentrations of the pure vitamin and 
esterified vitamin in the overall digesta after simulated intestinal digestion, respectively. 
9.2.6 Statistical analysis 
See details in 3.3.9. 
9.3 Results and discussion 
9.3.1 Physical and structural characterization during the GIT  
Oil-in-water emulsions with a broad range of target mean droplet diameters were 
prepared using different homogenization approaches: fine (» 0.1 μm), medium (» 1 μm) 
and coarse (10 μm) emulsions. The measured D3,2 values of these emulsions were 0.149, 
1.57, 11.1 μm for microfluidization, sonication, and simple blending, respectively (Figure 
9.2a). The light scattering results were supported by the confocal microscopy images of 
the initial emulsions (Figure 9.3), which showed that the size of the individual oil 
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droplets increased from fine to medium to large emulsions. In all the initial emulsions, 
the oil droplets were evenly dispersed throughout the microscopy images. The 
microscopy images also indicated that there was a wide distribution of droplet sizes 
within each type of emulsion, particularly the coarse one. Visibly, a cream layer was 
formed on top of the large emulsions after they were stored for a few hours, which can be 
ascribed to the rapid upward movement of the large droplets due to gravity (data not 
shown).  In contrast, the fine and medium emulsions remained homogeneous after a few 
hours of storage because the smaller droplets they contained creamed more slowly. These 
results suggest that vitamin-fortified emulsions should contain relatively small oil 
droplets (≤1 μm) if they are supposed to remain physical stable during storage. However, 
this problem may be overcome if they have a high viscosity or are gelled. 
The particles in the initial emulsions were all negatively charged, with the z-
potential values ranging from around -68.4 to -57.0 mV (Figure 9.2b), which can be 
attributed to the fact that quillaja saponin contains anionic carboxyl groups above pH 3 
212, 213. There was a significant (p < 0.05) difference in the surface potential of emulsions 
containing different oil droplet sizes, which may have been ascribed to differences in 
interfacial composition and the number of non-adsorbed saponin molecules 342.  
The potential gastrointestinal fate of the different emulsions was then established by 
passing them through the INFOGEST in vitro digestion model. The properties of the 
samples were assessed after each phase of the digestion process: mouth, stomach, and 
small intestine. In addition, they were analyzed at the initial stages of the small intestine 
phase (SI-initial) by adjusting the fluids arising from the end of the stomach phase to pH 
7 but without adding the enzymes and bile salts. The SI-initial phase was included 
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because it is the oil droplet size at the beginning of the small intestine phase that is 
important for lipid digestion, rather than the original droplet size of the emulsion 343. 
 
Figure 9.2 Physical and structural properties of soy oil-in-water emulsions with different 
initial oil droplet diameters during passage through a simulated GIT: (a) Mean particle 
diameter (D3,2); (b) surface potential (ζ-potential); (c) photographs of samples after 
digestion and centrifugation; (d) mean particle size of mixed micelles; (e) photographs of 
mixed micelles; and (f) sedimentation fraction of intestinal samples. Different capital 
letters (A, B, C) designate significant differences (p < 0.05) among emulsion samples 
with different oil droplet size (same GIT stage), while lower-case letters (a, b, c) 
designate different stages (same oil droplet size). 
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Similar to our previous study 339, the mean oil droplet size in all the emulsions 
remained fairly similar as they moved from the oral phase to the SI-intestinal phase, 
despite the considerable differences in pH, ionic strength, mucin levels, and enzyme 
activity in these different regions (Figure 9.2a). The confocal microscopy images were 
again consistent with the light scattering results (Figure 9.3): the droplet size remained 
fairly constant in each GIT stage, but the droplet concentration decreased because the 
samples were progressively diluted by digestive fluids. Presumably, the good stability of 
the emulsions to droplet aggregation in the mouth, stomach, and SI-initial phases is 
because the quillaja saponin remains securely attached to the droplet surfaces and 
generates strong repulsive interactions 343.  
The absolute value of the negative surface potential decreased significantly (p < 
0.05) after incubation in the oral phase, ranging from around -40.8 to -21.7 mV, and then 
further decreased in the stomach phase, ranging from around -9.8 to -2.9 mV (Figure 
9.2b). These results agree with those of previous studies on related systems 75, 343. This 
reduction in surface potential is a result of alterations in the composition and ionization 
state of the droplet surfaces when the pH, ionic strength, and composition of the GIT 
fluids are altered 231. Our results suggest that the adsorbed saponin molecules were able 
to stabilize the droplets against aggregation by generating strong steric repulsion, since 
extensive droplet aggregation was not observed under conditions where there was only a 
weak electrostatic repulsion (i.e., a low z-potential). When the pH was elevated to 7 at 
the beginning of the intestinal phase, the absolute values of the negative surface potential 
increased significantly (p < 0.05), reaching values that were fairly similar to the initial 
samples, i.e., -63.2 to -55.3 mV (Figure 9.3b). This increase in negative charge is due to 
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ionization of the carboxylic acid groups on the quillaja saponin at higher pH values 212. 
There were significant differences in the surface potentials of the different emulsions in 
the mouth, stomach, and SI-initial phases, but the general trends were similar for all 
systems. 
 
Figure 9.3 The confocal microscopy photos of soy oil in water emulsions with different 
oil droplet size during the GIT. 
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After intestinal digestion, the physical and structural properties of the emulsions 
changed greatly. The average particle size of the medium and large emulsions decreased 
significantly (p < 0.05) to 0.31 and 0.71 μm respectively, while that of the fine emulsion 
remained fairly similar, being around 0.20 μm (Figure 9.2a). The confocal microscopy 
images also showed that the size of the oil-rich particles in the medium and large 
emulsions decreased after the intestinal phase (Figure 9.3). This reduction in particle size 
is mainly attributed to hydrolysis of the large oil droplets, leading to the generation of 
digestive products (FFAs and monoacylglycerols). These digestive products then 
combine with other components within the digestive fluids (e.g., calcium ions, enzymes, 
bile acids, and mucin) to form a variety of colloidal particles. Some of these particles are 
readily dispersible in water (e.g., micelles and vesicles), while others are insoluble in 
water (e.g., calcium soaps, bile salt complexes, protein aggregates, and non-digested 
oils). In this study, centrifugation was used to separate the soluble fraction (the “mixed 
micelle” phase) from the insoluble fraction (the “sediment” phase) and undigested 
fraction (the “oil” phase).  The visual appearances of the centrifuged samples are shown 
in Figure 9.2c, which clearly show the sediment and mixed micelle phases.  
The size of the particles in the mixed micelle phase was analyzed by dynamic light 
scattering (Figure 9.2d). The average diameter of the mixed micelles in the medium 
emulsions (218 nm) and large emulsions (191 nm) were significantly (p < 0.05) greater 
than those in the fine emulsions (146 nm). The smaller size of the particles in the fine 
emulsions may be due to more through and complete digestion of the lipid phase. The 
visible appearance of the mixed micelle phases collected after centrifugation are shown in 
Figure 9.2e. The mixed micelles from the medium emulsions were slightly more turbid 
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than those collected from the fine and large emulsions, which may have been because 
they contained larger particles that scattered light more strongly (Figure 9.2d). 
Interestingly, the mixed micelles collected from the large emulsions were the least turbid, 
indicating fewer mixed micelles were present as a consequence of incomplete lipid 
digestion (Section 9.3.2). 
The average diameters of the colloidal particles in the entire digested intestinal 
samples (199 to 705 nm) (Figure 9.2a), were considerably larger than those in the mixed 
micelle phase (146 to 218 nm) (Figure 9.2d). This effect is due to the removal of the 
larger insoluble colloidal particles during the centrifugation step used to collect the mixed 
micelle phase, such as non-digested oil droplets and calcium soaps. It should be noted 
that different instruments were used for the particle size measurement of these two 
samples (static and dynamic light scattering), which might also partially account for the 
observed differences. The static light scattering results showed that the average size of 
the digested intestinal samples increased with increasing initial oil droplet size, which can 
again be attributed to the fact that not all of the oil droplets were fully digested for the 
larger droplets (Figure 9.2a). This hypothesis was supported by the confocal microscopy 
images (Figure 9.3), which showed that there were still some non-digested oil droplets in 
the large emulsions, as well as some other large structures, which were probably 
insoluble calcium salts and large vesicles.  
Previous research has shown that the bioaccessibility of the encapsulated 
hydrophobic bioactives decreases as the degree of lipid digestion decreases 182. This 
effect has been attributed to the fact that some of the hydrophobic bioactives are trapped 
inside the non-digested oil phase, as well as there are less mixed micelles generated to 
 
   189 
solubilize them 16. As a result, a significant fraction of the hydrophobic bioactives is 
either trapped within the sediment phase or the non-digested lipid phase. The total 
amount of sediment phase collected after centrifugation of the digested intestinal samples 
was similar (p > 0.05) in all samples, being 1.9, 1.8, 1.7 % for the fine, medium, and 
large emulsions, respectively (Figure 9.2f). This suggests that the initial droplet size did 
not have a major impact on the amount of sediment formed. Nevertheless, some of the 
non-digested lipid may have formed a thin layer on the top of the samples. 
The surface potentials of the colloidal particles in the total digested intestinal 
samples and in the mixed micelle samples were measured (Figure 9.2b). The magnitude 
of the negative charge significantly (p < 0.05) decreased from the beginning (SI-initial) to 
the end (SI-end) of the intestinal samples (Figure 9.2b). This effect is probably because 
the anionic FFAs generated during lipid digestion dominated the surface charge of the 
colloidal particles after digestion. Presumably, the surface charge density resulting from 
these FFAs was considerably smaller than that of the quillaja saponin. In addition, 
quillaja saponin may be hydrolyzed by the digested enzymes, thereby reducing its surface 
charge 344. The surface charge of the mixed micelle phases was similar to that of the total 
digested samples, which can again be attributed to the fact that the FFAs dominated the 
charge measurement. 
Overall, these experiments showed that there were considerable differences in the 
structures and physicochemical properties of the emulsions within different regions of the 
GIT depending on their initial droplet size.  
9.3.2 Lipid digestion process 
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Lipid digestion was monitored by titration of the released FFAs. An appreciable 
fraction of the FFAs from soy oil are long chain ones that are not fully ionized at pH 7 
280, so most of them are not detected by the titration method. As a result, the measured 
FFA values are much lower at pH 7 than expected (Figure 9.4a). For this reason, the 
samples were titrated to pH 9 using alkaline solution to determine the concentration of 
FFAs that were not ionized at pH 7. This led to a significant increase in the fraction of 
FFAs that were detected (Figure 9.4a), which agrees with previous studies using the 
INFOGEST method 16. Notably, the total amount of FFAs released was greater than 
100% after the back titration step was performed, which also agrees with previous 
research 100, 280, 339. This effect has been attributed to the fact that some of the 
monoglycerides were converted to FFAs under strongly alkaline conditions, thereby 
meaning more than two FFAs were released per triacylglycerol molecule. 
The fraction of FFAs released was fairly similar for the fine and medium emulsions 
at pH 9, being around 124 and 125%, respectively (Figure 9.4a). Conversely, the fraction 
released from the larger emulsions was significantly (p < 0.05) lower, being around 99% 
(Figure 9.4a). The kinetics of lipid digestion also depended on droplet size, with the 
initial digestion rate increasing as the droplet size decreased (Figure 9.4b). The specific 
surface areas of the emulsions increased as their droplet size decreased, so there was a 
larger number of triacylglycerol molecules exposed to the lipase 123, 156, 230. Despite the 
almost ten-fold difference in initial droplet size, the small and medium emulsions 
appeared to both be fully digested by the end of the small intestine phase. In contrast, the 
large emulsions were only partially digested because of their relatively low specific 
surface area. 
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Figure 9.4 The impact of oil droplet size on the final degree (a) and rate (b) of free fatty 
acid released of soy oil in water emulsions during the intestinal phase. Capital letters (A, 
B, C) and lower-case letters (a, b, c) were used to designate significant difference (p < 
0.05) among different oil droplet size. 
9.3.3 Gastrointestinal fate of vitamin A, D, E 
In the following section, the impact of oil droplet size and vitamin type on the GIT 
fate of the oil soluble vitamins was determined using the in vitro digestion model, 
including their stability, release, transformation, sedimentation, and bioaccessibility. We 
hypothesized that the molecular characteristics of the vitamins, such as their size and 
hydrophobicity, would impact their GIT fate. This hypothesis was based on previous 
studies that vitamins or pro-vitamins with more hydrophobic structures tend to remain 
inside non-digested oil droplets, thereby reducing their bioaccessibility 18, 92, 140, 345. 
Vitamin A palmitate and vitamin E acetate were used in this study because the esterified 
 
   192 
forms of these vitamins are typically employed in commercial products in order to 
improve oxidation stability during storage. All vitamins were added at a level that was 
10-fold higher than their recommended daily allowances (RDAs). These relatively high 
levels were used so that the concentration of the vitamins could be reliably measured 
using the analytical procedures employed. 
9.3.3.1 Vitamin stability 
The resistance of different vitamins to chemical degradation after they had passed 
through the entire GIT model was measured. It should be noted that conversion of the 
vitamins from the esterified to non-esterified form was not considered to be degradation 
in these experiments. Instead, this was considered to be transformation (see later). In all 
cases, there was an appreciable reduction in the vitamin concentration by the end of the 
digestion process (Figure 9.5). For instance, the percentages of the different vitamins 
remaining after digestion were around 40-41%, 79-83% and 75-91% for vitamins A, D, 
and E, respectively, which indicated that vitamin A was the least stable. All the oil-
soluble vitamins used in this study are known to be chemical reactive molecules, which 
are therefore susceptible to chemical degradation 54, 346, 347. For instance, the retinyl 
structure of vitamin A contains an electron-dense region that can scavenge free radicals 
31. The hydroxyl groups on the chromane ring of vitamin E have been linked to its strong 
free radical scavenging activity 60. The numerous double bonds in vitamin D make it 
susceptible to oxidation 348. The elevated temperatures (37 °C), prolonged times (> 4 
hours), and high oxygen levels in the GIT model may therefore have promoted the 
chemical degradation of the oil-soluble vitamins. The samples were covered throughout 
the GIT experiments to avoid exposure to light, but there was some slight exposure when 
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the samples were transferred from one GIT stage to another, which could also have 
promoted the chemical degradation of the vitamins. These results suggest that it is 
important to develop strategies to inhibit the chemical degradation of vitamins within the 
GIT so as to increase their effectiveness. 
The impact of oil droplet size on vitamin stability was also investigated. Droplet size 
did not significantly impact the stability of vitamins A and D (p > 0.05). However, the 
stability of vitamin E was significantly higher (p < 0.05) in the large emulsions (90.7%) 
than in the fine (74.8%) or medium (78.9%) ones. This may have been because some of 
the vitamin E was trapped within the non-digested oil phase (Figure 9.4), which protected 
it from oxidation by pro-oxidants in the aqueous phase or interfacial region. 
 
Figure 9.5 The stability of vitamins A, D, and E encapsulated in soy oil-in-water 
emulsions with different initial oil droplet diameters at the end of the in vitro digestion 
model.  Capital letters (A, B, C), lower-case letters (a, b, c) and Greek letters (α, β, γ) 
were used to designate significant differences (p < 0.05) among different oil droplet sizes. 
9.3.3.2 Vitamin bioaccessibility 
The bioaccessibility is an important factor contributing to the overall bioavailability 
of encapsulated vitamins. It depends on two main physicochemical processes: (i) release 
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of the vitamins from the oil droplets; and (ii) solubilization of the vitamins in the mixed 
micelles 12. Those vitamins that are not solubilized within the micelles typically end up in 
the sediments present in the digested samples. In this section, we therefore discuss the 
impact of oil droplet size on the release, sedimentation, and bioaccessibility of each 
vitamin. 
Vitamin A: The concentrations of vitamin A in each phase of the intestinal samples 
were measured and then the release, sedimentation, and bioaccessibility values were 
calculated from this data (Figure 9.6). As mentioned earlier, the encapsulated vitamins 
are released from the oil phase along with the lipid digestion, and so reducing lipid 
digestion should reduce the amount of vitamins released. Consequently, the fraction of 
vitamin A released decreased as the droplet size increased, being around 95.9%, 79.8%, 
and 51.3% for the fine, medium, and large emulsions, respectively (Figure 9.6a). 
Interestingly, the release of the vitamin A from the fine and medium emulsions was 
substantially different, though the final amount of lipid digestion was fairly similar 
(Figure 9.5). This suggests that the kinetics of the digestion process might be critical for 
the release of the vitamins. In particular, rapid digestion may have led to more efficient 
transfer of the oil-soluble vitamins from the oil droplets to the mixed micelles. Other 
studies have also reported that strongly hydrophobic bioactive molecules may not be fully 
released from large oil droplets that are not fully digested 91.  
In our study, the vitamin A palmitate was further hydrolyzed into vitamin A and 
palmitic acid by the esterases within the pancreatic enzymes. The degree of 
transformation was relatively high, ranging from 90.3% for the large emulsion to 97.1% 
for the fine emulsion (Figure 9.6a). Notably, the emulsions that gave the highest release 
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of the vitamins (fine emulsions) exhibited the greatest degree of vitamin A 
transformation, which is probably because the hydrolysis reaction mainly occurs within 
the aqueous phase, rather than inside the oil droplets 349. The conversion of the vitamin A 
to the non-esterified form would also account for its greater degradation, since this form 
is known to be more susceptible to oxidation. The relative concentrations of vitamin A 
and vitamin A palmitate in the different phases (total digesta, mixed micelles, and 
sediment) are shown in Figure 9.6b. These results show that there was a greater fraction 
of the non-esterified form of vitamin A in the mixed micelles than in the sediments, 
which again can be attributed to the greater exposure of the vitamins to the surrounding 
aqueous environment when they are solubilized within the micelles. 
After the release process, the vitamins were either solubilized to the mixed micelles 
in the aqueous phase or they formed insoluble complexes that became part of the 
sediment phase. In this study, most of the released vitamin A (vitamin A and vitamin A 
palmitate) was located in the micelle phase (Figure 9.6b). In the real human gut, this 
fraction of vitamin A would be available for absorption by the epithelium cells, thereby 
increasing the overall bioavailability. Vitamin A bioaccessibility decreased with 
increasing oil droplet size, changing from 86.8% for the fine emulsion to 39.0% of the 
large emulsions. As mentioned earlier, this can at least partly be attributed to a reduction 
in the amount of vitamin released from the oil droplets. A relatively small fraction 
(around 12%) of the vitamin A was also located in the sediment phase for all the 
emulsions, which is consistent with previous studies 81, 95. This vitamin A may have been 
released from the oil droplets and then precipitated when it came into contact with the 
aqueous phase, or it may have been solubilized within mixed micelles that were then 
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precipitated by calcium.  In the human body, the insoluble fraction of vitamins in the 
sediment phase would not be expected to be absorbed by the epithelium cells, thereby 
reducing the bioavailability.  
 
Figure 9.6 The effect of oil droplet size on (a) the release, transformation, 
bioaccessibility, and sedimentation, and (b) the vitamin A and vitamin A-palmitate (total 
vitamin A) concentration in each phase of the soy oil-in-water emulsions after in vitro 
digestion. Capital letters (A, B, C), lower-case letters (a, b, c), the Greek letters (α, β, γ) 
and Roman numbers (i, ii, iii) were used to designate significant difference (p < 0.05) 
among different oil droplet size. 
The distribution of vitamin A and vitamin A palmitate within the intestinal samples 
was somewhat different in the emulsions with different droplet sizes (Figure 9.6b). For 
example, the vitamin A palmitate concentration in the total intestinal sample increased 
with increasing oil droplet size, changing from 0.8 nmol/ml for the fine emulsions to 2.8 
nmol/ml for the large emulsions. This effect is probably because there were more non-
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digested oil droplets in the large emulsion, which protected the vitamin A palmitate from 
being converted to the vitamin A form. The total vitamin A palmitate concentration in the 
sediment phase also increased with increasing oil droplet size, changing from 0.04 to 2.0 
nmol/ml. Moreover, the fraction of the vitamin A palmitate in the sediment phase also 
increased with increasing oil droplet size. This effect is probably because the strongly 
hydrophobic vitamin A palmitate is more prone to be incorporated into the insoluble 
structures in the sediment phase. 
Vitamin D: The gastrointestinal fate of the vitamin D is shown in Figure 9.7. Almost 
complete release of the vitamin was observed for the fine emulsions (93.2%) and medium 
emulsions (97.4%), while a significantly lower (p < 0.05) release was observed for the 
large emulsions (68.2%) (Figure 9.7a). This difference can mainly be attributed to the 
extent of lipid digestion in different emulsions. As discussed earlier, the fine and medium 
emulsions were fully digested by the end of the small intestine phase, whereas the large 
emulsions were only partially digested (Section 9.3.2). Consequently, some of the 
hydrophobic vitamin D molecules remained inside the undigested oil phase in the large 
emulsions. As a result, the vitamin D bioaccessibility in the fine emulsions (75.8%) and 
medium emulsions (76.0%) was significantly (p < 0.05) higher than in the large 
emulsions (44.2%) (Figure 9.7a). A relatively high bioaccessibility has also been reported 
in emulsion delivery systems where the lipid phase was completely digested 17.  
Similar to vitamin A, the fraction of vitamin D in the sediment phase was higher in 
the medium emulsions (21.4%) and large emulsions (24.0%) than in the fine emulsions 
(17.4%) (Figure 9.7a). These results suggest that oil droplet size only has a modest 
influence on the micellization process of vitamin D, which then modifies the 
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bioaccessibility. The absolute vitamin D concentrations in each phase was also measured 
(Figure 9.7b), which also showed that there was less vitamin solubilized in the mixed 
micelles for the large emulsion. 
 
Figure 9.7 The effect of oil droplet size on (a) the release, bioaccessibility, and 
sedimentation, and (b) vitamin D concentration in each phase of the soy oil-in-water 
emulsions after in vitro digestion. Capital letters (A, B, C), lower-case letters (a, b, c) and 
the Greek letters (α, β, γ) were used to designate significant difference (p < 0.05) among 
different oil droplet size. 
Vitamin E: The gastrointestinal fate of vitamin E is shown in Figure 9.8. As with the 
other oil-soluble vitamins, the release of vitamin E decreased significantly (p < 0.05) with 
increasing oil droplet size, from 96.7% for the fine emulsion to 43.1% for the large 
emulsion (Figure 9.8a). The magnitude of the effect was similar to that observed for 
vitamin A palmitate, since the vitamin E acetate was also strongly hydrophobic (Table 
9.1). A hydrolysis of the vitamin E acetate was detected, but the hydrolysis level was  
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Figure 9.8 The effect of oil droplet size on (a) the release, transformation, and 
bioaccessibility, sedimentation, and (b) vitamin E and vitamin E-acetate (total vitamin E) 
concentrations in each phase of the soy oil-in-water emulsions after in vitro digestion. 
Capital letters (A, B, C), lower-case letters (a, b, c), the Greek letters (α, β, γ) and Roman 
numbers (i, ii, iii) were used to designate significant difference (p < 0.05) among 
different oil droplet size. 
much lower than that reported for vitamin A palmitate, ranging from 2.6 to 3.6% (Figure 
9.8a). There was no significant (p > 0.05) difference in the hydrolysis level among the 
emulsions containing different oil droplet sizes. The bioaccessibility of vitamin E 
significantly (p < 0.05) decreased with increasing oil droplet size, from 77.4% for the fine 
emulsion to 20.7% for the large emulsion (Figure 9.8a). This effect can partly be due to 
the reduction in the release of the vitamins from the oil droplets with increasing droplet 
size discussed above, as well as an appreciable fraction being incorporated into the 
sediment phase (19-30%). Interestingly, the sediment phase contained much more 
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vitamin E acetate than vitamin E (Figure 9.8b). This may be because the non-esterified 
form of the vitamin E can easily be incorporated into the mixed micelles, whereas the 
esterified form cannot 350. In addition, the vitamin E acetate may be more prone to 
precipitation in the aqueous phase than the vitamin E because it is larger and more 
hydrophobic. 
9.3.3.3 Impact of vitamin properties on gastrointestinal fate  
In this section, we examined the impact of the molecular characteristics of the 
different vitamins on their gastrointestinal fate in emulsions containing different droplet 
sizes. The release of the vitamins from the oil droplets appeared to be correlated to their 
hydrophobicity. Vitamin A palmitate (logP = 14.8) and vitamin E acetate (logP = 10.9) 
are much more hydrophobic than vitamin D (logP = 7.5) (Table 9.1). As a result, in the 
large emulsions that were not fully digested, a much higher fraction of the vitamin A 
palmitate and vitamin E acetate were not released than for the vitamin D. This result 
suggests that the most strongly hydrophobic oil-soluble vitamins remained within the 
hydrophobic core of the oil droplets as they were hydrolyzed by lipase. In contrast, for 
the fine emulsions, which were fully digested by the end of the small intestine phase, the 
bioaccessibility was relatively high for all the vitamins because there was no more non-
digested oil for the vitamins to accumulate. 
As discussed earlier, the vitamin A and vitamin E used in this study were initially in 
an esterified form but were partially hydrolyzed by the digestive enzymes used in the GIT 
model. The extent of transformation was highly dependent on vitamin type being much 
higher for vitamin A palmitate than for vitamin E acetate. This difference may be due to a 
number of physicochemical processes. First, there are differences in the ability of 
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digestive enzymes to hydrolyze different esterified vitamins. For instance, it has been 
shown that only cholesteryl ester hydrolase can hydrolyze vitamin E acetate 350, whereas 
several esterases can hydrolyze vitamin A palmitate, including cholesteryl ester hydrolase 
and pancreatic lipase351. Second, the total concentration of vitamin E acetate added was 
considerably higher (around 10-fold) than vitamin A palmitate, which might also account 
its lower transformation. In detail, the total vitamin E concentration in the intestinal phase 
ranged from 0.24 to 0.29 μmol/ml for all samples (Figure 9.8b), whereas the total vitamin 
A concentration ranged from 0.028 to 0.029 μmol/ml (Figure 9.6b). The extent of vitamin 
transformation in the GIT would be expected to have a major impact on its 
bioavailability, as it alters their molecular weight and hydrophobicity, thereby impacting 
their tendency to be solubilized in mixed micelles or precipitate into the sediment phase. 
The incorporation of the vitamins into the insoluble sediment phase was also 
influenced by vitamin type. There was considerably less vitamin A (around 12%) in the 
sediment phase than for vitamin D (around 17-24%) and vitamin E (around 19-30%). 
This effect may be because the non-esterified form of vitamin A was smaller and less 
hydrophobic than the other vitamins and was therefore more easily solubilized within 
mixed micelles rather than the sediment. 
Vitamin bioaccessibility depends on the release of the vitamins from the interior of 
the oil droplets, followed by their solubilization within the mixed micelles. The impact of 
vitamin type on bioaccessibility clearly depended oil droplet size. For the fine emulsions, 
lipid digestion was complete and the vitamins were fully released. In this case, the 
bioaccessibility was mainly determined by the ability of the vitamins to be incorporated 
into the mixed micelles. As a result, the bioaccessibility of vitamin A was much higher 
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than that of vitamin D and vitamin E acetate because the smaller vitamin A molecules 
could be solubilized more easily. In contrast, for the large emulsions, lipid digestion was 
incomplete and some of the more hydrophobic vitamins remained trapped within the non-
digested oil phase. In particular, vitamin E acetate and vitamin A palmitate showed less 
release and higher accumulation within the oil droplets. However, there was more 
vitamin D and vitamin E acetate in the sediment phase than vitamin A. Overall, vitamin E 
acetate had the lowest bioaccessibility, followed by vitamin A, then vitamin D for the 
large emulsions. The vitamin E acetate was also lowest in the medium emulsion, except 
that the bioaccessibility of vitamin D was higher than that of vitamin A in this case. 
Among all the vitamins, the bioaccessibility of vitamin E acetate was most strongly 
impacted by the size of the oil droplets in the emulsions. 
 
Figure 9.9 The Schematic diagram describing the impact of oil droplet size and vitamin 
type on the bioaccessibility of oil soluble vitamins: (a) large oil droplet size reduces the 
enzyme absorption on the interface, inhibits lipid digestion process as well as the release 
of the vitamins; and it also influences the vitamin micellization process; (b) the size and 
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hydrophobicity of the vitamins influence their release from the oil droplets and the 
solubilization into the micelle structures. The 3D structure of the oil soluble vitamins was 
obtained from National Center for Biotechnology Information, U.S. National Library of 
Medicine. 
9.4 Conclusions 
Emulsions of different oil droplet sizes were successfully prepared using different 
homogenization methods. The oil droplets were resistant to aggregation in the mouth, 
stomach, and small intestine before lipase addition, but were digested after lipase was 
added to the small intestine phase. The good stability of the oil droplets to aggregation 
under GIT conditions was attributed to the strong steric repulsion generated by the 
saponin molecules that coated them. However, the surface charge of the oil droplets 
depended on the pH of the different GIT regions, due to changes in surface composition 
and ionization. As expected, the rate of lipid digestion increased with decreasing droplet 
size because of the increase in specific surface area. Complete lipid digestion was 
measured in the fine and medium emulsions by the end of the small intestine phase, but 
not for the large emulsions. Consequently, the release of the hydrophobic vitamins was 
suppressed in the large emulsions because they tended to accumulate in the non-digested 
oil phase. Moreover, the incorporation of the vitamins into the mixed micelle phase was 
reduced in the large emulsions, which was attributed to fewer mixed micelles being 
formed. As a result, more of the vitamins released from the large droplets ended up in the 
sediment phase after lipid digestion. In combination, these two effects caused the 
bioaccessibility of the vitamins to decrease with increasing oil droplet size. 
The chemical stability of the vitamins in the GIT depended on vitamin type. The 
vitamin A palmitate was the least stable, followed by vitamin D and vitamin E acetate. 
Furthermore, vitamin type also impacted the bioaccessibility of the vitamins. For the 
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large emulsions, vitamin D was released more easily from the oil droplets than vitamin E 
acetate and vitamin A palmitate, which was attributed to it lower hydrophobicity and 
molar mass.  After release, the esterified vitamins were exposed to pancreatic enzymes in 
the gastrointestinal fluids, which partially hydrolyzed them. Vitamin A palmitate was 
almost completed hydrolyzed to vitamin A, while most of the vitamin E acetate remained 
in the esterified form. Vitamin type also impacted the incorporation of the vitamins into 
the mixed micelles or sediment. More sedimentation and less micelle solubilization were 
observed for vitamin E acetate and vitamin D than for vitamin A. 
Overall, this study enriches our understanding about the physiochemical 
mechanisms that contribute to the bioavailability of oil-soluble vitamins vehiculated 
within emulsion-based delivery systems. In particular, it highlights the importance of 
incorporating this type of vitamin within small oil droplets so as to increase their 
bioaccessibility. It also shows that the molecular characteristics of specific oil-soluble 
vitamins influences their bioaccessibility, which should be considered when designing 
delivery systems. The knowledge generated in this study may be used to design 
functional foods and supplements with enhanced vitamin bioavailability and therefore 
efficacy. In future, it would be recommended to test the impact of vitamin type and 
droplet size on bioavailability using in vivo animal and human feeding studies. 
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CHAPTER 10 
CONCLUSIONS AND FUTURE WORK 
The impact of different food matrix effects on vitamin and nutraceutical 
bioaccessibility encapsulated within model food emulsions was investigated using an in 
vitro digestion system. Specially, food matrix effects such as oil concentration, oil droplet 
size, emulsifier type, oil digestibility, calcium level and chitosan concentration were 
evaluated, and they could influence the bioaccessibility of lipophilic nutraceuticals to 
different degrees. 
In the experiment of oil concentration, almost complete lipid digestion was observed 
in all of the emulsions at the end of the small intestine phase when the standardized in 
vitro digestion model (INFOGEST) was used. The bioaccessibility of the β-carotene 
increased from 60.5% to 93.2% when the oil concentration was raised from 2.5% to 
10 %, but then decreased to 80.3% when the oil concentration was further raised to 20%. 
This effect was ascribed to the precipitation of some of the long-chain fatty acids at 
higher oil concentrations. 
In the second experiment on oil droplet size, the initial rate and final degree of lipid 
digestion increased with decreasing droplet size. The incomplete lipid digestion degree of 
large sized samples led to a reduction in carotenoids bioaccessibility. Moreover, some of 
the carotenoids may have formed dense crystals that were trapped in the sediment phase, 
leading to less bioaccessibility. 
In the third experiment on emulsifier type, several different factors were shown to 
contribute to the overall bioaccessibility of the carotenoids, including chemical 
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degradation, lipid digestion, mixed micelle formation, carotenoid crystallization, and 
sedimentation processes. Emulsifier type impacted each of these processes differently, 
which influences the final level of carotenoids present in a form suitable for absorption 
by the human body. Particularly, this research showed that synthetic or natural surfactants 
(Tween 20 or quillaja saponin) gave the highest bioaccessibility because they made small 
lipid droplets (high surface area) that were stable to aggregation when they entered the 
small intestine, whereas lysolecithin gave the lowest bioaccessibility because it formed 
large oil droplets (low surface area) that were digested more slowly. 
In the fourth experiment on oil digestibility, vitamin D dissolved in digestible oil 
could be released from the oil droplets and solubilized within the mixed micelles formed, 
whereas vitamin D in the non-digestible oil could not be liberated and remained trapped 
inside the oil phase throughout the digestion process. However, for digestible oil droplets, 
the bioaccessibility reached a maximum value and then decreased steeply in the small 
intestine, because insoluble calcium soaps formed overtime to trap some of the vitamins. 
In the fourth experiment on calcium concentration, the presence of calcium was 
found not to influence the lipid digestion degree, but it did change the ionization state of 
the carboxylic acid groups on the free fatty acids. Besides, increasing the level of calcium 
in the small intestine phase decreased the bioaccessibility of the carotenoids, which was 
attributed to the ability of the cationic calcium ions to precipitate the anionic b-carotene-
loaded mixed micelles. 
In the sixth experiment on chitosan addition, it was shown that chitosan induced 
severe droplet flocculation in the small intestine phase but this did not reduce the final 
lipid digestion degree. The presence of chitosan (0.1 to 0.5%) decreased the 
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bioaccessibility of vitamin D3 by about 37% when compared to the samples containing 
no chitosan, with the chitosan level used not having a major effect. Cationic chitosan 
molecules bind to anionic vitamin-loaded mixed micelles, leading to the formation of 
insoluble precipitates that are removed from the mixed micelle phase. 
The seventh experiment investigated the impact of oil droplet size on the 
gastrointestinal fate of different oil-soluble vitamins (A, D, E). All the vitamins behaved 
similarly but to different degrees. Increasing oil droplet size reduced vitamin 
bioaccessibility by inhibiting the digestion and release process. The vitamins with the 
highest hydrophobicity (vitamin A palmitate and vitamin E acetate) were located in the 
inner core of the oil droplets, which reduced their release rate. The vitamins with 
relatively large molecular weights, such as vitamin E acetate, could not be fully 
accommodated in the mixed micelles, which reduced their bioaccessibility. In addition, 
vitamin A palmitate was greatly hydrolyzed by lipase under GIT conditions, whereas 
vitamin E acetate was only slightly hydrolyzed. 
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Figure 10.1 The schematic conclusion of the thesis: (a) the food matrix effect influences 
the digestion process including the lipid digestion, nutraceutical bioaccessibility and 
potentially their absorption; (b) The factors should be tailored to prepare emulsified food 
products with lipophilic vitamin fortification. 
In future, there are several interesting areas that worth further investigation. 
• The impact of different oil type, such as long chain oils and medium chain oils, 
needs further investigation. 







•  Oil concentration
ü Higher than 2.5%; less than 20%
•  Oil droplet size
ü ~ 0.1 μm
•  Emulsifier type
ü Stable emulsifiers (Tween, Gum 
Arabic, Saponin)
•  Oil type
ü Digestible oils
•  Calcium concentration
ü Low calcium level
•  Chitosan concentration
ü Low chitosan level
• Vitamin type
ü Low hydrophobicity and molecular weight
(stability)
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• Other dietary fibers, such as carrageenan and alginate, could also significantly 
influence the bioaccessibility and bioavailability of oil soluble vitamins. 
• New techniques could be used for further understanding the mechanisms of 
different food matrix effects. For example, computer simulation could be used to 
understand the micellization and sedimentation process of those release oil soluble 
vitamins. 
• It would be useful to examine the digestion and bioavailability of nutraceuticals 
and vitamins using more realistic models, such as cell cultures, animal models, or 
human feeding studies.  
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